Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.7190867616346138,-2.476791604831198,0.0,0.0,0.0,17/29,18.40%,GRIA4;GABRB2;GABRB3;GRIK2;GLRA3;GRIK3;GRIK4;GABRG3;GRID2;GABRA2;GRID1;GABRA1;GABRB1;GLRA2;GABRE;GRIA2;GABRG2
prerank,glutamate receptor activity (GO:0008066),-0.749339020187089,-2.262424825474178,0.0,0.0032200173451600992,0.006,10/19,5.58%,GRIA4;GRM7;GRIK2;GRIK3;GRIK4;GRM1;GRID2;GRM5;GRID1;GRM3
prerank,ligand-gated anion channel activity (GO:0099095),-0.6984412152422435,-2.1417429884909343,0.0,0.00858671292042693,0.021,11/17,18.40%,GABRB2;GABRB3;GLRA3;GABRG3;GABRA2;GABRA1;GABRB1;GLRA2;GLRA1;GABRE;GABRG2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6837463077613894,-2.078464835602911,0.0,0.012611734601877055,0.041,10/19,18.40%,GRIK2;GRIK3;GRIK4;GABRG3;GRID2;GABRA2;GRID1;GABRA1;GABRE;GABRG2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6861622941830512,-1.9035629048464517,0.0037735849056603774,0.08157377274405585,0.299,8/12,18.40%,GABRB2;GABRB3;GABRG3;GABRA2;GABRA1;GABRB1;GABRE;GABRG2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.7127562476454439,1.8309704585895155,0.0,0.09949855623880628,0.089,9/26,12.13%,LGALS3;MGAT5;PPP1R14A;PPP1R9B;CABIN1;SAG;PPP1R14B;BOD1L1;PPME1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6879622269829111,1.8131017364101634,0.0,0.06994452963322026,0.124,17/32,19.43%,MFSD12;SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC6A19;SLC6A14;SLC36A4;SLC36A3;SLC6A7;SFXN1;SLC1A5;SLC7A8;SFXN2;SLC43A2;SLC38A7;SLC38A2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6380859876005862,-1.8085208992375668,0.00819672131147541,0.14597411964725782,0.526,8/13,18.40%,GLRA3;GABRG3;GABRA2;GABRA1;GLRA2;GLRA1;GABRE;GABRG2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6703181185041618,-1.7967753004283429,0.014336917562724014,0.13784740920471092,0.568,7/11,26.36%,KCND3;KCNJ3;KCNH2;KCNQ1;KCNE3;KCNE4;KCNJ5
prerank,serotonin receptor activity (GO:0099589),-0.5259868358672491,-1.7817688515809362,0.005319148936170213,0.10819258279737932,0.614,6/22,8.20%,CHRM2;HTR2A;HTR2C;CHRM3;HRH2;HTR1F
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5259868358672491,-1.7817688515809362,0.005319148936170213,0.10819258279737932,0.614,6/22,8.20%,CHRM2;HTR2A;HTR2C;CHRM3;HRH2;HTR1F
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5259868358672491,-1.7817688515809362,0.005319148936170213,0.10819258279737932,0.614,6/22,8.20%,CHRM2;HTR2A;HTR2C;CHRM3;HRH2;HTR1F
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5746077614165843,-1.7730669794571994,0.013513513513513514,0.10626057239028329,0.639,7/17,4.46%,GRIA4;GRIK2;GRIK3;GRIN2A;GRIA3;GRIK4;GRIN2B
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6362324565778026,1.7583065627145904,0.0,0.12314177752327508,0.298,21/47,20.39%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;PDPN;SLC7A11;SLC6A19;SLC6A14;SLC36A4;SLC36A3;SLC7A6;SLC1A5;SLC38A11;SLC7A8;SLC43A2;SLC38A7;SLC38A10;SLC16A2;SLC38A2;SLC25A44
prerank,phosphatase inhibitor activity (GO:0019212),0.7174576558756269,1.753839720556643,0.0,0.10417794378469074,0.324,7/20,12.13%,LGALS3;MGAT5;PPP1R9B;CABIN1;SAG;BOD1L1;PPME1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5705546911345626,-1.7500178801503865,0.014285714285714285,0.10609544329565967,0.693,8/17,17.93%,EPHA6;EPHA4;EPHB1;EPHA5;EFNA3;EPHA2;EPHB6;EPHB4
prerank,ephrin receptor activity (GO:0005003),-0.5705546911345626,-1.7500178801503865,0.014285714285714285,0.10609544329565967,0.693,8/17,17.93%,EPHA6;EPHA4;EPHB1;EPHA5;EFNA3;EPHA2;EPHB6;EPHB4
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6605207426480556,-1.7456847492987064,0.031007751937984496,0.1025038854875965,0.707,6/11,20.80%,KCND2;KCND3;KCND1;KCNK2;KCNQ1;KCNIP2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.7612063610551615,1.7344706075469871,0.0,0.10278233697276029,0.44,8/16,4.99%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.7612063610551615,1.7344706075469871,0.0,0.10278233697276029,0.44,8/16,4.99%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,death domain binding (GO:0070513),0.8016286593300913,1.7085595094290058,0.002699055330634278,0.1293340497644455,0.566,7/11,10.27%,BCL2;BCL2L1;MCL1;DAPL1;RACK1;BAX;DAP
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7442016160771036,1.6963966024317036,0.0012919896640826874,0.13508652994303277,0.631,5/14,22.05%,RDH12;DHRS3;DHRS9;AKR1A1;RDH10
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6564147627416519,-1.6845060735575963,0.03571428571428571,0.14683279093930052,0.837,8/10,34.39%,SLC6A11;SLC6A1;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,cation transmembrane transporter activity (GO:0008324),0.6014770619036564,1.6819709349277734,0.0010869565217391304,0.14930256403710868,0.712,20/48,22.42%,MFSD12;SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;SLC6A14;SLC36A4;SLC36A3;SLC6A7;SLC22A3;SFXN1;SLC1A5;SLC8B1;SLC7A8;SFXN2;SLC38A7;SLC38A2;SLC7A2;SLC39A1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.6852475919776652,1.6811271336810858,0.0035714285714285713,0.13624406265175157,0.716,8/22,4.99%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,receptor antagonist activity (GO:0048019),0.7240717875667334,1.673791657202084,0.0025348542458808617,0.13953082864091826,0.757,4/17,11.65%,DKK2;WFIKKN1;LRPAP1;CCL5
prerank,GABA receptor activity (GO:0016917),-0.5180734054363062,-1.673296058432408,0.017142857142857144,0.14845621635081874,0.858,10/21,18.40%,GABRB2;GABRB3;GABRG3;GABRA2;GABBR1;GABRA1;GABRB1;GABRR2;GABRE;GABRG2
prerank,translation initiation factor activity (GO:0003743),0.628041159671365,1.6648919122342811,0.0,0.1459640536242554,0.796,25/36,27.67%,EIF3L;EIF4A1;EIF1;AGO2;EIF3A;EIF4G1;EIF4G2;EIF2S1;EIF2A;EIF4G3;EIF5B;EIF3M;EIF4E2;EIF2B2;EIF3E;EIF2S2;EIF4A2;EIF3B;EIF2B4;EIF3H;EIF3I;EIF3G;EIF1B;EIF4E;EIF2D
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.6742824197945029,1.658079215117981,0.0025252525252525255,0.13841135793616122,0.821,7/21,12.99%,CDK14;CDK6;CDK8;CDK5;CDK13;CDK11B;CDK2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.6742824197945029,1.658079215117981,0.0025252525252525255,0.13841135793616122,0.821,7/21,12.99%,CDK14;CDK6;CDK8;CDK5;CDK13;CDK11B;CDK2
prerank,GTPase inhibitor activity (GO:0005095),0.7370777467617357,1.6526672616270788,0.010296010296010296,0.13890392504625432,0.845,6/13,12.48%,IQGAP1;IPO5;RTKN;CPEB2;CDC42SE1;IQGAP2
prerank,wide pore channel activity (GO:0022829),0.6545996147339921,1.643733752686457,0.00849514563106796,0.14850898369306978,0.879,7/23,18.72%,GJB2;PANX3;PANX1;PRF1;GJD2;GJC2;GJB6
prerank,phosphotyrosine residue binding (GO:0001784),0.6057757466952504,1.6332022885828095,0.0034129692832764505,0.16109841953633167,0.901,10/37,8.41%,BCAR3;LCK;STAP1;SH3BP2;ABL2;FGR;NCK2;GRB2;CRKL;SAMSN1
prerank,semaphorin receptor activity (GO:0017154),0.7692372767940834,1.6317883855644333,0.004087193460490463,0.15554174743162127,0.908,5/11,10.12%,PLXNC1;NRP2;PLXNA2;NRP1;PLXND1
prerank,cholesterol transfer activity (GO:0120020),0.6880796459319772,1.6285757536212957,0.0076824583866837385,0.15414758087439867,0.918,7/16,19.48%,ABCG1;ABCA1;APOA2;OSBPL2;GRAMD1B;NPC2;STARD4
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5874927480688075,1.620018545063739,0.004429678848283499,0.16466518490412346,0.944,11/42,8.41%,BCAR3;LCK;STAP1;SH3BP2;ABL2;FGR;FBXW7;NCK2;GRB2;CRKL;SAMSN1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.4753156455178035,-1.6162278358781779,0.02127659574468085,0.2007144145149795,0.929,11/28,18.40%,GRIK2;GRIK3;GRIK4;GABRG3;GRID2;GABRA2;GRID1;GABRA1;GABRE;CHRNA7;GABRG2
prerank,chemoattractant activity (GO:0042056),0.6429785704725558,1.6134028397875606,0.007134363852556481,0.17089733162563472,0.954,7/26,11.65%,LGALS3;GPNMB;FGF2;VEGFA;DEFB130A;FGF7;CCL5
prerank,phospholipase inhibitor activity (GO:0004859),0.757031102365811,1.6116375519590584,0.016973125884016973,0.16693547149337076,0.96,4/10,11.04%,ANXA5;ANXA1;ANXA4;APOC1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5939225383997034,1.6062143118023864,0.006756756756756757,0.17137052238978215,0.968,23/37,30.65%,EPRS1;AARS1;VARS1;VARS2;CARS1;LARS2;GARS1;RARS1;EARS2;FARSA;SARS2;SARS1;FARSB;FARS2;NARS1;YARS1;LARS1;TARS1;TARS2;RARS2;MARS2;NARS2;QARS1
prerank,channel activity (GO:0015267),0.5875414671057104,1.5963291567166702,0.0033783783783783786,0.18655979294776176,0.976,7/41,9.98%,BCL2;PDPN;PANX3;PANX1;TMEM120B;PRF1;BAX
prerank,neuropeptide binding (GO:0042923),-0.508513777770336,-1.5904852943645156,0.018779342723004695,0.22230045671771947,0.947,5/18,17.95%,GPR37;SORL1;GPR149;OPRD1;SSTR2
prerank,cAMP binding (GO:0030552),-0.6106644502261371,-1.5851600872389702,0.03558718861209965,0.21709695890263617,0.952,7/11,20.54%,PDE10A;RAPGEF2;HCN1;PDE4D;POPDC3;PDE2A;PDE4B
prerank,ligand-gated channel activity (GO:0022834),-0.458876783632738,-1.5775611693786027,0.019736842105263157,0.2157948290814793,0.957,9/29,5.48%,GRIA4;GRIK2;GRIK3;GRIN2A;GRIA3;GRIK4;GRID2;GRIN2B;GRID1
prerank,ligand-gated ion channel activity (GO:0015276),-0.458873371413638,-1.5773739235176423,0.013986013986013986,0.20577444177165968,0.957,9/30,5.48%,GRIA4;GRIK2;GRIK3;GRIN2A;GRIA3;GRIK4;GRID2;GRIN2B;GRID1
prerank,gap junction channel activity (GO:0005243),0.6342251995031519,1.5751224184471793,0.013546798029556651,0.23355562092174448,0.993,6/22,18.72%,GJB2;PANX3;PANX1;GJD2;GJC2;GJB6
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7222349820453695,1.5745553558732133,0.013386880856760375,0.22677031953132354,0.994,4/12,9.57%,CDK6;CDK8;BRD4;CDK13
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7338338473075782,1.572755915250153,0.02130492676431425,0.2229322253828773,0.994,4/11,4.27%,SLC23A1;SLC23A2;SLC5A1;SLC17A5
prerank,alanine transmembrane transporter activity (GO:0022858),0.7167297369381438,1.5705943285402255,0.01706036745406824,0.2209515322417622,0.994,5/12,5.05%,SLC3A2;SLC6A6;SLC6A14;SLC36A4;SLC36A3
prerank,SH2 domain binding (GO:0042169),0.599503291522852,1.5674129178829994,0.015046296296296295,0.2216212293963715,0.996,11/31,9.53%,SH3PXD2B;LCK;LAX1;SKAP1;DAG1;SQSTM1;BLNK;DLC1;INPPL1;LILRB1;RACK1
prerank,cholesterol binding (GO:0015485),0.5624366624330034,1.566799233786359,0.00544069640914037,0.2161056101015129,0.996,16/47,19.63%,OSBPL8;ABCG1;ABCA1;SIDT1;VDAC2;APOA2;SOAT1;CAV1;ANXA6;SOAT2;OSBPL2;NPC1;GRAMD1B;NPC2;STARD4;SULT2B1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5961081625150605,1.5599673253793236,0.009205983889528193,0.22651731359636254,0.997,10/35,10.28%,LCK;PEAK1;ABL2;ITK;FGR;TEC;PTK2B;TXK;PKDCC;FYN
prerank,sterol transfer activity (GO:0120015),0.653872223005635,1.559436551727544,0.02295918367346939,0.22057770898856655,0.997,8/17,23.40%,ABCG1;ABCA1;APOA2;OSBPL2;GRAMD1B;NPC2;STARD4;OSBP
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5532437036251614,1.5541935260493236,0.005434782608695652,0.22687939616409475,0.998,26/55,24.23%,SLC38A1;SLC6A6;SLC38A6;SLC7A1;PDPN;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC36A3;SLC46A1;SLC7A6;SLC16A9;SLC38A11;SLC16A3;SLC7A8;SLC38A7;SLC19A1;SLC13A3;SLC38A10;SLC16A2;SLC38A2;SLC7A2;SLC19A2;SLC16A13;SLC16A1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.5363093723094218,-1.5513096606816887,0.046296296296296294,0.226425765134667,0.977,7/15,19.81%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;CMKLR1;CCR9
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.6666497612225213,1.5503319505613586,0.028314028314028315,0.22999986587759008,0.998,4/15,12.98%,SH3PXD2B;VEPH1;SESTD1;PLEKHF1
prerank,GABA-A receptor activity (GO:0004890),-0.5050461320422215,-1.5473170619788732,0.05472636815920398,0.22129452537317668,0.978,9/18,18.40%,GABRB2;GABRB3;GABRG3;GABRA2;GABRA1;GABRB1;GABRR2;GABRE;GABRG2
prerank,carboxypeptidase activity (GO:0004180),0.5742803945007481,1.546647963324665,0.01799775028121485,0.23226650242790084,0.998,13/35,14.51%,CTSZ;CPVL;CTSA;CPA4;CPA3;AGBL5;CPXM2;AGBL2;CPA6;AEBP1;SCPEP1;CPD;BLMH
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6768042330261377,1.5427642339368868,0.011335012594458438,0.23648694252358746,0.999,8/15,23.39%,CXXC1;KMT2A;RBBP5;PRDM9;WDR5;SETD1A;SETMAR;KMT2D
prerank,protein kinase C binding (GO:0005080),0.5627746139395131,1.5415643170681115,0.01124859392575928,0.23294430520024514,0.999,14/43,16.83%,NELL2;PLEK;HDAC9;HDAC7;SQSTM1;NELL1;HSPB1;PRKCB;RACK1;YWHAG;PRKD2;TIRAP;CAVIN2;PKP2
prerank,androgen receptor binding (GO:0050681),0.6043387788865838,1.5406922745244218,0.02068126520681265,0.2291733291170004,1.0,16/25,30.91%,RNF14;DAXX;RNF6;PRKCB;KDM3A;PRMT2;PRPF6;TMF1;CALR;SMARCA4;SNW1;NSD1;KDM1A;TRIM68;TGFB1I1;EP300
prerank,protein phosphatase binding (GO:0019903),0.5117472514265758,1.5356222929040668,0.0,0.23625539388209063,1.0,26/117,12.13%,LGALS3;IQGAP1;CTNNB1;LCK;SKAP1;ANK1;SLC9A1;SIRPA;KCNN4;ADCY8;TRAF2;PPP1R9B;PTPA;SPHK1;MFHAS1;TRAF3;CD22;IKBKE;LILRB1;MVP;RACK1;VCP;BOD1L1;JUP;JAK1;PPME1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5615376711024548,1.5228782493645427,0.008869179600886918,0.2652473887851346,1.0,21/44,27.26%,CXXC1;KMT2A;DOT1L;TTLL12;KMT5A;RBBP5;SMYD3;KMT5B;PRDM9;WDR5;EED;SETD1A;SMYD2;EHMT1;SMYD1;SETMAR;NSD3;KMT2D;SMYD5;NSD1;SETDB1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.48767354746065983,-1.510255246083988,0.05365853658536585,0.2580933347072074,0.99,9/18,28.79%,ACVR2B;BMPR1B;ACVR1B;ENG;ACVR2A;AMHR2;LTBP1;BMPR2;TGFBR1
prerank,mannose binding (GO:0005537),0.6784485024297651,1.508824232332797,0.03537414965986395,0.2987119176915817,1.0,5/12,19.59%,LMAN1;MBL2;CLEC6A;LMAN2;CLEC4D
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6679557652511238,1.5055887599320026,0.033766233766233764,0.3010054154202265,1.0,5/14,9.47%,CYBA;CYBB;MICAL1;CYB5R4;NCF4
prerank,serine-type peptidase activity (GO:0008236),0.5071751727106955,1.5010831324319993,0.002066115702479339,0.3066058434593471,1.0,31/96,24.87%,PLAU;MMP8;ST14;GZMB;GZMA;TMPRSS2;MMP9;RHBDF2;PRSS8;KLK1;KLK6;CLPP;HPR;HP;F11;RHBDF1;CD5L;MASP1;GZMM;GZMK;FURIN;KLK3;PRSS53;TMPRSS7;MASP2;TPP1;PREP;PARL;TMPRSS4;CORIN;F9
prerank,protein tyrosine kinase binding (GO:1990782),0.5169270633149651,1.4996689259907736,0.011603375527426161,0.3043840846234409,1.0,26/71,16.66%,ITGAX;CD247;SIRPA;CD4;NRG1;TRIM6;ALKAL2;TJP2;SQSTM1;NEDD9;ANGPT4;LRP4;BLNK;NCK1;ANGPT1;TREM2;RACK1;PTPN2;SOCS5;ANGPT2;GAS6;CPNE3;CBL;DUSP3;CBLB;PIK3R2
prerank,lipase activator activity (GO:0060229),0.6972765989254459,1.4930660709130845,0.048582995951417005,0.31727889451463576,1.0,6/10,16.20%,LCK;PDPK1;ARHGAP6;FYN;CCL5;APOH
prerank,histone methyltransferase activity (GO:0042054),0.5592390570959115,1.492379944460768,0.023755656108597284,0.31282294683173556,1.0,17/32,24.89%,DOT1L;TTLL12;KMT5A;PRMT5;PRMT7;SMYD3;KMT5B;PRDM9;CARM1;EED;PRMT2;PRMT6;SMYD2;EHMT1;SMYD1;NSD3;NTMT1
prerank,CCR chemokine receptor binding (GO:0048020),0.5843659115547463,1.490260666931351,0.030232558139534883,0.3119731432606684,1.0,8/28,13.90%,CCL4;NES;CCL13;DEFB130A;CCR2;CCL7;CCL5;CCL14
prerank,nucleotidase activity (GO:0008252),0.6475429399127469,1.4902032570243808,0.039950062421972535,0.30555579729441995,1.0,9/15,34.20%,NT5DC2;NT5C3B;BPNT1;ACP3;BPNT2;NT5M;NT5C3A;NT5C2;NT5DC1
prerank,aspartic-type peptidase activity (GO:0070001),0.7054294019637062,1.4899107183134004,0.03611111111111111,0.300284994136757,1.0,4/10,12.24%,CTSD;NAPSA;CTSE;DDI2
prerank,protein heterodimerization activity (GO:0046982),0.4845784614127188,1.4866050251014609,0.0020100502512562816,0.3033425290797349,1.0,50/178,17.16%,BCL2;CYBA;ABCG1;HIF1A;ZHX2;CD3E;BCL2L1;ATF3;SDCBP;RRAGD;CYBB;ADCY8;IRAK2;MCL1;RALGAPA2;PDGFA;APOA2;TPM2;HEXA;PPP2R1A;ATP1A1;BHLHE40;P4HB;GTF2A2;BHLHE41;NOLC1;TPM4;SRI;BAX;METTL3;HIP1;PRMT5;FZD4;QTRT1;LSM6;DDIT3;GCA;RCC1;VAPB;SMC3;ATP1A2;BARD1;NR4A2;NPAS4;FXR2;TCOF1;PIK3R2;BMP6;DGKD;ITGA3
prerank,beta-tubulin binding (GO:0048487),0.5695324230875611,1.482586229148997,0.02402745995423341,0.30935146149572557,1.0,15/31,23.23%,FGF13;UXT;ARL8B;EML4;HTT;VAPB;SMC3;ARL8A;RACGAP1;IFT74;GJB6;CCT5;TAOK1;GABARAP;PEX14
prerank,receptor tyrosine kinase binding (GO:0030971),0.5256977614491201,1.4825392350555293,0.020342612419700215,0.303553954039298,1.0,22/56,16.66%,STAP1;ITGAX;NRG1;ALKAL2;SQSTM1;ANGPT4;LRP4;BLNK;TRAT1;NCK1;ANGPT1;RACK1;PTPN2;SOCS5;ANGPT2;GAS6;CPNE3;CBL;SH2B1;DUSP3;CBLB;PIK3R2
prerank,manganese ion binding (GO:0030145),0.5283846895825235,1.4770804989799555,0.012222222222222223,0.31487120169724986,1.0,12/48,11.69%,FAM20C;ABL2;MGAT5;LARGE1;B4GALT7;ATP13A2;DYRK2;GYG1;PAPOLA;NEK4;PIM1;PCK2
prerank,mannosyltransferase activity (GO:0000030),-0.45688761142525136,-1.4762953676723063,0.05172413793103448,0.29418078465382663,0.996,5/21,7.51%,TMTC2;TMTC3;POMT2;TMTC1;PIGV
prerank,protein phosphatase regulator activity (GO:0019888),0.5201005782803927,1.4738097946927071,0.014038876889848811,0.318690920230236,1.0,14/53,15.22%,LGALS3;MGAT5;PPP1R9B;PTPA;PPP2R5C;CABIN1;PPP2R1A;SAG;RCAN1;BOD1L1;PPME1;PPP2R2D;RCAN3;PPP1R15B
prerank,phospholipase activator activity (GO:0016004),0.6908811505146083,1.4723010283293034,0.049247606019151846,0.3175177149316506,1.0,5/10,11.65%,LCK;PDPK1;ARHGAP6;FYN;CCL5
prerank,water transmembrane transporter activity (GO:0005372),0.6876410812660515,1.4705522859681752,0.052269601100412656,0.31751227750251326,1.0,3/11,17.26%,PDPN;SLC5A1;AQP4
prerank,tRNA binding (GO:0000049),0.5365838881623477,1.4694173888528097,0.020179372197309416,0.3154676301940127,1.0,21/43,27.26%,PUS1;AARS1;THG1L;IGHMBP2;CARS1;EEF1A1;XPOT;TRMT10C;EIF2A;ALKBH1;YRDC;SARS2;SARS1;FARS2;NSUN2;MRPS27;TERT;RPUSD4;AIMP1;NAT10;ELP5
prerank,peptidase inhibitor activity (GO:0030414),0.5586830867830233,1.4660567764475398,0.029748283752860413,0.31994781561461144,1.0,12/33,22.67%,RENBP;CST7;HRG;A2M;TFPI;CAST;CSTB;PROS1;TIMP2;SERPINF2;TIMP1;USP14
prerank,MHC class II protein complex binding (GO:0023026),0.6662915761325593,1.4623361721170394,0.0639686684073107,0.32491062356954714,1.0,6/11,23.08%,CD4;PKM;ANXA11;HSPA8;HSP90AB1;CD74
prerank,nucleosomal DNA binding (GO:0031492),0.5961194200996619,1.4568198505306837,0.03907203907203907,0.3358979312761549,1.0,12/21,27.05%,HDAC1;HNRNPC;SMARCB1;GATAD2B;SMARCC1;H1-0;ACTB;RCC1;SMARCD2;HDAC2;SMARCA4;H3-3A
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5469019573733774,1.456726909014127,0.03421633554083885,0.33074670212153107,1.0,14/38,15.41%,STAP1;CD3E;LAT;DEDD2;CD3G;NCK2;BLNK;TRAT1;NCK1;SPAG9;CARD10;SAV1;SORBS1;SH2B1
prerank,Toll-like receptor binding (GO:0035325),0.6900129701739071,1.4453494760533478,0.04704301075268817,0.3590019769497907,1.0,2/11,0.36%,S100A8;S100A9
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5682027990881753,-1.444876367720381,0.06227106227106227,0.32951510832138353,0.998,5/10,18.40%,GABRG3;GABRA2;GABRA1;GABRE;GABRG2
prerank,lipoprotein particle binding (GO:0071813),0.5975307633726172,1.4446108512683553,0.03634085213032581,0.3553988977205075,1.0,4/20,7.29%,COLEC12;LPL;APOA2;TREM2
prerank,MAP-kinase scaffold activity (GO:0005078),0.6795931708597552,1.4436148767279222,0.047244094488188976,0.3528627634929448,1.0,3/11,8.63%,IQGAP1;AKAP13;SPAG9
prerank,ankyrin binding (GO:0030506),0.5942737578863704,1.4362672013838027,0.04720496894409938,0.3700618808351764,1.0,4/19,12.47%,PTPRC;CDH1;PLEC;CACNA1D
prerank,5'-nucleotidase activity (GO:0008253),0.6443829448414943,1.4329345864531169,0.057068741893644616,0.37529135906275224,1.0,7/13,34.20%,NT5DC2;NT5C3B;ACP3;NT5M;NT5C3A;NT5C2;NT5DC1
prerank,serine-type endopeptidase activity (GO:0004252),0.48690753759876804,1.4226917197336417,0.013499480789200415,0.40339040792251374,1.0,15/80,10.81%,PLAU;MMP8;GZMB;GZMA;MMP9;RHBDF2;KLK1;KLK6;CLPP;HPR;HP;F11;RHBDF1;CD5L;MASP1
prerank,mRNA binding (GO:0003729),0.45499636517039527,1.4172585630196706,0.002,0.41585702633007204,1.0,97/249,24.97%,RBM47;SNRNP35;PKM;EIF4A1;ADARB1;AGO2;SHFL;EIF3A;LUC7L2;EIF4G1;UNK;PABPC5;RPS14;NCL;CPEB4;PTBP3;RPS7;RPL41;SNIP1;RBM25;RPS26;CPEB2;ETF1;HNRNPM;FUBP1;RBM4B;GRSF1;DENR;NOCT;EIF4G2;LSM14A;CELF1;EIF2A;HNRNPC;HNRNPLL;RPS2;PABPC1;LARP4;METTL3;CPEB3;SHMT1;RBPMS;YTHDF3;DXO;LARP1;HNRNPK;PCBP4;EIF4G3;DCP1A;YBX3;SYNCRIP;HNRNPA2B1;EIF4A3;EIF4ENIF1;RBM15;RBFOX2;MRPS7;TPR;PCBP1;YTHDF2;ZC3H12B;NOVA2;C1QBP;DHX36;FXR2;PUM1;THOC2;PPIE;HNRNPU;DHX33;CNBP;CELF6;GNL3;RPL13A;DHX9;TARDBP;EIF2S2;RNF20;RPS3;CCT5;ZC3H12D;RPS13;PABPC4;SAMD4A;UPF3B;HDLBP;CALR;SLC4A1AP;RBMS2;PPP1R8;G3BP1;CPEB1;SF3B1;EDC3;HNRNPL;NUP98;KHSRP
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5021677263423108,1.4167428304142307,0.032327586206896554,0.4117147175001373,1.0,16/53,19.43%,SLC3A2;SLC38A1;SLC38A6;SLC7A1;SLC7A11;SLC36A4;SLC36A3;SLC6A7;SFXN1;SLC7A6;SLC1A5;SLC7A8;SLC43A2;SLC38A7;SLC25A18;SLC38A2
prerank,chemokine activity (GO:0008009),0.5438687253492673,1.4152793504723025,0.04844290657439446,0.41127946358173617,1.0,7/31,13.99%,CCL4;CCL13;CCL7;CCL5;CCL28;CCL14;CXCL16
prerank,protein phosphatase 2A binding (GO:0051721),0.5622935945930039,1.4114906829524594,0.07270560190703218,0.41823803942355847,1.0,7/23,15.88%,ADCY8;PTPA;SPHK1;MFHAS1;BOD1L1;PPME1;FOXO1
prerank,frizzled binding (GO:0005109),0.5288693729891991,1.400650691052921,0.040369088811995385,0.45057576395766363,1.0,8/34,14.85%,SDCBP;CCDC88C;ZNRF3;WNT6;BAMBI;MYOC;FZD1;LRP6
prerank,ferrous iron binding (GO:0008198),0.5688148347644887,1.398095788694211,0.058465286236297195,0.45368804586903955,1.0,9/21,22.17%,FTL;ACP5;HEPH;ALKBH1;CDO1;EGLN1;FTH1;ALKBH3;EGLN3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.4585651764669721,1.3951913996578869,0.010131712259371834,0.4582737891309429,1.0,47/134,24.23%,MFSD12;SLC3A2;SLC27A1;SLC26A1;SLC38A1;SLC6A6;SLC38A6;SLC25A24;SLC7A1;PDPN;SLC25A25;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC25A1;SLC36A3;SLC6A8;SLC35D2;SLC6A7;SLC22A3;SLC46A1;SFXN1;SLCO5A1;SFXN5;SLC1A5;SLC52A2;SLC2A8;SLC26A4;SLC35B1;SLC7A8;SFXN2;SLC25A21;SLC38A7;SLC19A1;SLC13A3;SLC25A18;SLC17A9;SLC38A2;SLC13A5;SLC2A6;SLC26A6;SLC7A2;SLC19A2;MPC2;SLCO2A1;SLC16A1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.6396251484156829,1.3936197078724122,0.08695652173913043,0.45811368263245505,1.0,6/11,21.33%,GNPTAB;SGMS1;PIGN;DPAGT1;AASDHPPT;SAMD8
prerank,protein kinase activator activity (GO:0030295),0.49280083562254556,1.3931404704009138,0.03111587982832618,0.4535765346415202,1.0,25/60,26.14%,IQGAP1;FGF13;ERCC6;LTF;ALS2;CD24;NRG1;DAXX;STK3;GPRC5C;GAS6;PAK2;GPRC5B;CAB39;STK11;DBF4;EPO;MARK2;TAOK1;ABI1;MAP2K2;CALM3;NCKAP1L;PARP16;RPLP1
prerank,semaphorin receptor binding (GO:0030215),-0.42754815713547717,-1.3907822860270256,0.07514450867052024,0.41458717151450214,1.0,9/23,24.41%,SEMA6D;SEMA6A;RIT2;SH3BP1;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA7A
prerank,snoRNA binding (GO:0030515),0.5350887791706587,1.3903496378304137,0.06373117033603708,0.45788270917199925,1.0,14/30,29.61%,TSR1;NUDT5;NUDT1;DDX21;BMS1;GAR1;ISG20;RRP9;DKC1;WDR3;SNU13;BYSL;NOP14;XRCC5
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.6644964314303841,1.3896115993562081,0.08163265306122448,0.4547910017267295,1.0,6/10,26.44%,CYBA;CYBB;NCF4;NCF2;NOX4;NCF1
prerank,mRNA 5'-UTR binding (GO:0048027),0.5523555600869907,1.3865498736046826,0.07913669064748201,0.4598456899188145,1.0,11/24,21.26%,RPS14;NCL;RPS7;RPL41;SHMT1;LARP1;SYNCRIP;DHX36;GNL3;CCT5;RPS13
prerank,RNA binding (GO:0003723),0.4339114881221417,1.3861478073437241,0.0,0.4554521783475853,1.0,563/1321,29.81%,LGALS3;APOBEC1;RFTN1;RBM47;MYO5A;DDX31;SNTB2;FAU;C1D;LRP1;PUS1;TSR1;FLNA;EPRS1;SLC3A2;SNRNP35;RPS12;MRPS12;AARS1;LGALS1;TMSB4X;EIF3L;PKM;MSN;EIF4A1;EIF1AX;EIF1;ADARB1;FNDC3B;RBM28;AGO2;SHFL;SYNE1;ESF1;EIF3A;ALDOA;SRPK1;RPS27A;LUC7L2;THG1L;VIM;SIDT1;MACF1;ANXA11;BRIX1;RPS6;TRUB2;EIF4G1;MBNL3;BICC1;CNOT4;UNK;PABPC5;C4BPA;GTPBP4;IMMT;CCDC9;RPS14;NCL;CMSS1;ZC3H7B;RPL10A;RPL18;HNRNPA3;NUDT5;EEF2;NSA2;CPEB4;ZNF346;DYNC1H1;RRP7A;LLPH;GRWD1;RPS24;HNRNPUL1;GOLGB1;HSPB1;DDX50;NUDT1;IGHMBP2;PTBP3;PRDX1;DDX56;DDX21;RPS7;ASCC3;RPL41;SNIP1;NOC2L;RBM25;RPL36A;RPS20;CARS1;MRPL4;UBAP2;IPO5;RPS26;EEF1A1;CPEB2;RPL23;RPL17;MRPL23;ETF1;ACTN1;RPS25;TPT1;ZCCHC9;TRIM28;GRB2;KNOP1;HNRNPM;FUBP1;RBM4B;AKAP1;XPOT;GRSF1;MEX3A;PATL1;CRKL;DENR;MAK16;MRPL21;NOCT;RPL35A;NFX1;TRMT10C;HEATR6;EIF4G2;LSM14A;RPS28;CELF1;CHCHD1;RRP12;OTUD4;PUS7;DUSP14;EIF2S1;EIF2A;RPL28;NOL8;POLR1G;CAST;XRN2;P4HB;ZFR;UBE2L3;BTF3;KRI1;SAMSN1;NOC3L;PATL2;NPM3;CHD3;HNRNPC;DDX17;PPAN;TBCA;CSTB;PSMA1;SON;HNRNPLL;RPL27A;RNASEL;PABPN1;RPL11;RPS2;LRRFIP1;ZNF326;SELENOH;DDX49;BRCA1;BMS1;NOLC1;RACK1;CDK13;UBTF;RCC1L;PABPC1;LARP4;VCP;SEC61B;WDR43;BCCIP;NOL6;METTL3;CPEB3;CHERP;FAM120A;PLEC;SYF2;SRSF11;UTP11;UTP20;ARHGEF1;MSI2;DHX34;JUN;MRM1;LONP1;ARL6IP4;ENO1;RNASEH1;RBPMS;S100A16;NVL;ALKBH1;DIAPH1;HUWE1;RPL32;DDX1;TAF15;YTHDF3;YWHAG;CFAP65;EXOSC9;TRAP1;DXO;SMNDC1;MRPS15;SRP14;SRSF7;RPL21;EXOSC10;IBA57;FTSJ3;LARP1;DHX29;SEC63;MRM3;DAP3;HNRNPK;RBM19;CDK11B;PPARGC1B;SAFB2;MRPL12;GAR1;HSPA8;RPL9;PCBP4;AGFG1;PKN2;GTF2F1;RPL36;ILF3;R3HDM1;RPL37;EIF4G3;H1-0;DCP1A;YY1;YBX3;CPNE3;DDX39B;RBM11;DDX18;RPL38;SUMO2;SYNCRIP;ISG20L2;HNRNPA2B1;PPIA;EIF4A3;DCN;POLR2D;MBNL2;LSM6;RPS18;SLC16A3;EIF4ENIF1;RBM15;RCAN3;FNDC3A;RBFOX2;MRPS7;MKRN2;PUF60;EIF5B;SART1;HSPD1;RPS19;RPS27;WBP11;TPR;HSPA9;YRDC;HELZ2;DEK;PCBP1;FARSA;YTHDF2;ZC3H12B;SRF;NOVA2;RPS23;C1QBP;BARD1;ZC3HAV1;PSMA6;TFRC;DUSP11;DHX36;PNN;DDX52;CKAP4;CHTOP;EIF4E2;FXR2;PUM1;TCOF1;RPL14;RPS16;SARS2;SARS1;MRPL11;ZNF638;PSPC1;THOC2;MYBBP1A;RBM15B;PRPF6;SRP9;UTP4;PPIE;UBAP2L;RBM39;RAE1;ZYX;RPL30;FLNB;PPP1R10;RPL31;UTP14A;HNRNPU;DHX33;CNBP;RPL12;PURA;GSPT1;DRG2;CELF6;HNRNPF;EIF3E;ACIN1;GNL3;MEX3B;KIN;RPL13A;CWC22;FARS2;KRR1;DHX9;FAM98A;RPS9;SNRNP40;CCAR2;CCAR1;LYAR;NOC4L;RPL4;ADAR;NSUN2;TARDBP;RPP25L;RNMT;ATXN2;AGO3;BST2;SRSF2;IFIT2;EIF2S2;TOP1;RRBP1;HMGB1;RAD51AP1;UBC;ZRANB2;RPS3;MTDH;ZGRF1;DUT;SRFBP1;PRRC2C;FASTKD3;ZC3H12D;MRPS35;MRPS28;ANXA7;CHD2;PPIG;EIF5A;MARK2;CPSF7;RALY;PRPF8;RRP9;RPS13;HSP90AB1;AHNAK;PABPC4;SRPK2;NPM1;MRPS30;YARS1;RPSA;EIF4A2;SND1;SAMD4A;DKC1;MRPL15;CCDC86;RPL15;TES;UPF3B;MRPS27;WDR3;GIGYF2;SREK1;HDLBP;TERT;USP36;SF3A3;CALR;CANX;NOL10;ACTN4;PFN1;PPRC1;LSM4;MRPL1;GTF2E2;MRPS14;SLC4A1AP;EIF4B;PDAP1;RSRC2;RBMS2;PPP1R8;SUCLG1;RBM26;EIF3B;XRN1;SNU13;RPP38;RBM22;POLDIP3;SRRM1;FASTKD5;MRPL37;HSPE1;G3BP1;PIN4;SNRPG;DIMT1;DQX1;RPL7A;SUMO1;SF3B2;SF3B1;RPUSD4;EDF1;AIMP1;PYM1;EIF3H;EDC3;HDAC2;HNRNPL;USO1;NUP98;TNPO1;FASN;KHSRP;RRP1B;RRP1;SNRPF;DNTTIP2;YWHAZ;TXN;RPL23A;GANAB;RPL8;ACAA2;EIF3I;LSM3;EIF3G;NAT10;HMGB3;NUP42;MAP4;R3HDM2;RPL29;SNW1;GEMIN5;ATP5F1C;MTPAP;SLTM;MAPRE1;FASTKD2;MRPL39;EIF1B;NOL3;ARC;TARBP2;PRPF40A;RPL37A;SNRPA;RC3H1;NAA15;SF3B5;CS;KDM1A;ELP5;HNRNPUL2;FUS;SUPV3L1;EIF4E;BYSL;CSTF2;MRPL41;MRPL27;GTPBP10;NQO1;SMG1;NOP14;SRSF1;DNAJC2;MEX3C;RPS15A;SRSF10;RARS2;TRMT6;DDX41;MRPL42;OASL;RIDA;SERPINH1;NUDT21;WBP4;HSP90B1;DHX57;ERI3;TRA2B;LBR;RO60;APTX;TIAL1;TENT4B;DDX59;SAFB;ZC3H15;POP1;ZC3H12C;CSNK1E;TRIP6;PRPF31;MAZ;PURB;XRCC5;TRMT2A;SUGP1;NXF1;HDGF;HMGB2
prerank,E-box binding (GO:0070888),0.5221164778205295,1.3859974761234481,0.06575963718820861,0.4502671493794263,1.0,8/34,12.66%,MITF;TCF15;PPARG;GATA3;BHLHE40;BHLHE41;PRMT5;TFAP4
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3794548691160309,-1.3835861731127939,0.050359712230215826,0.4130822251362527,1.0,16/32,25.25%,KCNB2;KCNA6;KCNB1;KCNQ3;KCNH1;KCNC2;KCNS3;KCNH2;KCNC1;KCNC3;KCNG2;KCNQ1;KCNG1;KCNE3;KCNE4;KCNG3
prerank,solute:anion antiporter activity (GO:0140323),0.6227950115760352,1.3815816459184398,0.0783289817232376,0.4606824000885372,1.0,6/14,21.90%,SLC26A1;SLC7A11;SLC26A11;SLC26A4;SLC4A2;SLC26A6
prerank,ribosome binding (GO:0043022),0.5046776942381276,1.3806648066673952,0.048943270300333706,0.4579449833427011,1.0,24/46,27.11%,SHFL;EIF6;EEF2;CPEB4;IGHMBP2;CPEB2;ETF1;EIF2S1;EIF2A;NAA16;RACK1;SEC61B;CPEB3;YTHDF3;EFL1;C1QBP;RPSA;MRPS27;CPEB1;PYM1;GTPBP6;TMCO1;GEMIN5;NAA15
prerank,sterol binding (GO:0032934),0.4878413154943928,1.3792973234242856,0.04021739130434782,0.45741892845145704,1.0,16/56,19.63%,OSBPL8;ABCG1;ABCA1;SIDT1;VDAC2;APOA2;SOAT1;CAV1;ANXA6;SOAT2;OSBPL2;NPC1;GRAMD1B;NPC2;STARD4;SULT2B1
prerank,Tat protein binding (GO:0030957),0.6703721483071935,1.3792511671358376,0.08309859154929577,0.4522345561372418,1.0,6/10,25.02%,MDFIC;SMARCB1;ACTB;NPM1;DNAJA1;SMARCA4
prerank,SUMO transferase activity (GO:0019789),0.5931857584216195,1.377874137510381,0.08343868520859671,0.4516840399553731,1.0,10/16,32.10%,NSMCE2;HDAC4;TRIM28;EGR2;RANBP2;PIAS1;MDM2;PIAS4;MUL1;PIAS3
prerank,ion channel activity (GO:0005216),-0.32570506405040167,-1.374593114529638,0.021739130434782608,0.415604307687388,1.0,21/80,11.76%,GRIA4;TRPM3;UNC80;GRIK2;GRIK3;GRIN2A;GRIA3;CALHM2;GRIK4;GRID2;TMEM63A;GRIN2B;GRID1;ABCC9;TRPM4;LRRC8A;MCOLN1;TRPM6;TRPV4;GRIN1;GABRB1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.5281659585004786,-1.3731354216532483,0.14035087719298245,0.40386173102408,1.0,5/10,24.04%,KAT2B;CDKN2C;CDKN2D;CDKN1B;HEXIM2
prerank,pseudouridine synthase activity (GO:0009982),0.6043376026204127,1.3634579161694877,0.0994550408719346,0.49713043297511234,1.0,6/13,24.52%,PUS1;TRUB2;PUS7;DKC1;RPUSD1;RPUSD4
prerank,phospholipase binding (GO:0043274),0.6092237334465389,1.3621087019497844,0.11559139784946236,0.49645167343860735,1.0,8/13,24.73%,LCK;BLNK;PDPK1;ARHGAP6;FYN;SYK;WAS;BTK
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4562619492983961,1.359997494081593,0.035306334371754934,0.49854432895715145,1.0,15/85,10.85%,LPL;AARS1;PLAAT3;CEL;LIPA;GDPD3;PRDX6;PNPLA7;PON1;ABHD12;MGLL;PGLS;PGAP1;ABHD5;PAFAH2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6056808417604027,1.3587821826511872,0.1111111111111111,0.4975803486802702,1.0,4/13,7.03%,ITGA5;PDGFA;ERN1;VEGFA
prerank,phosphatase binding (GO:0019902),0.45417258594568866,1.3573080798847414,0.0326530612244898,0.49750360684480266,1.0,22/105,14.59%,LGALS3;IQGAP1;CTNNB1;LCK;SKAP1;ANK1;SIRPA;KCNN4;TRAF2;TRAF3;CD22;IKBKE;MVP;RACK1;VCP;JUP;JAK1;PPME1;SYTL2;GTF2F1;SH2D4A;RCAN3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4990960908540264,1.3523942786155743,0.08987485779294653,0.5099997025981345,1.0,8/38,12.98%,SH3PXD2B;TECPR1;RUFY4;WDR45;NCF4;HIP1;SESTD1;PLEKHF1
prerank,potassium ion leak channel activity (GO:0022841),-0.4614912084807334,-1.351586552718864,0.11203319502074689,0.4304782328212421,1.0,8/15,20.95%,KCNK12;KCNK1;KCNK5;KCNK2;KCNK10;KCNK6;KCNK4;KCNK7
prerank,cyclic nucleotide binding (GO:0030551),-0.41560193891985264,-1.3503065362245958,0.07653061224489796,0.4192395499703758,1.0,9/21,21.18%,PDE10A;RAPGEF2;HCN1;KCNH1;PDE4D;POPDC3;PDE2A;PDE4B;PDE5A
prerank,actin binding (GO:0003779),0.4396421306658951,1.3433222239294373,0.014184397163120567,0.5391332394687837,1.0,35/170,12.85%,GAS2L3;LCP1;MYO9B;MICAL2;ABL2;MRTFA;MYO1F;TMSB4X;TNNT3;DAG1;COTL1;ADCY8;SYNE1;ALDOA;MACF1;PDLIM1;SCIN;TPM2;SPATA32;MICAL1;CAP1;MSRB1;FXYD5;TLNRD1;KCNMA1;MTSS1;TMSB10;P4HB;CORO7;ABLIM1;BCL7B;PARVA;GSN;IQGAP2;UTRN
prerank,copper ion binding (GO:0005507),0.4878648602576295,1.3428907178874365,0.08968609865470852,0.5351479647379572,1.0,7/42,7.57%,P2RX4;ATP7A;AOC2;ATP13A2;RNF7;ATOX1;HEPH
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.501128781051944,1.3425963966533816,0.06469920544835414,0.530582921158391,1.0,11/38,17.58%,HRG;SERPINA10;A2M;TFPI2;SERPINB9;TFPI;SERPINE2;SERPINE1;FURIN;SPINK5;SERPINF2
prerank,syntaxin-1 binding (GO:0017075),-0.42775895579672535,-1.3390280316491572,0.1282051282051282,0.42757927292398645,1.0,7/22,10.36%,SNAP25;CPLX1;LRRK2;UNC13B;SYT1;STXBP3;STXBP1
prerank,phospholipase activity (GO:0004620),0.45491823012834876,1.3376811523687477,0.06256627783669141,0.5431270715811984,1.0,13/67,8.69%,LPL;PLD3;DDHD1;PLAAT3;PLCB4;GDPD3;PRDX6;PNPLA7;ABHD12;MGLL;NAPEPLD;PLCB2;SMPD4
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5232048004103717,-1.3363033561455044,0.13409961685823754,0.4209699146834306,1.0,4/10,10.78%,DPP10;DPP6;PRCP;NAALAD2
prerank,MHC class I protein binding (GO:0042288),0.591668117869625,1.33580986984633,0.12466124661246612,0.5442815786414318,1.0,6/13,17.54%,CD8B;CD8A;TAPBP;LILRB1;DERL1;TUBB
prerank,ATPase binding (GO:0051117),0.46147511842855765,1.33565265350021,0.05064655172413793,0.5393308283819392,1.0,13/71,9.30%,LCK;ANK1;ABCA1;TCIRG1;ATP1B3;ATP6V0A1;ATP6V1G1;CAV1;CLPP;TOR1AIP2;CHMP4A;ATXN3;SNX10
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6210870429272223,1.3311344978002482,0.13443072702331962,0.5510681614110264,1.0,7/11,22.07%,PRMT5;PRMT7;CARM1;PRMT2;PRMT6;PRMT3;FBXO11
prerank,sialyltransferase activity (GO:0008373),-0.4196637507985472,-1.3305333203045018,0.10476190476190476,0.4189395900212582,1.0,4/20,3.96%,ST3GAL6;ST3GAL5;ST8SIA4;ST6GAL2
prerank,actin monomer binding (GO:0003785),0.5443306556983061,1.3299941014308454,0.10157194679564692,0.5500004351299559,1.0,5/22,7.97%,ABL2;MRTFA;TMSB4X;MTSS1;TMSB10
prerank,rRNA binding (GO:0019843),0.4831633548223768,1.3293153073550108,0.080773606370876,0.5468762916574249,1.0,18/42,26.83%,RPS14;DDX21;RPL23;PPAN;RPL11;RCC1L;MRPS7;MRPL11;TST;RPL12;RPS9;RPS3;RPS13;MRPS27;FASTKD5;MDM2;MRPL18;FASTKD2
prerank,alpha-actinin binding (GO:0051393),0.5309554230096873,1.3292531311211757,0.11750599520383694,0.5417079229588591,1.0,6/24,13.14%,DAG1;PDLIM1;PPARG;MAGI1;CACNA1D;PALLD
prerank,thioesterase binding (GO:0031996),0.6225782870371178,1.3282587912417778,0.11512717536813923,0.5400926629096561,1.0,4/11,12.86%,TRAF2;TRAF3;TRAF1;CDC42
prerank,ATP binding (GO:0005524),0.42614980505059663,1.3278848134785868,0.002002002002002002,0.5362066615584641,1.0,87/266,23.15%,MYO9B;PEAK1;ABCG1;CDK6;ERCC6;ABCA1;MYO1F;P2RX4;AARS1;ATP7A;SRPK1;MLKL;THG1L;GCK;PTPA;EIF4G1;HSPA4;SPHK1;MAP4K5;MAP4K2;DYRK2;ABCD4;IGHMBP2;CARS1;ERN2;STK3;PI4K2A;ERN1;SIK1;MAP4K3;ATP1A3;ATP1A1;PDXK;PAPOLA;MTHFS;PFKL;P2RY1;PGK1;LONP1;PIM1;NVL;ABCD2;CDK11B;BLM;HSPA8;EIF4A3;PFKP;DAPK1;HSPA9;AK6;CAD;ATP1A2;STK38;ABCD3;DHX36;MINK1;TLK1;SARS2;PRKAG1;STK11;KIFC1;EIF2B2;HNRNPU;NLK;NEK6;OLA1;DAPK3;RTEL1;DHX9;TOP1;PDK3;MCM6;TRIP13;MARK2;LMTK2;HSP90AB1;PRAG1;SRPK2;MARK4;RUNX3;NIM1K;TAOK1;PRPS2;LATS1;CLPX;PMVK;TARS1
prerank,potassium channel activity (GO:0005267),-0.3035077189389024,-1.3275285899329212,0.07407407407407407,0.41263925978718313,1.0,35/89,21.42%,GRIK2;KCND2;KCNB2;GRIK3;KCNK12;KCNA6;KCND3;GRIK4;KCNB1;KCNQ3;KCND1;KCNH7;HCN1;KCNMB2;ABCC9;KCNK1;KCNH1;KCNN2;KCNC2;KCNS3;KCNK5;KCNK2;KCNK10;KCNH2;KCNC1;KCNC3;KCNK6;KCNK4;KCNH4;KCNG2;KCNN1;KCNQ1;KCNK7;KCNG1;LRRC55
prerank,CoA-ligase activity (GO:0016405),0.5837803158731901,1.325589234843513,0.12062256809338522,0.5396565258180007,1.0,5/14,15.13%,ACSBG1;SLC27A5;ACSBG2;ACSL1;AACS
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5575129065823617,1.3254198792465288,0.1175030599755202,0.5352531617281496,1.0,8/19,13.29%,ERCC6;CD24;NRG1;ALKAL2;ANGPT4;CCL5;GAS6;PAK2
prerank,histone methyltransferase binding (GO:1990226),0.6229419169247131,1.3244780192175978,0.1313969571230982,0.533648127761052,1.0,4/11,21.40%,CTNNB1;PHF1;CBX3;HSP90AB1
prerank,alkali metal ion binding (GO:0031420),0.5847301285945316,1.320600551591693,0.13593539703903096,0.5427542256436974,1.0,6/13,15.47%,HDAC4;ATP1A1;PDXK;DRG1;ATP1A2;ACAT1
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3068253442418498,-1.320172172725656,0.04878048780487805,0.41465700839386,1.0,30/80,21.42%,KCND2;KCNB2;KCNA6;KCND3;KCNJ3;KCNB1;KCNQ3;KCND1;KCNH7;HCN1;KCNK1;KCNN3;KCNH1;KCNN2;KCNC2;KCNJ13;KCNS3;KCNK2;KCNH2;KCNC1;KCNC3;KCNJ12;KCNK6;KCNH4;KCNG2;KCNN1;KCNQ1;KCNIP2;KCNG1;LRRC55
prerank,sequence-specific mRNA binding (GO:1990825),0.6299749005202605,1.3179735984708731,0.11827956989247312,0.5471742748487428,1.0,3/10,18.62%,SHFL;ETF1;DHX9
prerank,lipase activity (GO:0016298),0.4717070307117968,1.317066966043593,0.1106145251396648,0.5455225523109277,1.0,7/43,9.02%,LPL;DDHD1;CEL;LIPA;ABHD12;MGLL;ABHD5
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6297827150647428,1.3166486414768317,0.12771739130434784,0.5422942005048417,1.0,7/10,33.57%,PRDM9;SMYD2;SETMAR;NSD3;NSD1;ASH1L;SETD2
prerank,triglyceride lipase activity (GO:0004806),0.52984965711329,1.3143898459342682,0.13793103448275862,0.5447704279217175,1.0,3/20,9.02%,LPL;CEL;ABHD5
prerank,cadherin binding (GO:0045296),0.4188268715013189,1.3142702875543582,0.002,0.5403504787731054,1.0,140/315,28.40%,IQGAP1;TRPC4;CTNNB1;TLN1;NIBAN2;FLNA;P2RX4;SLC3A2;ANXA1;ASAP1;PKM;CAPG;ALDOA;TAGLN2;MACF1;PDLIM1;PRDX6;PKP4;PKP1;TJP2;PAK6;FMNL2;EEF2;CC2D1A;S100A11;PRDX1;UBAP2;TBC1D2;RPS26;FXYD5;STK24;NCK1;LASP1;CRKL;CHMP4B;EIF4G2;EIF2A;CAST;CDH1;SH3GLB2;SCYL1;EEF1D;RPS2;LRRFIP1;RACK1;EVPL;JUP;PLEC;LDHA;ENO1;RARS1;PARVA;EFHD2;NDRG1;MRTFB;PPME1;RANBP1;LARP1;DHX29;HNRNPK;HSPA8;PKN2;PAK2;SH3GL1;ATIC;CCT8;PFKP;PUF60;CBL;LYPLA2;VAPB;PCBP1;CSNK1D;STK38;ZC3HAV1;KDR;RAB1A;GOLGA3;RPL14;PKP2;AFDN;DNAJB1;EPS15L1;FLNB;EHD4;YWHAB;OLA1;EIF3E;VASP;MARK2;YKT6;BAIAP2;PI4KA;HSP90AB1;AHNAK;TMPO;SND1;ABI1;RPL15;TES;GIGYF2;PROM1;HDLBP;PFN1;TBC1D10A;EHD1;BAG3;SNX1;UNC45A;PDXDC1;RPL7A;GIPC1;USP8;IST1;USO1;FASN;HSPA5;ABCF3;YWHAZ;GOLGA2;CLINT1;RPL23A;HCFC1;PAK4;ESYT2;PSMB6;RPL29;PTPRM;MAPRE1;CDH4;STX5;PACSIN2;BAIAP2L1;ITGB1;CORO1B;ARHGAP1;NUDC;BSG;CDH18;CDH24
prerank,chloride channel inhibitor activity (GO:0019869),-0.5181869720339276,-1.3127811366489281,0.17063492063492064,0.4168792631334904,1.0,6/10,28.84%,WNK1;WNK3;STX1A;VAMP8;WNK4;WNK2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5269901946602658,-1.3121129576039545,0.137546468401487,0.40778629917296744,1.0,3/10,7.24%,SLCO2B1;SLCO1B1;SLCO4A1
prerank,kinase activator activity (GO:0019209),0.5068199738619181,1.311568151430227,0.10433763188745604,0.5450730357233755,1.0,11/30,20.93%,FGF13;MALT1;DAXX;TREM2;GPRC5C;GPRC5B;CAB39;STK11;IL2;EPO;MARK2
prerank,ribonuclease activity (GO:0004540),0.4530541950597504,1.3069007430890236,0.08134490238611713,0.5567978612492407,1.0,21/56,23.20%,AGO2;RNASE3;EXOSC4;ERN2;PIWIL2;ERN1;RNASEH2A;RNASEL;RNASEH1;EXOSC9;RNASE12;EXOSC10;ZC3H12B;RNASE7;RNASE6;EXOSC5;AGO3;ZC3H12D;CNOT6;SND1;PPP1R8
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5087690275224319,1.2994998897649874,0.1324736225087925,0.5786814289955837,1.0,12/29,21.90%,SLC26A1;SLC46A1;SLC1A5;SLC25A14;SLC26A4;SLC25A21;SLC38A7;SLC19A1;SLC13A3;SLC25A18;SLC13A5;SLC26A6
prerank,tropomyosin binding (GO:0005523),0.5594671001104043,1.2960544685495143,0.15404699738903394,0.5863653597757865,1.0,2/16,5.07%,TNNT3;S100A6
prerank,methyltransferase activity (GO:0008168),0.46171287949929873,1.295062293141579,0.12035010940919037,0.5848942231527545,1.0,18/46,21.86%,AS3MT;DNMT1;MRM2;METTL3;MGMT;PRMT5;PRMT7;FTSJ3;COQ5;EEF1AKMT3;COQ3;NSUN3;DNMT3B;NSUN2;EHMT1;AMT;PRMT3;GCSH
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5893055601345545,1.2949552320059774,0.16102841677943167,0.5804179029049993,1.0,4/12,15.00%,XDH;SDHB;ISCA1;CIAPIN1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4948746771607533,1.2941296331884282,0.13641618497109825,0.5786021653226953,1.0,15/34,29.11%,IQGAP1;LTF;ALS2;STK3;CCNB1;CAB39;CCNT2;DBF4;CKS2;TAOK1;MAP2K2;CALM3;PARP16;RICTOR;STK4
prerank,intracellular chloride channel activity (GO:0061778),0.560101513109274,1.2938745814067856,0.15424164524421594,0.5700293443082334,1.0,5/16,18.37%,TTYH2;ANO9;ANO8;ANO5;ANO6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.560101513109274,1.2938745814067856,0.15424164524421594,0.5700293443082334,1.0,5/16,18.37%,TTYH2;ANO9;ANO8;ANO5;ANO6
prerank,MHC protein binding (GO:0042287),0.5241379507027367,1.2930097400196412,0.15316455696202533,0.5684865188178565,1.0,9/20,24.46%,CD8B;CD4;CD8A;TAPBP;LILRB1;DERL1;TUBB;CD74;ATP5F1B
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.49109801103599393,1.2908658355768823,0.12775842044134728,0.5713381245539567,1.0,18/35,28.44%,MMP12;AGO2;HDAC1;UBTF;SMARCB1;TBPL1;TBP;DR1;NR3C1;NPM1;TAF1C;SMARCA4;POU2F1;PIH1D1;H3-3A;KLF10;RUVBL2;ZBTB17
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.48561691482424935,1.287751346579322,0.11995515695067265,0.577485679873151,1.0,13/34,22.85%,DOT1L;TTLL12;ETFBKMT;KMT5A;SMYD3;KMT5B;PRDM9;EEF1AKMT3;SMYD2;EHMT1;SMYD1;EEF2KMT;NSD3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5821283123771703,1.2846400689232509,0.16380449141347425,0.5840204035337193,1.0,7/12,27.36%,AGO2;CYFIP2;LARP1;EIF4E2;GEMIN5;CYFIP1;EIF4E
prerank,voltage-gated anion channel activity (GO:0008308),0.5606340839891567,1.284153600582045,0.15943877551020408,0.5809732101518573,1.0,6/15,20.52%,VDAC2;CLCN1;ANO6;CLCN4;GPR89A;GPR89B
prerank,endopeptidase activity (GO:0004175),0.4103874978067862,1.2839332879381993,0.016016016016016016,0.5772732603069233,1.0,82/257,25.26%,PLAU;ADAM33;CTSB;MMP8;CTSZ;MMP12;MALT1;CTSW;GZMB;GZMA;ADAMTS13;MMP9;ECEL1;RHBDF2;KLK1;KLK6;CLPP;ADAMTS10;USP12;HPR;HP;NAPSA;PSEN2;F11;USP9X;PSMA1;RHBDF1;ADAM17;ADAMTS14;USP5;TASP1;CD5L;MASP1;ADAMTSL5;PSMA8;ADAMTS2;CTSE;DDI2;AFG3L2;TPP2;USP40;GZMM;MMP19;CASP7;USP47;CASP4;FURIN;PSMA6;KLK3;MBTPS2;PSMA5;USP18;PRSS53;USP46;CASP9;ADAMTSL1;MASP2;MMP17;TPP1;USP28;SENP1;MMP28;PITRM1;PREP;USP33;USP36;NLN;USP14;ADAMTSL4;PARL;TMPRSS4;ECE1;TRABD2B;PSMA3;CORIN;USP2;USP8;PSMB8;F9;PSMB10;SFRP1;USP1
prerank,neuropeptide receptor activity (GO:0008188),-0.3619497925855919,-1.2815389531865862,0.1342281879194631,0.455471453472896,1.0,8/29,23.59%,SORCS1;GPR37;TACR3;GRPR;NPSR1;SSTR2;NTSR1;GAL
prerank,metalloendopeptidase activity (GO:0004222),0.43331323470691446,1.2787502263682804,0.09214659685863874,0.5915387340745977,1.0,22/76,23.80%,ADAM33;MMP8;MMP12;ADAMTS13;MMP9;ECEL1;ADAMTS10;ADAM17;ADAMTS14;ADAMTSL5;ADAMTS2;AFG3L2;MMP19;MBTPS2;ADAMTSL1;MMP17;MMP28;PITRM1;NLN;ADAMTSL4;ECE1;TRABD2B
prerank,poly-purine tract binding (GO:0070717),0.49799746163225656,1.2762185656428893,0.15217391304347827,0.5961804961900691,1.0,12/27,23.19%,PABPC5;PATL1;ATXN1;PABPC1;LARP4;RBPMS;DDX1;EIF4A3;PPIE;HNRNPU;PABPC4;RBMS2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.49560382798768854,1.2754226256449515,0.13436385255648037,0.5944345005254842,1.0,8/27,14.58%,SLC9A1;SLC3A2;SLC23A1;ASIC3;SLC9A8;SLC9A7;SLC9A6;SLC8B1
prerank,lysophospholipase activity (GO:0004622),0.5133016068454966,1.2738640929665772,0.16009852216748768,0.5958270878998905,1.0,6/20,16.55%,GDPD3;PNPLA7;ABHD12;MGLL;LYPLA2;PNPLA6
prerank,translation elongation factor activity (GO:0003746),0.5547644815081235,1.2717453905928058,0.18085106382978725,0.5990727112363889,1.0,6/14,22.04%,EEF2;EEF1A1;GTPBP2;EIF5AL1;EIF5A;GFM2
prerank,ATPase regulator activity (GO:0060590),0.47199852120658703,1.271673703637163,0.1382857142857143,0.5948593305384049,1.0,14/38,28.43%,FNIP2;ATP1B3;TOR1AIP2;DNAJC15;SIL1;DNAJC1;DNAJB1;PFN1;BAG3;DNAJC10;DNAJA1;ATP1B2;FNIP1;DNAJB6
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5923704777362048,1.270807123924365,0.1695827725437416,0.5938389079282419,1.0,5/11,22.24%,RDH12;AKR1B10;AKR1A1;RDH13;RDH14
prerank,cytokine activity (GO:0005125),0.41941912116008345,1.2708032633776791,0.06395939086294417,0.5894796890039179,1.0,33/131,25.40%,CSF1;CCL4;FAM3D;BMP8B;NRG1;GDF6;FGF2;VEGFA;KITLG;CCL13;WNT6;CCL7;CCL5;CCL28;CCL14;CXCL16;FAM3C;BMP6;IL6;IL2;BMP5;HMGB1;TIMP1;EPO;TNFRSF11B;BMP4;IL34;MIF;IL17D;TNF;AIMP1;CX3CL1;NDP
prerank,endodeoxyribonuclease activity (GO:0004520),0.5250068545492084,1.267739117361647,0.16938519447929737,0.5958623879980257,1.0,7/20,21.92%,ERCC1;ZRANB3;RAD50;MBD4;ERCC4;RPS3;SETMAR
prerank,NADP binding (GO:0050661),-0.35355636942120566,-1.2658580273394082,0.13008130081300814,0.47491328990690534,1.0,13/32,20.13%,CRYZL1;ME3;DPYD;DHCR7;NDOR1;NOS1;CRYZ;CBR3;NOX1;QDPR;HMGCR;GMDS;GRHPR
prerank,ADP binding (GO:0043531),0.5039132798466291,1.264300094544075,0.16826923076923078,0.6037445038987518,1.0,5/25,11.06%,MYO9B;ABCG1;ERN1;PGK1;LONP1
prerank,transition metal ion binding (GO:0046914),0.39956372777071614,1.26116182568968,0.01,0.6103225422398179,1.0,106/397,22.50%,FAM20C;LITAF;S100A8;ADAM33;S100A9;FTL;LCN2;ANPEP;MMP8;ABL2;EEA1;MMP12;P2RX4;EPRS1;KMT2A;MGAT5;LTF;CD4;RNF125;ATP7A;LARGE1;SORD;B4GALT7;AOC2;ADAM8;ATP13A2;HRG;ADAMTS13;DHH;DYRK2;ZDHHC15;WDFY1;MMP9;HDAC4;RNF7;PPARG;GYG1;MSRB1;ATOX1;TRIM28;APIP;NAPEPLD;HEPH;NFU1;PDXK;RASGRP1;PAPOLA;SCD5;CHD3;KDM3A;TET3;NEK4;BBOX1;SIRT5;RABGGTB;SHMT1;TIMM9;PIM1;SEC24A;RNF2;PCK2;RIOX1;ATAD3A;UPB1;HPF1;BLM;TMEM163;SEC24D;RPS27;FBXL19;CAD;TIMP2;QPCT;SMPD1;MYT1;MELTF;CHORDC1;CBLB;SOD3;XPNPEP1;BAZ1B;GALT;S100B;BMI1;B4GALT1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ARHGEF2;FTH1;SOD2;HHIP;TIMP1;DUSP12;TRIM24;TNFSF10;DOHH;TES;PITRM1;USP33;CALR
prerank,DNA replication origin binding (GO:0003688),0.5109091415628085,1.2602936772416626,0.1619718309859155,0.609024048265112,1.0,9/23,21.20%,ORC3;MCM7;MCM2;GRWD1;HSPD1;KAT7;DHX9;MCM6;MCM8
prerank,kinase binding (GO:0019900),0.39759036555993105,1.2556419172815072,0.003,0.6211935001188306,1.0,128/434,22.86%,BCAR3;LYST;CSPG4;IQGAP1;CTNNB1;LCK;STAP1;HIF1A;LAX1;SKAP1;CD3E;BCL2L1;FLNA;SMCR8;PTPRC;CD226;CD4;MSN;SASH1;KIF13B;FGR;LAT;HDAC7;TRAF2;RPS6;CD24;TRIM6;NR4A3;TSKS;PTPN23;SQSTM1;PRKCD;EEF2;CAV1;FAM83H;HSPB1;DAXX;RPS7;GYS1;PTPN22;EEF1A1;BLNK;SIK1;GRB2;PPP1R12A;ATP1A4;HTT;RHOD;FBXO5;TPCN2;WDR45;ILK;PFKL;MVP;SLC12A4;TICAM1;PTPN2;CCNB1;NISCH;PRAM1;DCTN1;ATF5;RHOG;CEBPA;IRF5;EXOC2;TRAP1;GSN;TNIP2;RHOA;MAP3K12;UTRN;CDC42;SP100;PAK2;KIF20A;SMAD1;DCX;SIKE1;GHR;GPRC5B;CEP250;JTB;ACTB;MAP3K1;CAB39;IL31RA;UBQLN1;EIF4ENIF1;RPS19;ACTA2;ITGB2;RACGAP1;DUSP3;BARD1;TFRC;CCND2;CHP1;MAP2K3;ADIPOR1;PRKAG1;DGKD;GSKIP;TEX14;NEK6;TPRKB;FERMT2;FAM83D;CASP9;NR3C1;FBXO7;SPRED2;RPS3;LAPTM4B;FBXW5;SLC12A7;HSP90AB1;HSF1;GSK3B;NPM1;CKS2;TRIM21;SUFU;LATS1;IRAK4;WAS;PPP1R15A;LLGL1
prerank,double-stranded RNA binding (GO:0003725),0.4314751518806277,1.2551389859689461,0.1239406779661017,0.6186434775821414,1.0,23/70,21.40%,RFTN1;SLC3A2;MSN;EIF4A1;ADARB1;AGO2;VIM;SIDT1;ZNF346;ACTN1;ZFR;LRRFIP1;ILF3;HSPD1;TFRC;DHX36;HNRNPU;DHX33;DHX9;ADAR;AGO3;MTDH;HSP90AB1
prerank,poly(A) binding (GO:0008143),0.512568567072721,1.254956746789374,0.17537313432835822,0.6149304249109137,1.0,10/21,23.19%,PABPC5;PABPC1;LARP4;RBPMS;DDX1;EIF4A3;PPIE;HNRNPU;PABPC4;RBMS2
prerank,disordered domain specific binding (GO:0097718),0.5136597893144845,1.254542331766505,0.18094089264173704,0.6121582996977878,1.0,8/23,25.53%,FN1;FYN;NUMA1;DFFB;HSP90AB1;CALM3;MDM2;HSPA2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.45906868983148563,-1.2526992419789682,0.19367588932806323,0.4903370857268795,1.0,4/11,16.77%,SLC25A47;SLC22A5;SLC25A20;SLC25A29
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5668488212570313,1.2505326272598118,0.19840213049267644,0.6223330659934896,1.0,3/12,9.62%,ITGA5;VEGFA;CADM4
prerank,lysine-acetylated histone binding (GO:0070577),0.5009804688828817,1.24981031479575,0.18523153942428036,0.6164728692565199,1.0,7/20,25.02%,KMT2A;BRD4;THAP7;CARM1;TRIM24;ATAD2B;SMARCA4
prerank,acetylation-dependent protein binding (GO:0140033),0.5009804688828817,1.24981031479575,0.18523153942428036,0.6164728692565199,1.0,7/20,25.02%,KMT2A;BRD4;THAP7;CARM1;TRIM24;ATAD2B;SMARCA4
prerank,glycerophospholipid flippase activity (GO:0140333),-0.47768390271202865,-1.2498074932394627,0.2109090909090909,0.48460012975921063,1.0,2/11,3.32%,ATP8A2;ABCA3
prerank,phospholipase C activity (GO:0004629),-0.3648590923424645,-1.249238221768732,0.15476190476190477,0.47497695248191135,1.0,6/25,5.78%,PLCL1;PLCB1;CCR5;PLCG2;CCR1;CHRM3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5752402445769256,1.246751585330024,0.1905424200278164,0.6236764934377462,1.0,4/12,11.88%,TRAF2;TRAF3;TRAF1;TRAP1
prerank,ATP hydrolysis activity (GO:0140603),0.46159886789546717,1.2464497436914697,0.15842696629213482,0.6205948888829367,1.0,9/41,14.67%,MYO1E;ATP2B1;ABCA4;CHD3;VCP;VWA8;ABCD2;VPS4B;CLU
prerank,adenyl ribonucleotide binding (GO:0032559),0.3973659951079826,1.2417184880619188,0.024,0.633520114317342,1.0,90/291,23.15%,MYO9B;PEAK1;ABCG1;CDK6;ERCC6;ABCA1;MYO1F;P2RX4;AARS1;ATP7A;SRPK1;MLKL;THG1L;GCK;PTPA;EIF4G1;HSPA4;SPHK1;MAP4K5;MAP4K2;DYRK2;ABCD4;IGHMBP2;CARS1;ERN2;STK3;PI4K2A;ERN1;SIK1;MAP4K3;ATP1A3;ATP1A1;PDXK;PAPOLA;MTHFS;PFKL;P2RY1;PGK1;LONP1;PIM1;NVL;ABCD2;CDK11B;BLM;HSPA8;EIF4A3;PFKP;APRT;DAPK1;HSPA9;AK6;CAD;ATP1A2;STK38;ABCD3;DHX36;MINK1;TLK1;SARS2;PRKAG1;STK11;KIFC1;EIF2B2;HNRNPU;NLK;NEK6;OLA1;DAPK3;SLC19A1;RTEL1;DHX9;TOP1;PDK3;MCM6;TRIP13;MARK2;LMTK2;HSP90AB1;PRAG1;SRPK2;MARK4;RUNX3;NIM1K;TAOK1;PRPS2;CNBD2;LATS1;CLPX;PMVK;TARS1
prerank,metallocarboxypeptidase activity (GO:0004181),0.48444230888759754,1.2416633274889954,0.18492343934040048,0.6295399111050825,1.0,8/26,13.94%,CPA4;CPA3;AGBL5;CPXM2;AGBL2;CPA6;AEBP1;CPD
prerank,proton transmembrane transporter activity (GO:0015078),0.4559171562037776,1.241167949011358,0.16890380313199105,0.6271481106336692,1.0,14/39,24.68%,SLC9A1;ATP6V1B2;COX7A1;SLC46A1;COX6A2;COX5B;ATP6V1F;COX10;UQCRH;CLCN4;COX7A2L;UQCR10;SLC11A2;UQCR11
prerank,lipoprotein particle receptor binding (GO:0070325),0.484498455998451,1.238707826570265,0.1875746714456392,0.6317865356412444,1.0,6/27,16.13%,APOE;LRP1;APOA2;LRPAP1;CLU;HSPG2
prerank,titin binding (GO:0031432),-0.448583582379375,-1.237834735701684,0.18106995884773663,0.4859602473354953,1.0,2/13,4.10%,CAPN3;MYBPC1
prerank,gated channel activity (GO:0022836),0.5489173783062661,1.236048200855399,0.21484375,0.6370875795895072,1.0,3/14,7.02%,PACC1;PIEZO1;PIEZO2
prerank,protein kinase binding (GO:0019901),0.39064657400706837,1.2360062969441863,0.002,0.6330980955288235,1.0,140/479,22.89%,LYST;CSPG4;IQGAP1;LCK;STAP1;HIF1A;LAX1;NELL2;SKAP1;CD3E;CD247;BCL2L1;PLEK;SIRPA;SMCR8;PTPRC;CD226;CD4;MSN;SASH1;KIF13B;FGR;LAT;HDAC9;HDAC7;TRAF2;TNIP1;RPS6;CD24;TRIM6;NR4A3;DUSP9;MAP4K2;TJP2;TSKS;PTPN23;SQSTM1;NELL1;PRKCD;NEDD9;EEF2;CAV1;FAM83H;HSPB1;DAXX;RPS7;GYS1;EEF1A1;BLNK;SIK1;GRB2;SOX9;PPP1R12A;TREM2;RHOD;PRKCB;FBXO5;TPCN2;SPAG9;MAPKAPK3;WDR45;ILK;MVP;MAPKAPK2;RACK1;SLC12A4;TICAM1;PTPN2;CCNB1;NISCH;PRAM1;DCTN1;DUSP6;RHOG;YWHAG;IRF5;EXOC2;TRAP1;TNIP2;RHOA;MAP3K12;UTRN;CDC42;PAK2;KIF20A;SMAD1;DCX;SIKE1;GHR;GPRC5B;CEP250;JTB;ACTB;MAP3K1;IL31RA;PRKD2;RPS19;ACTA2;TPR;ITGB2;RACGAP1;STK38;DUSP3;TFRC;CCND2;TIRAP;CAVIN2;MAP2K3;PKP2;ADIPOR1;PRKAG1;GSKIP;TEX14;NEK6;PIN1;TPRKB;FERMT2;FAM83D;CASP9;NR3C1;FBXO7;SPRED2;RPS3;FBXW5;SLC12A7;HSF1;GSK3B;NPM1;PRKAR1A;CKS2;TRIB2;TRIM21;SUFU;LATS1;IRAK4;WAS;PPP1R15A;LLGL1;MAPK7;DUSP16
prerank,carboxylic acid binding (GO:0031406),-0.3276865503231879,-1.2355170612412603,0.1206896551724138,0.48008591939615247,1.0,12/38,14.06%,GRM7;GLRA3;GLUD1;GRIN2B;SESN1;EPDR1;NOS1;GRIN1;GLRA2;MAG;CASTOR1;GLRA1
prerank,potassium:proton antiporter activity (GO:0015386),0.5821896176966944,1.2342412479049532,0.21685082872928177,0.6350263592801548,1.0,4/10,14.56%,SLC9A1;SLC9A8;SLC9A7;SLC9A6
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.4774958522858475,1.2333841667239855,0.20952380952380953,0.6339119090989244,1.0,8/27,21.90%,ANKH;SLC26A1;SLC26A11;SLC25A14;SLC26A4;XPR1;GET3;SLC26A6
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5864860644317504,1.2326126677644618,0.21853388658367912,0.6324125241725707,1.0,4/10,21.74%,SIRPA;JUP;PKP2;CD47
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.47307792399260984,1.231102169698779,0.1687715269804822,0.6338254439674726,1.0,9/30,13.81%,LTF;CST7;PRDX5;SERPINB9;CAST;CSTB;BIRC6;GAS6;BIRC5
prerank,zinc ion binding (GO:0008270),0.39160242598031103,1.2271202267738648,0.031,0.6438283125138154,1.0,84/293,24.61%,LITAF;S100A8;ADAM33;S100A9;ANPEP;MMP8;EEA1;MMP12;P2RX4;EPRS1;KMT2A;CD4;RNF125;SORD;ADAM8;ATP13A2;HRG;ADAMTS13;DHH;ZDHHC15;WDFY1;MMP9;HDAC4;PPARG;MSRB1;TRIM28;APIP;NAPEPLD;PDXK;RASGRP1;CHD3;TET3;BBOX1;SIRT5;RABGGTB;SHMT1;TIMM9;SEC24A;RNF2;ATAD3A;UPB1;HPF1;BLM;TMEM163;SEC24D;RPS27;FBXL19;CAD;TIMP2;QPCT;SMPD1;MYT1;CHORDC1;CBLB;BAZ1B;GALT;S100B;BMI1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ARHGEF2;HHIP;TIMP1;DUSP12;TRIM24;TNFSF10;TES;PITRM1;USP33;CALR;EGR1;TARS1;RXRA;ECE1;MDM2;ADH5;SIRT3;BIRC2
prerank,metallopeptidase activity (GO:0008237),0.40496797630578574,1.2264140130208747,0.11213047910295616,0.6423992942527246,1.0,35/113,26.68%,ADAM33;ANPEP;MMP8;MMP12;ADAM8;ADAMTS13;BMP1;MMP9;ECEL1;ADAMTS10;ADAM17;ADAMTS14;ADAMTSL5;MYSM1;ADAMTS2;COPS6;AFG3L2;PSMD14;ADAM15;MMP19;MBTPS2;ADAMTSL1;PRPF8;MMP17;MMP28;PITRM1;NLN;ADAMTSL4;ECE1;TRABD2B;EIF3H;PSMD7;METAP1D;LAP3;BRCC3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.46417910616474106,-1.2256845481839795,0.22083333333333333,0.48871185238600084,1.0,7/11,37.88%,PADI2;DDAH2;ARG2;ARG1;AGMAT;PADI1;PADI4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5717080993348679,1.2217623908609183,0.22361111111111112,0.6544270948998666,1.0,1/10,0.13%,APOBEC1
prerank,chloride transmembrane transporter activity (GO:0015108),0.5253796669813133,1.2195455242743536,0.21176470588235294,0.6583053660450402,1.0,2/16,1.46%,CLCN7;SLC26A1
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5219373768404487,1.2193989549056767,0.24310776942355888,0.6548139106249862,1.0,4/17,13.05%,ABCG1;ABCA1;PITPNC1;ABCA7
prerank,sodium channel regulator activity (GO:0017080),0.4511084336420763,1.2193119749906678,0.17777777777777778,0.6511617785222279,1.0,11/37,16.83%,FGF13;SGK1;SGK3;SGK2;PRSS8;FXYD5;RANGRF;SCN1B;FXYD4;SCN3B;PKP2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4365215372225117,1.2183118270771964,0.17070484581497797,0.6509719450642455,1.0,9/46,9.14%,MGAT5;LARGE1;GCNT2;B4GAT1;B3GNT3;PIGQ;HEXA;PIGA;EXTL2
prerank,anion:anion antiporter activity (GO:0015301),0.5217426159447167,1.2175722111626217,0.23462986198243413,0.6499231299940998,1.0,6/17,21.90%,SLC26A1;SLC26A11;SLC26A4;SLC4A2;SLC19A1;SLC26A6
prerank,endopeptidase regulator activity (GO:0061135),0.44910669941110754,1.2167917873095189,0.18333333333333332,0.6488750730293109,1.0,9/40,13.66%,RENBP;CST7;HRG;A2M;TFPI;CAST;CSTB;PROS1;PSMD14
prerank,endopeptidase inhibitor activity (GO:0004866),0.4121319860587309,1.216440960106117,0.12757201646090535,0.6462480484421477,1.0,21/82,17.58%,LTF;RENBP;CST7;HRG;SERPINA10;A2M;TFPI2;SERPINB9;TFPI;CAST;CSTB;SERPINE2;SERPINE1;BIRC6;TIMP4;ROCK1;PROS1;TIMP2;FURIN;SPINK5;SERPINF2
prerank,Notch binding (GO:0005112),0.49501345821448633,1.215468961393656,0.23030303030303031,0.6456627628172136,1.0,11/22,26.57%,NCOR2;JAG1;ADAM17;DLL4;DLK2;KCTD10;CUL3;SNED1;TCIM;NOTCH4;SNW1
prerank,histone deacetylase activity (GO:0004407),0.4996627605065068,1.2152957312737416,0.21287128712871287,0.6425379523146629,1.0,11/19,31.23%,HDAC9;HDAC4;HDAC1;SUDS3;MIER2;HDAC11;SIRT3;HDAC2;HDAC3;SIRT1;SIRT2
prerank,hexose transmembrane transporter activity (GO:0015149),0.5420565771231313,1.2133597960882652,0.24691358024691357,0.6453430995654651,1.0,5/12,21.90%,SLC5A1;SLC2A1;SLC2A8;SLC5A3;SLC2A6
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.4817647091737498,1.2118970743460074,0.21368547418967587,0.646612491159442,1.0,6/24,26.35%,OSBPL8;SESTD1;PLEKHF1;OSBP;GOLPH3;GOLPH3L
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5006257352757746,1.2115376493057848,0.2028985507246377,0.6441985163288868,1.0,2/21,2.26%,P2RX4;CHRNB2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.45307142710276016,1.2079307309479155,0.21071012805587894,0.652862521063398,1.0,13/33,20.52%,AGO2;LLPH;ZNF326;WDR43;ELOF1;SMYD2;TBP;HNRNPU;PAF1;RPRD1A;DHX9;CCAR2;RECQL5
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.552302975002706,1.2077877087702094,0.2214941022280472,0.6496344473240377,1.0,5/12,19.82%,STAP1;BLNK;TRAT1;SH2B1;GAB2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.4110842643247338,-1.2065669329772963,0.2037037037037037,0.5168351451297596,1.0,5/16,15.56%,ALOX5;BCO2;ETHE1;HAAO;ALOXE3
prerank,fibroblast growth factor receptor binding (GO:0005104),0.48770466083574354,1.20526857712576,0.23536585365853657,0.6548693643012914,1.0,5/21,14.03%,NPTN;FGF2;FGF7;FGF20;FGF18
prerank,hormone receptor binding (GO:0051427),0.5330298762117378,1.2020841816589647,0.2333767926988266,0.6620655405842385,1.0,6/14,24.48%,NPPA;JAK1;VIP;NPPC;SOCS2;JAK2
prerank,potassium ion antiporter activity (GO:0022821),0.5166902475692474,1.2013906731019213,0.23008849557522124,0.6607333739590755,1.0,5/15,14.56%,SLC9A1;SLC24A4;SLC9A8;SLC9A7;SLC9A6
prerank,sulfate transmembrane transporter activity (GO:0015116),0.5352083870508428,1.199621231226996,0.240473061760841,0.663296343419259,1.0,5/14,21.90%,SLC26A1;SLC26A11;SLC25A14;SLC26A4;SLC26A6
prerank,P-type ion transporter activity (GO:0015662),0.5461009540614281,1.1985621185926054,0.2609853528628495,0.663359993128697,1.0,2/12,2.26%,ATP7A;ATP2B1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.38023229434289313,1.198353622402798,0.023023023023023025,0.660391761174821,1.0,125/431,21.76%,MYO9B;PEAK1;ABCG1;CDK6;ERCC6;ABCA1;TSR1;RRAGD;MYO1F;P2RX4;RAP2A;AARS1;ARF3;ATP7A;REM1;SRPK1;MLKL;THG1L;GCK;PTPA;EIF4G1;HSPA4;GIMAP7;GTPBP4;SPHK1;MAP4K5;MAP4K2;DYRK2;MFHAS1;ARL8B;ABCD4;IGHMBP2;CARS1;ERN2;EEF1A1;STK3;ARL1;PI4K2A;ERN1;SIK1;MAP4K3;RASL12;ATP1A3;ATP1A1;ANXA6;RHOD;PDXK;RHOQ;PAPOLA;MTHFS;GEM;PFKL;P2RY1;PGK1;BMS1;ARL11;RAB32;RAB8A;NRAS;KRAS;DNM2;LONP1;PIM1;RHOG;RAB7A;NVL;ABCD2;DRG1;RHOA;RHOU;CDK11B;BLM;RAB5A;CDC42;HSPA8;EIF4A3;PFKP;DAPK1;HSPA9;AK6;CAD;ATP1A2;ARL8A;STK38;ABCD3;PSMA6;DHX36;GBP2;MINK1;RAB22A;TLK1;SARS2;PRKAG1;RIT1;STK11;KIFC1;TUBB;RALB;EIF2B2;HNRNPU;NLK;NEK6;DRG2;OLA1;DAPK3;GNL3;ADSS1;RTEL1;DHX9;RRAD;RHOT2;TOP1;PDK3;MCM6;TRIP13;ARL4C;MARK2;LMTK2;HSP90AB1;PRAG1;SRPK2;MARK4;RUNX3;NIM1K;TAOK1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.43796014891481105,1.1982092873506955,0.19144144144144143,0.6572137227947121,1.0,10/40,14.40%,DNMT3A;AS3MT;PEMT;GNMT;DNMT1;DPH5;PRMT7;METTL9;METTL2B;METTL2A
prerank,mRNA 3'-UTR binding (GO:0003730),0.41066649614782397,1.1969681344066572,0.16736401673640167,0.6579732872584944,1.0,30/79,27.10%,PABPC5;CPEB4;EXOSC4;RPS7;RPL41;CPEB2;CELF1;HNRNPC;PABPC1;LARP4;CPEB3;EXOSC9;LARP1;PCBP4;ILF3;YBX3;HNRNPA2B1;DHX36;FXR2;PUM1;HNRNPU;TARDBP;RNF20;CCT5;PABPC4;RBMS2;CPEB1;KHSRP;GEMIN5;RC3H1
prerank,Hsp90 protein binding (GO:0051879),0.4506514857840317,1.1968697020488828,0.21345707656612528,0.6547468279849433,1.0,12/33,26.92%,HIF1A;ERN1;KDR;CHORDC1;PTGES3;NR3C1;RPS3;HSF1;AHR;UNC45A;USP19;PACRG
prerank,protein homodimerization activity (GO:0042803),0.3800941982483443,1.196411429573445,0.011,0.652709681499283,1.0,136/589,18.60%,BCL2;LPL;MYO9B;APOE;ABCG1;IKZF3;ZHX2;EEA1;CSF1;MYOM3;BCL2L1;ATF3;PLEK;FLNA;ATG7;EPRS1;KMT2A;RABEP1;TBC1D22A;CD4;ADCY8;NECTIN1;IRAK2;SYNE1;XDH;MCL1;PDGFA;CST7;PTPA;ALS2;GZMA;TYRP1;TRIM6;APOA2;GIMAP7;PON1;TPM2;NR4A3;TBX18;GLIPR2;PSAP;TMEM192;NUDT5;S100A6;S100A11;RBM44;GLB1;HSPB1;GYG1;MGLL;ACTN1;ERN1;ZBTB7B;VEGFA;CADM1;TPD52;KLHL7;CHMP4A;CHMP4B;PDXK;BHLHE40;PDCD6IP;NECTIN3;GTF2A2;HOOK1;BHLHE41;LILRB1;LRRFIP1;RACK1;TPM4;MMUT;BAX;B2M;JUP;HMOX1;HIP1;GLA;MASP1;SHMT1;TIMM9;NRF1;JAML;ENO1;CEBPA;RBPMS;S100A16;ABCD2;VPS4B;XPA;CCL5;UPB1;PRDM9;TFAP4;MAP3K12;BLM;PPCS;ZBTB16;GHR;ATIC;EFEMP2;FZD4;QTRT1;RBM11;CLCN1;DDIT3;GCA;SLC8B1;TPST1;SPPL3;LRP6;TPR;VAPB;ACP3;SRF;CAT;PRMT2;BARD1;ABCD3;APPL2;TFRC;GBP2;FXR2;ST6GAL1;SARS1;TKT;DGKD;XPNPEP1;ODC1;SERPINF2;SP1;HIP1R;DAPK3;S100B;USF2;ALDH3A2;JCHAIN
prerank,snRNA binding (GO:0017069),0.4295794525287296,1.1955523898727056,0.20735785953177258,0.6521377813735283,1.0,23/42,32.91%,SNRNP35;DDX21;SF3B3;PRPF4;DDX39B;ISG20;HNRNPU;CCNT2;SNRPB2;EIF5A;PRPF8;LSM4;SNU13;RBM22;GEMIN5;SNRPA;PRPF31;LSM11;HEXIM1;EFTUD2;TOE1;TUT1;SART3
prerank,deoxyribonuclease activity (GO:0004536),0.5318163378584314,1.1945275572931067,0.24966622162883845,0.6522269747465758,1.0,6/14,21.25%,ZRANB3;MBD4;ERCC4;DFFB;RPS3;DNASE1L1
prerank,protease binding (GO:0002020),0.401529079294453,1.1939687271105115,0.1605316973415133,0.6508192797178266,1.0,31/99,24.38%,BCL2;FN1;DERL3;A2M;PSAP;CD28;SERPINB9;SELL;CSTB;VCP;SRI;SERPINE1;RIOK3;ECM1;TIMP4;BFAR;TWNK;DERL1;TIMP2;FURIN;ITGA3;SERPINF2;POLG;UBC;CRADD;TIMP1;GSK3B;INSL3;ADAMTSL4;TNF;SUMO1
prerank,galactosyltransferase activity (GO:0008378),0.5565228242452415,1.1938545911990597,0.24796747967479674,0.6477724140249622,1.0,5/11,19.72%,B4GALT5;B4GALT7;B3GALT6;B4GALT3;B4GALT1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.41126336442910105,-1.1931194458022985,0.22477064220183487,0.5350924061739517,1.0,3/15,5.12%,P2RY12;GPR34;P2RY13
prerank,3'-5' DNA helicase activity (GO:0043138),0.5105908675477975,1.190741876574925,0.2366412213740458,0.6550368898620288,1.0,7/16,20.52%,MCM7;MCM2;ASCC3;BLM;DHX9;MCM6;RECQL5
prerank,ATPase activator activity (GO:0001671),0.4905575228535082,1.1906844627829931,0.2619047619047619,0.6517535120789175,1.0,9/20,28.43%,ATP1B3;TOR1AIP2;DNAJC15;DNAJC1;DNAJB1;DNAJC10;DNAJA1;ATP1B2;DNAJB6
prerank,kinase inhibitor activity (GO:0019210),0.449140541645279,1.1892116851349597,0.2330654420206659,0.6534655602936674,1.0,10/33,21.52%,SMCR8;TAOK3;NCK1;PARVA;SPRY4;LRP6;GSKIP;YWHAB;ITPRIP;NPM1
prerank,nuclear receptor binding (GO:0016922),0.3950927296206631,1.189130606033387,0.15967246673490276,0.6503612377119974,1.0,45/111,30.91%,CTNNB1;HIF1A;LEF1;JMJD1C;NR4A3;NCOR2;RNF14;TRIP12;DAXX;RNF6;PRKCB;KDM3A;JUP;MED17;PPARGC1B;ASXL1;MED13;PRMT2;TACC2;NR4A2;PRPF6;WBP2;GTF2H1;TAF7;TMF1;LATS1;CALR;ACTN4;STAT5B;RXRA;SMARCA4;SNW1;NSD1;KDM1A;BRD8;OASL;MED1;SIRT1;TRIP6;TRIM68;TGFB1I1;MED30;TRIP4;DCAF13;EP300
prerank,vinculin binding (GO:0017166),0.5492109027960309,1.1890776087018746,0.2657718120805369,0.6472129747808942,1.0,4/11,12.85%,TLN1;DAG1;ACTN1;UTRN
prerank,SH3 domain binding (GO:0017124),0.4109303875867257,1.1867104315576213,0.19915700737618547,0.6518422034782051,1.0,34/62,33.04%,CYBA;SKAP1;CD3E;SH3BP2;MICAL1;PTPN22;GRB2;WIPF1;DNM2;PTPN12;RUFY2;ADAM15;CBL;ESPN;CBLB;CASP9;EVL;VASP;ABI1;WAS;SYNJ2;MAPK15;ABI2;GPX1;NCF1;RAD9A;ADAM12;RUFY1;SOCS7;PLSCR1;ZNF106;SYNJ1;REPS1;AFAP1
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5439506682057141,1.1851745555489233,0.25471698113207547,0.6536190527089217,1.0,1/12,0.06%,IGF1
prerank,insulin-like growth factor I binding (GO:0031994),-0.4272972515275729,-1.1833618120114986,0.22957198443579765,0.5454280047055187,1.0,6/13,17.17%,ITGA6;IGFBP5;ITGB4;IGFBP3;LRP2;IGFBP6
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3656397544383162,-1.1831661998701777,0.21578947368421053,0.5350279800566016,1.0,6/19,11.50%,GRIN2A;RYR3;GRIN2B;TRPM4;MCOLN1;GRIN1
prerank,1-phosphatidylinositol binding (GO:0005545),0.5113133207615278,1.183132675588699,0.25064599483204136,0.65685565529789,1.0,5/15,12.34%,EEA1;SCIN;WDFY1;SNX10;SESTD1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.5430747944178659,1.1827986778801525,0.27123287671232876,0.6546786191807261,1.0,3/11,21.38%,LEF1;THAP7;ZXDC
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5422645523220029,1.1824335287921537,0.26104417670682734,0.6526021641623487,1.0,3/11,15.76%,SASH1;MAP4K2;STK38
prerank,magnesium ion binding (GO:0000287),0.38930104509732805,1.182231020000054,0.15517241379310345,0.6499827363813611,1.0,52/135,30.60%,ABL2;RAP2A;DCTPP1;CERK;SRPK1;THG1L;FIGNL1;SPHK1;DYRK2;MTHFD2;NUDT5;ERN2;STK3;PI4K2A;ERN1;SIK1;PDXK;PAPOLA;GEM;DXO;ADPRS;STK38;DHX36;TKT;STK11;NLK;NEK6;CLYBL;IDH3A;AASDHPPT;DUT;MARK2;SRPK2;NIM1K;LATS1;GEN1;STK38L;RRAGC;MAPK12;SIK3;HMGCL;HPRT1;SRR;MTPAP;PGM1;STK4;NT5C3A;XYLT2;IDH2;PPA1;PLSCR1;TDP2
prerank,protein kinase C activity (GO:0004697),0.5146778504901289,1.1806380879615412,0.2700636942675159,0.6519247624634187,1.0,4/14,8.10%,PRKCH;PRKCQ;PRKCD;PRKCB
prerank,thiol-dependent deubiquitinase (GO:0004843),0.39753670490695914,1.1799174425005814,0.18640576725025745,0.6508825468671616,1.0,46/83,34.32%,TANK;JOSD1;OTULIN;USP12;OTUD4;ATXN3;USP9X;USP5;BAP1;MYSM1;USP40;PSMD14;USP47;USP53;USP18;DESI2;USP46;USP28;PAN2;USP33;USP36;USP14;OTUD1;USP50;USP2;USP8;USP32;USP1;USP19;OTUD5;BRCC3;TNFAIP3;USP34;STAMBP;USP42;USP30;USP13;USP48;STAMBPL1;USP15;USP11;USP38;ZC3H12A;USP35;USP22;USP31
prerank,RNA cap binding (GO:0000339),0.5070469788953087,1.1792199897349191,0.2503242542153048,0.6499036690533289,1.0,8/16,27.36%,EIF4A1;AGO2;CYFIP2;LARP1;EIF4E2;GEMIN5;CYFIP1;EIF4E
prerank,transcription cis-regulatory region binding (GO:0000976),0.37514592742522057,1.1790611811452534,0.041,0.6472764324573664,1.0,112/406,24.78%,HIF1A;TCF7;MMP12;ATF3;FOXN1;NFYA;NFE2L2;ARID5B;LEF1;AGO2;TBX21;DEAF1;PRDX5;TCF15;TBX18;MEF2D;NFIL3;MNT;CIC;TFEB;HDAC4;PPARG;FOXJ1;RUNX1;GATA3;CUX1;RFX5;ZBTB7B;SOX9;SATB1;EGR2;HDAC1;NFX1;XRN2;ZNF395;CHD3;BASP1;E2F3;FOXN3;BRCA1;NKX2-1;OTP;AEBP1;SOX7;CREB3L2;ATF5;JUN;LONP1;ENO1;RBBP5;CEBPA;ARID4B;ZFP41;GBX1;ASCL4;PRDM9;CARM1;TFAP4;TIPARP;MAFK;YY1;NFYB;STOX1;ETV6;DDIT3;NFKB1;MTF1;ELK3;DHX36;NPAS4;PSPC1;TCF12;TBP;SP1;PURA;GABPB1;GABPB2;ZNF177;DR1;TAF7;NR3C1;HMGB1;DACH1;RPS3;SREBF1;ZFP57;RFXANK;TCF24;PBX1;RXRB;HSF1;NPM1;RUNX3;TEAD1;ZBTB43;ACTN4;KLF11;AHR;EGR1;ZNF568;CREBZF;PBX2;KMT2D;LHX4;RXRA;E2F6;ZBTB4;SOX10;TNF;GLIS2;ATF4;HNRNPL
prerank,deubiquitinase activity (GO:0101005),0.39397346006853706,1.1768372967589986,0.19140225179119755,0.6514510874303157,1.0,45/88,32.38%,TANK;JOSD1;OTULIN;USP12;OTUD4;ATXN3;USP9X;USP5;BAP1;MYSM1;USP40;PSMD14;USP47;USP53;USP18;DESI2;USP46;USP28;PAN2;USP33;USP36;USP14;OTUD1;USP50;USP2;USP8;EIF3H;USP32;USP1;USP19;OTUD5;BRCC3;TNFAIP3;USP34;STAMBP;USP42;USP30;USP13;USP48;MINDY2;STAMBPL1;USP15;USP11;USP38;ZC3H12A
prerank,voltage-gated cation channel activity (GO:0022843),-0.26261149191313704,-1.1746958267555723,0.14285714285714285,0.5426761283436164,1.0,30/97,16.91%,CACNB2;CACNA2D1;KCND2;KCNB2;GRIN2A;KCNA6;KCND3;CACNG3;KCNB1;KCNQ3;GRIN2B;KCND1;KCNH7;HCN1;NCS1;KCNK1;KCNH1;CACNG8;KCNC2;GRIN1;KCNS3;KCNH2;CACNA2D2;CACNA1C;KCNC1;CACNA1B;KCNC3;TMC1;CACNA1E;GRIN3A
prerank,cGMP binding (GO:0030553),-0.4505949178538949,-1.172529464378108,0.2669491525423729,0.5375403798275756,1.0,4/11,21.18%,PDE10A;RAPGEF2;PDE2A;PDE5A
prerank,cation:chloride symporter activity (GO:0015377),-0.46106272538375026,-1.170246442938413,0.24344569288389514,0.5326743508206513,1.0,5/10,10.71%,SLC12A2;SLC12A9;SLC12A6;SLC6A1;SLC12A8
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3833469653653441,1.1685711029623076,0.13253012048192772,0.6752785737713063,1.0,59/188,25.29%,TCF7;ATF3;FOXN1;NFYA;NFE2L2;ARID5B;TBX21;TBX18;TFEB;HDAC4;PPARG;FOXJ1;RUNX1;GATA3;EGR2;CHD3;BASP1;BRCA1;NKX2-1;SOX7;CREB3L2;ATF5;JUN;RBBP5;CEBPA;ARID4B;PRDM9;CARM1;TFAP4;MAFK;YY1;NFYB;DDIT3;NFKB1;DHX36;PSPC1;TCF12;TBP;SP1;GABPB1;GABPB2;DHX9;TAF7;HMGB1;PBX1;HSF1;KLF11;AHR;EGR1;ZNF568;CREBZF;KMT2D;RXRA;SOX10;TNF;GLIS2;ATF4;HNRNPL;GRHL1
prerank,GTPase binding (GO:0051020),0.37373766469482844,1.168195774338659,0.12864321608040202,0.6731924166086828,1.0,76/194,28.35%,IQGAP1;LCP1;MYO9B;MYO5A;ABCA1;RRAGD;FLNA;EPRS1;DMXL2;RGP1;OPTN;AKAP13;SPHK2;ALS2;GOLGA4;RAF1;CAV1;RUSC2;RTKN;FGD6;RAPGEF6;RIC1;RANGRF;ATP6AP1;RANBP9;RAB8A;RABGGTB;ENO1;NDRG1;EXOC2;GCC2;RANBP1;IQGAP2;PAK2;SIKE1;YBX3;BIRC5;RANBP2;RCC1;HPS6;DOCK7;GGA2;AP1G1;RASA1;ATG16L1;AFDN;RAB3GAP2;DAPK3;TBC1D20;GNB1;STOML2;ARHGEF2;RAB11FIP4;FGD5;ARHGDIB;RNF41;TRIOBP;USP33;WAS;EHD1;BNIP3;SGSM1;AIMP1;RRAGC;RAB3GAP1;ABI2;GGA1;MAPKAP1;RILP;CYFIP1;EXOC4;NUTF2;PARD6A;AMBRA1;ARHGAP1;LAMTOR1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3861972169408754,1.1677991230170608,0.1963001027749229,0.6712252074506008,1.0,35/100,26.90%,OSBPL8;SH3PXD2B;IQGAP1;MYO10;TECPR1;SNX24;RUFY4;VEPH1;ARAP2;WDR45;NCF4;HIP1;SESTD1;IQGAP2;PLEKHF1;OGT;RACGAP1;ARHGAP9;HIP1R;TTPAL;FERMT2;GAB2;LAPTM4B;ATG2B;MYO1G;SNX12;SNX11;OSBP;GOLPH3;ZFYVE19;BTK;MAPKAP1;GOLPH3L;DENND1B;KIF16B
prerank,iron ion binding (GO:0005506),0.4182017768640132,1.167715781895324,0.23887079261672095,0.6683009816283159,1.0,17/48,22.17%,FTL;LCN2;LTF;ACP5;HEPH;NFU1;SCD5;KDM3A;ALKBH1;RIOX1;MELTF;CDO1;EGLN1;FTH1;ALKBH3;DOHH;EGLN3
prerank,actinin binding (GO:0042805),0.4788642012716355,1.1664101811308538,0.2783882783882784,0.6695877923602085,1.0,8/21,22.31%,DAG1;CSRP3;PPARG;MAGI1;CACNA1D;NFKB1;CSRP2;PROM1
prerank,nuclease activity (GO:0004518),0.4114944756493143,1.1651513245124216,0.24645583424209377,0.670472127167764,1.0,18/52,21.92%,RNASE3;ERN2;XRN2;RNASEH2A;RNASEL;AEN;RNASEH1;DDX1;RNASE12;ISG20L2;DFFB;RNASE7;ISG20;REXO5;RNASE6;DNASE1L1;SND1;SETMAR
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4057779852378728,-1.1640392796823167,0.25213675213675213,0.5361426455974753,1.0,10/14,31.95%,KCND3;KCNJ3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNJ5;KCNA5;KCNE2
prerank,glucuronosyltransferase activity (GO:0015020),0.48341661746798026,1.1635039798250895,0.27889447236180903,0.6724304184913218,1.0,2/19,3.85%,LARGE1;B4GAT1
prerank,GTPase regulator activity (GO:0030695),0.37671375887067166,1.163141788926818,0.12236710130391174,0.670439078007935,1.0,73/212,25.72%,RGS1;IQGAP1;MYO9B;ABR;ARHGAP25;ARHGAP10;TBC1D10C;ARHGAP24;SIRPA;TBC1D22A;RGS3;ASAP1;RGPD1;RALGAPA2;ALS2;GNAQ;SIPA1L2;NRP1;IPO5;TBC1D2;RTKN;CPEB2;DLC1;RASGRP3;GDI1;RIN2;CDC42SE1;ARHGAP19;ARL2BP;JUN;NPRL2;RANBP1;IQGAP2;ELMOD3;LLGL2;RANBP2;RACGAP1;NF1;RASA1;TBC1D22B;TBC1D12;ARHGAP30;ARHGAP9;KRIT1;RAB3GAP2;TBC1D20;ARFGEF1;RIC8A;ITGB1BP1;ARHGAP17;ELMOD2;BNIP2;NPRL3;GMIP;ARFGAP3;ARFGAP1;WAS;HTR2B;LLGL1;TBC1D10A;LARS1;VAV3;ASAP2;SMAP1;SIPA1L3;CCDC88A;SGSM1;SIPA1;TBC1D16;RAB3GAP1;NCKAP1L;ARFGAP2;RALGAPB
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.39572314843833034,1.1583045778662795,0.21940928270042195,0.6831333064537706,1.0,24/75,25.95%,SORD;RDH12;DHRS3;MDH1B;DHRS9;AKR1B10;LDHA;HSD17B8;ME2;KDSR;AKR1A1;BDH1;DHRS11;CBR1;EHHADH;RDH10;GLYR1;HIBADH;ADH5;GFUS;HADHA;HADH;KCNAB1;ME1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.34333888245635064,-1.156991444328817,0.2147239263803681,0.5412120819957483,1.0,4/25,4.33%,FCHSD2;ADAP2;DAPP1;COMMD1
prerank,protein tyrosine kinase activity (GO:0004713),0.39014106350728034,1.1539917273590723,0.20246659815005139,0.6944056050668982,1.0,18/108,11.56%,FLT1;LCK;PEAK1;ABL2;ITK;FGR;TEC;AXL;DYRK2;PTK2B;TXK;IGF1R;SCYL1;PKDCC;WEE1;FYN;HIPK1;JAK1
prerank,chemokine receptor activity (GO:0004950),-0.35278097775799605,-1.1529840104422104,0.21604938271604937,0.5399084053826337,1.0,10/24,22.56%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;ACKR3;CMKLR1;CCR9;CXCR5;CXCR6
prerank,sodium:proton antiporter activity (GO:0015385),0.5335826538487586,1.1521402195591854,0.30666666666666664,0.6971981007608101,1.0,4/11,14.56%,SLC9A1;SLC9A8;SLC9A7;SLC9A6
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5372977374436992,1.1500694860834442,0.3169107856191744,0.7009365545554201,1.0,3/12,10.14%,GALNS;GNS;ARSA
prerank,receptor ligand activity (GO:0048018),0.3710568869088727,1.1490682687011793,0.13841524573721165,0.701298608198489,1.0,53/245,25.40%,LGALS3;GPNMB;IGF1;CSF1;CCL4;PDGFA;FAM3D;BMP8B;NRG1;GDF6;NPPA;POMC;FGF2;JAG1;VEGFA;TAFA4;KITLG;WNT6;CRH;DEFB130A;LRPAP1;FGF7;CCL5;FGF20;GAS6;FGF18;OSGIN2;FAM3C;VIP;BMP6;DAND5;IL6;IL2;BMP5;HMGB1;NPPC;GNRH1;TIMP1;EPO;TNFRSF11B;METRNL;BMP4;IL34;CSPG5;AMH;MIF;IL17D;TNF;AIMP1;CX3CL1;FGF1;MDK;NDP
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5368544817346204,1.1472108609695078,0.30675675675675673,0.7041246838780871,1.0,1/11,2.26%,CHRNB2
prerank,kinesin binding (GO:0019894),0.45056171425731795,1.1470362925108581,0.2893815635939323,0.701491344327974,1.0,8/27,22.65%,PLEKHM2;SPAG9;ACTB;IFT88;AP1G1;NEK6;FAM83D;TOR1B
prerank,methylated histone binding (GO:0035064),0.3958182617487803,1.14668428688132,0.24705882352941178,0.699618360451965,1.0,20/62,22.05%,CXXC1;TTLL12;NCAPG2;MSL3;ING4;BPTF;MTF2;THAP7;RBBP5;WDR5;PHF1;ING3;ING2;CHD5;ING5;ATRX;CBX2;TAF7;TRIM24;GLYR1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4703814858197569,1.1465667027807898,0.28381642512077293,0.6969228226114567,1.0,9/22,28.75%,EXOSC4;CPEB2;CPEB3;EXOSC9;ILF3;DHX36;CPEB1;KHSRP;NUDT21
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.4768940244166724,1.1447246097592432,0.31474597273853777,0.6998630987916565,1.0,3/18,5.09%,ANXA1;PDLIM1;S100A11
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5230395780053132,1.141312785293773,0.2987721691678035,0.7079480992459874,1.0,2/11,8.24%,PPP1R14A;PPP1R14B
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.48746358403008777,1.1402123731221925,0.30375,0.7082940683099813,1.0,5/17,17.84%,AK8;AK4;AK3;AK5;NME6
prerank,RNA polymerase II complex binding (GO:0000993),0.42919670020372586,1.1395855402110833,0.30689655172413793,0.7070225842108154,1.0,17/32,30.08%,AGO2;BRD4;ZNF326;WDR43;ELOF1;SMYD2;HNRNPU;PAF1;RPRD1A;DHX9;CCAR2;RECQL5;SCAF1;SUPT4H1;CTR9;PCIF1;RTRAF
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4447456678650428,1.1390481178456582,0.2941874258600237,0.7056801589625915,1.0,7/28,16.52%,TRAF2;TRAF3;BID;TRAF1;TRAP1;TMBIM1;TNFSF9
prerank,C-C chemokine binding (GO:0019957),-0.3575767988758096,-1.1373193665164485,0.3016759776536313,0.5646874095989384,1.0,9/22,22.56%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;ACKR3;CCR9;CXCR5;CXCR6
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3919414754280953,1.1372887088470687,0.2735949098621421,0.7082598815599822,1.0,11/74,9.86%,FAM20C;DGKZ;PKM;GK;SPHK2;PIK3CB;SPHK1;CHKB;PDXK;HK1;GALK2
prerank,lysine N-methyltransferase activity (GO:0016278),0.47187391696221054,1.1351185440415617,0.3048780487804878,0.7122477580023615,1.0,6/20,20.96%,ETFBKMT;KMT5A;EEF1AKMT3;SMYD2;EHMT1;EEF2KMT
prerank,protein serine/threonine kinase activity (GO:0004674),0.36264395014686107,1.134548568886498,0.114,0.7110280865574222,1.0,100/334,23.00%,FAM20C;CDK14;CDK6;PRKCH;CDK8;PRKCQ;SGK1;IRAK2;SGK3;SGK2;SRPK1;MAPK13;MAP4K5;MAP4K2;DYRK2;PTK2B;SQSTM1;RAF1;PAK6;CDK5;PRKCD;TAOK3;ERN2;PDPK1;STK24;STK3;ERN1;SIK1;IKBKE;BRD4;MAP4K3;SBK1;PLK2;PRKCB;MAPKAPK3;ILK;MAPKAPK2;CSNK1G1;CDK13;STK32A;NEK4;GAK;HIPK1;PIM1;RIOK3;MAP3K12;CDK11B;LIMK1;CDK2;PKN2;PAK2;ROCK1;CPNE3;MAP3K1;STKLD1;PRKD2;FASTK;DAPK1;CSNK1D;MAPK9;STK38;CDC7;SYK;HTATIP2;PLK4;KALRN;MINK1;TLK1;RPS6KA2;CAMK4;STK11;RIPK3;MAP3K8;NLK;NEK6;DAPK3;CLK4;TESK1;ATM;TP53RK;CSNK2A2;PIKFYVE;MAP3K9;TOP1;CDK16;PDK3;MAK;MARK2;LMTK2;RPS6KC1;GSK3B;SRPK2;MARK4;NIM1K;TAOK1;MELK;LATS1;IRAK4;MAPK7;TGFBR2
prerank,I-SMAD binding (GO:0070411),0.5168900644392644,1.1344174956463444,0.3152909336941813,0.7084261535550207,1.0,3/13,13.40%,CTNNB1;SMAD7;SMAD1
prerank,hormone activity (GO:0005179),0.4071199629719134,1.1332140059354538,0.3040614709110867,0.7090091315513493,1.0,11/54,23.57%,IGF1;TRH;NPPA;POMC;CRH;AGRP;VIP;NPPC;GNRH1;METRNL;AMH
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.40841666887295797,1.1324499554671172,0.2903225806451613,0.7082273048078797,1.0,12/49,14.43%,TNIP1;OPTN;SQSTM1;IKBKE;TNIP3;AGAP3;ZRANB3;VCP;ABRAXAS1;SHARPIN;TNIP2;UBQLN1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.511796164174547,1.1318097114435628,0.330567081604426,0.7072802574280663,1.0,4/12,14.71%,NAPSA;CTSE;DDI2;SPPL3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5010407442645681,1.1306741062357766,0.3170731707317073,0.7081278352219793,1.0,6/14,26.76%,AK8;AK4;AK5;NME6;AK7;DTYMK
prerank,myosin V binding (GO:0031489),-0.384012910607054,-1.1295613071210209,0.24423963133640553,0.5727446671055109,1.0,6/15,16.35%,RAB6B;RAB3A;RAB27B;RAB10;RAB39B;RAB3B
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4608637522717561,1.1277935965215036,0.3078817733990148,0.714492494125764,1.0,4/20,6.49%,AK8;TJP2;AK4;AK3
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.282404157448835,-1.1271772831039881,0.21212121212121213,0.5688876199635351,1.0,14/60,11.31%,CSF1R;EPHA6;MERTK;EPHA4;BMPR1B;EPHB1;ERBB3;EGFR;NTRK2;EPHA5;TYRO3;RET;ACVR1B;NTRK3
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3602072198038865,1.1269186910339914,0.17735470941883769,0.7143299293397217,1.0,65/248,19.35%,MYO1E;TSR1;RRAGD;RAP2A;GNA13;ATP2B1;GNAQ;GIMAP7;GTPBP4;ARL8B;EEF2;GPN2;ABCA4;EEF1A1;ARL1;RAB5C;IRGC;RASL12;RHOD;RHOQ;KLC1;CHD3;GEM;AGAP3;BMS1;MMUT;RAB32;RAB8A;VCP;RAB8B;NRAS;KRAS;DNM2;RHOG;RAB7A;VWA8;ABCD2;VPS4B;DRG1;RHOA;KIF1A;RHOU;DHX29;RAB5A;CDC42;EFL1;GNA11;CLU;GNG5;TBC1D24;ARL8A;NKIRAS2;GBP2;RAB22A;RAB1A;SAR1A;RIT1;RALB;GSPT1;DRG2;RAB11A;PIN1;DHX9;GNB1;RHOT2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.541513287737211,1.1260976393120152,0.3360655737704918,0.71382660718672,1.0,3/10,10.43%,B4GALT5;B4GALT7;B3GALT6
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3986971456752097,1.126069000667262,0.3052749719416386,0.7109672619824637,1.0,7/49,7.35%,ANXA5;ANXA1;ESYT1;MCTP1;ANXA4;FER1L5;ANXA6
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3678463043397373,1.125929586108537,0.21407035175879396,0.7084341351296692,1.0,46/173,21.41%,MITF;ATF3;TBX21;DEAF1;SOX30;TBX18;TGIF1;NFIL3;MNT;CC2D1A;PPARG;KLF12;BCL6;GATA3;SATB1;NFX1;ZBTB2;BHLHE40;BHLHE41;PPARD;IRF8;LRRFIP1;OTP;AEBP1;FOXP4;JUN;ZNF148;ENO1;ZKSCAN3;ZBTB34;ZBTB16;MAFK;YY1;ETV6;NFKB1;ELK3;ZBTB25;ZNF177;ZBTB6;NR3C1;ZBTB39;DACH1;JDP2;NFATC3;ZFP57;HSF1
prerank,regulatory RNA binding (GO:0061980),0.4163144544502436,1.1256585269520212,0.30884041331802525,0.7063493774786316,1.0,9/38,19.31%,AGO2;ZC3H7B;ZNF346;DDX21;PIWIL2;HNRNPA2B1;PUM1;DHX9;AGO3
prerank,omega peptidase activity (GO:0008242),0.3766111816679782,1.124571423323079,0.2804503582395087,0.7067790733046999,1.0,44/89,32.38%,TANK;JOSD1;OTULIN;USP12;OTUD4;ATXN3;USP9X;USP5;BAP1;MYSM1;USP40;PSMD14;USP47;GGH;USP53;USP18;DESI2;USP46;USP28;PAN2;USP33;USP36;USP14;OTUD1;USP50;USP2;USP8;USP32;USP1;USP19;OTUD5;BRCC3;TNFAIP3;USP34;STAMBP;USP42;USP30;USP13;USP48;STAMBPL1;USP15;USP11;USP38;ZC3H12A
prerank,RNA polymerase core enzyme binding (GO:0043175),0.42139949573522156,1.1234931996800042,0.3035509736540664,0.7071285357625892,1.0,12/33,20.52%,AGO2;MAF1;ZNF326;WDR43;ELOF1;SMYD2;HNRNPU;PAF1;RPRD1A;DHX9;CCAR2;RECQL5
prerank,pyrophosphatase activity (GO:0016462),0.4078073383010348,1.1234463958184782,0.31053203040173727,0.7043910722131373,1.0,16/50,21.01%,DCTPP1;CILP;NUDT5;NUDT1;NUDT6;DXO;ITPA;DHX29;PRUNE1;ENTPD5;NUDT9;NUDT22;DHX9;ENTPD6;BNIP2;NUDT15
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.35911100899627507,1.1231501600748937,0.18518518518518517,0.7023206067797378,1.0,67/254,24.57%,LITAF;MITF;HIF1A;ATF3;ELF4;NFIC;LEF1;MYBL2;MAFF;SOX30;NR4A3;FOXJ1;KLF6;RUNX1;GATA3;RFX5;SOX9;EGR2;ZNF395;PRDM15;E2F3;HOXA7;MEF2B;ATF5;JUN;NRF1;CEBPA;IRF5;TFAP4;ZBTB16;ELK4;FOXJ3;SMAD1;YY1;EHF;NFYB;DDIT3;PRRX1;NFKB1;SP7;SRF;CEBPG;FOXO1;MTF1;NR4A2;ELK3;NPAS4;GMEB1;TCF12;SP1;NR3C1;NFATC3;SPIB;MEIS3;RFXANK;RXRB;ETV4;RLF;SMARCD2;EGR1;PBX2;REL;LHX4;MDM2;SOX10;GLIS2;ATF4
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3228886272328482,-1.1228902152303515,0.2534246575342466,0.569274432611829,1.0,12/31,21.15%,SLC12A2;SLC12A9;HCN1;ABCC9;SLC12A6;KCNK1;SLC12A8;KCNK5;KCNK10;KCNK4;KCNK7;KCNG1
prerank,ligand-gated cation channel activity (GO:0099094),-0.2627376224555148,-1.1215276708215312,0.17647058823529413,0.562879806239438,1.0,24/75,19.48%,GRIA4;GRIK2;GRIK3;GRIN2A;KCNJ3;GRIA3;GRIK4;GRIN2B;KCNK1;TRPM4;KCNN3;MCOLN1;KCNN2;KCNJ13;GRIN1;KCNH2;KCNJ12;KCNK6;GRIA2;CHRNA7;GRIN3A;KCNN1;TRPM2;P2RX3
prerank,acetylcholine receptor activity (GO:0015464),-0.35413828459806596,-1.1204029714859527,0.2694610778443114,0.556688183878869,1.0,11/22,33.16%,CHRM2;CHRM3;CHRFAM7A;CHRNA7;CHRNA5;HRH3;CHRNA4;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,NAD+ binding (GO:0070403),-0.4158931174979794,-1.1201029119167196,0.30454545454545456,0.54866076795267,1.0,3/12,3.36%,HPGD;CRYL1;GLUD1
prerank,phosphatidylinositol binding (GO:0035091),0.37612187860664925,1.1196684700609683,0.2647362978283351,0.7104173782744384,1.0,42/91,30.85%,MYO1E;EEA1;SNX24;SNX8;ESYT1;SCIN;WDFY1;WDR45;SNX10;HIP1;PITPNC1;SESTD1;GPAA1;PLEKHF1;NUMA1;ING2;APPL2;SNX4;HIP1R;ITPR3;SNX31;SNX12;SNX11;SNX1;PLEKHF2;WDFY3;CCDC88A;ESYT2;NCF1;DENND1B;MREG;PITPNM1;ITPR1;EPB41;AIDA;SNX27;SNX17;PIGU;SH3YL1;FES;RNF34;PLEKHN1
prerank,calcium channel regulator activity (GO:0005246),0.4096370718723214,1.1188835538948896,0.32840909090909093,0.7097931779595616,1.0,16/37,31.26%,SGK1;REM1;SGK3;GEM;SRI;PHPT1;CACNG7;CACNB3;RRAD;INAFM2;FKBP1B;ITPR1;FKBP1A;PRKG1;STIM1;CALM1
prerank,poly-pyrimidine tract binding (GO:0008187),0.45046134270827276,1.1179458315425734,0.3407960199004975,0.7097081002163914,1.0,9/23,23.19%,PABPC5;PATL1;ATXN1;HNRNPC;PABPC1;RBM11;HNRNPU;PABPC4;RBMS2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5056194969885431,1.1177541497570291,0.34564643799472294,0.707436705126353,1.0,4/12,14.56%,SLC9A1;SLC9A8;SLC9A7;SLC9A6
prerank,store-operated calcium channel activity (GO:0015279),0.5286513236687259,1.1173560896928283,0.3604336043360434,0.7060036998458725,1.0,1/10,0.25%,TRPC4
prerank,single-stranded DNA binding (GO:0003697),0.3773501117983523,1.1173466679047352,0.27703398558187436,0.7032490090156993,1.0,30/93,24.93%,RAD51B;MCM7;MCM2;ERCC1;IGHMBP2;FUBP1;POLR2H;LONP1;DMC1;BLM;POLR2D;ERCC4;HSPD1;TWNK;WBP11;PCBP1;DHX36;HNRNPU;PURA;JCHAIN;DHX9;TOP1;HMGB1;RAD51AP1;MCM6;MCM8;SETMAR;WDR48;XPC;SMC6
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5274955634264307,1.1169988266656756,0.34010840108401086,0.7014700781286326,1.0,4/10,20.98%,DAXX;ANKRD13B;ANKRD13A;LAPTM5
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.43458999680566623,-1.115215050004951,0.2886178861788618,0.5498633721871085,1.0,6/10,29.05%,MGME1;POLD1;FEN1;APEX1;EXD2;DCLRE1B
prerank,low-density lipoprotein particle binding (GO:0030169),0.48280849701957235,1.1132874983839383,0.35751295336787564,0.7102197170553414,1.0,2/16,7.29%,COLEC12;TREM2
prerank,glucose transmembrane transporter activity (GO:0005355),0.4659522442155371,1.1117350623318223,0.33722438391699094,0.7125147436533394,1.0,5/17,21.90%,SLC5A1;SLC2A1;SLC2A8;SLC5A3;SLC2A6
prerank,ubiquitin protein ligase binding (GO:0031625),0.3591094187626062,1.1111635352693543,0.2042042042042042,0.711440075099079,1.0,80/254,25.81%,BCL2;HIF1A;PSMD1;UBA52;TANK;TRAF2;RPS27A;CCT2;PRDX6;SQSTM1;FBXW7;MFHAS1;TRAF3;DAXX;PTPN22;RPL23;TRIM28;IKBKE;EGR2;ATXN3;ACTG1;UBE2L3;RPL11;BRCA1;VCP;TRAF1;JUN;JAK1;TNFRSF1B;SHPRH;MAP1LC3B;HSPA8;SMAD7;FZD4;SUMO2;UBE2L6;CLU;HSPD1;DERL1;HSPA9;FOXO1;EIF4E2;WFS1;TUBB;RALB;ELOB;NLK;GPI;NEK6;ATP6V0C;CUL3;FBXO7;UBC;RNF20;LAPTM4B;SPART;LAPTM5;CUL1;HSP90AB1;GSK3B;PRKAR1A;MAP1LC3A;TRIOBP;TRIB2;GABARAP;CUL2;CALR;DNAJA1;PSMA3;SCAMP3;MDM2;USP2;SUMO1;PRR5L;HSPA5;SMC6;YWHAZ;CUL4A;ABI2;PIAS4
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.526770261362374,1.110800213115125,0.33643617021276595,0.7099367841168315,1.0,2/11,5.41%,NUDT5;NUDT1
prerank,amyloid-beta binding (GO:0001540),0.3786732045607826,1.1097878866366622,0.29936974789915966,0.7102168608095097,1.0,17/79,16.13%,CACNA1A;APBB2;APOE;LRP1;FPR2;GSAP;TREM2;ATP1A3;LILRB1;LILRB3;LRPAP1;IAPP;PFDN1;FZD4;CLU;ITGB2;HSPG2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5014620811054634,1.105683888279328,0.3413333333333333,0.719756557860366,1.0,6/12,26.58%,SLC25A24;SLC25A25;SLC19A1;SLC17A9;SLC35B3;SLC25A23
prerank,C-C chemokine receptor activity (GO:0016493),-0.3510684470964499,-1.1050944886282865,0.28272251308900526,0.5636331371139329,1.0,9/21,22.56%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;ACKR3;CCR9;CXCR5;CXCR6
prerank,exoribonuclease activity (GO:0004532),0.5022104516828174,1.104033145619494,0.34562841530054644,0.7221829519296541,1.0,5/12,20.91%,EXOSC4;EXOSC9;EXOSC10;EXOSC5;CNOT6
prerank,voltage-gated chloride channel activity (GO:0005247),0.525573292730112,1.1033127954590485,0.35157318741450067,0.7215485376862655,1.0,3/10,18.39%,CLCN1;ANO6;CLCN4
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.43618316666247475,1.103164542725748,0.3418491484184915,0.7192871027441209,1.0,5/23,12.34%,SH3PXD2B;ATP13A2;WDR45;HIP1;SESTD1
prerank,protein kinase regulator activity (GO:0019887),0.36937725857063053,1.102670115212766,0.3079331941544885,0.7180055247011099,1.0,27/95,22.43%,FGF13;CCNY;SMCR8;TAOK3;DAXX;CCNL1;NCK1;CCNC;CCNB1;GPRC5C;CCNL2;PARVA;GPRC5B;CAB39;SPRY4;CCND2;PRKAG1;GSKIP;STK11;YWHAB;CCNT2;ITPRIP;EPO;MARK2;NPM1;PRKAR1A;ELP3
prerank,metal ion binding (GO:0046872),0.3485811115911649,1.1013929795419617,0.159,0.7190845440626571,1.0,103/477,19.88%,IQGAP1;LCP1;LPL;S100A8;S100A9;APOE;LRP1;ABL2;ASPH;MMP12;POSTN;MAN1C1;RAP2A;DCTPP1;ANXA5;ANXA1;SLC25A24;PLSCR2;CERK;ESYT1;SRPK1;THG1L;ANXA11;ADAM8;GJB2;FIGNL1;MCTP1;ANXA4;SCIN;HRG;S100A7A;FER1L5;ADAMTS13;PON1;DHH;SPHK1;DYRK2;MTHFD2;NUDT5;S100A6;S100A11;ERN2;CRACR2A;DSG3;STK3;PI4K2A;TPT1;ERN1;SIK1;SELL;TPD52;ANXA6;CAPN1;PDXK;RASGRP1;RASGRP3;PRF1;CDH1;PAPOLA;GEM;TPM4;SRI;ARSA;MASP1;S100A16;EFHD2;FBLN1;DXO;GSN;ADPRS;PIR;GCA;RCN3;RASGRP2;CLEC6A;STK38;MCTP2;DHX36;CHP1;ANXA3;TKT;CLEC4E;STK11;NUDT22;NLK;NEK6;S100B;MEX3B;CLYBL;IDH3A;SPARCL1;ITPR3;AASDHPPT;BNIP2;SYT8;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,inward rectifier potassium channel activity (GO:0005242),-0.33544844412578445,-1.0986994338061862,0.3103448275862069,0.5693343105952475,1.0,10/24,18.65%,KCNJ3;ABCC9;KCNK1;KCNN3;KCNN2;KCNJ13;KCNH2;KCNJ12;KCNK6;KCNN1
prerank,ribosomal small subunit binding (GO:0043024),0.46216032245972904,1.0972856803941446,0.3515527950310559,0.7291666098808391,1.0,8/17,26.93%,EIF1;CPEB2;PIM1;LARP1;DHX29;NPM1;EIF4B;EIF1B
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5073216550146498,1.0972421523452625,0.37057220708446864,0.7265698189962768,1.0,6/11,26.58%,SLC25A24;SLC25A25;SLC19A1;SLC17A9;SLC35B3;SLC25A23
prerank,poly(U) RNA binding (GO:0008266),0.45264950073054244,1.0957990303131009,0.3480453972257251,0.7280547747716176,1.0,8/20,23.19%,PABPC5;PATL1;ATXN1;HNRNPC;PABPC1;RBM11;PABPC4;RBMS2
prerank,small GTPase binding (GO:0031267),0.3518868747227447,1.0948727536485452,0.2972699696663296,0.7280288922134261,1.0,43/169,18.07%,IQGAP1;MYO9B;MYO5A;ABCA1;FLNA;DMXL2;RGP1;OPTN;AKAP13;SPHK2;ALS2;GOLGA4;RAF1;CAV1;RUSC2;RTKN;FGD6;RAPGEF6;RIC1;RANGRF;ATP6AP1;RANBP9;RAB8A;RABGGTB;NDRG1;EXOC2;GCC2;RANBP1;IQGAP2;PAK2;SIKE1;YBX3;BIRC5;RANBP2;RCC1;HPS6;DOCK7;GGA2;AP1G1;AFDN;RAB3GAP2;DAPK3;TBC1D20
prerank,microtubule minus-end binding (GO:0051011),0.49364118547586827,1.0939874905393798,0.38992042440318303,0.7279775666276327,1.0,3/13,14.57%,MACF1;TUBGCP4;NUMA1
prerank,GTPase activity (GO:0003924),0.3517134969553478,1.0935832619155157,0.2716297786720322,0.7264963522894636,1.0,50/192,18.12%,TSR1;RRAGD;RAP2A;GNA13;GNAQ;GIMAP7;GTPBP4;ARL8B;EEF2;GPN2;ABCA4;EEF1A1;ARL1;RAB5C;IRGC;RASL12;RHOD;RHOQ;GEM;AGAP3;BMS1;MMUT;RAB32;RAB8A;RAB8B;NRAS;KRAS;DNM2;RHOG;RAB7A;DRG1;RHOA;RHOU;RAB5A;CDC42;EFL1;GNA11;GNG5;TBC1D24;ARL8A;NKIRAS2;GBP2;RAB22A;RAB1A;SAR1A;RIT1;RALB;GSPT1;DRG2;RAB11A
prerank,single-stranded RNA binding (GO:0003727),0.39666788461571667,1.09078284986111,0.3436123348017621,0.7320637810470763,1.0,13/43,19.31%,PUS1;AGO2;ZFR;LONP1;EXOSC10;ILF3;RBM11;POLR2D;HNRNPU;CNBP;HNRNPF;DHX9;AGO3
prerank,miRNA binding (GO:0035198),0.41622217990684396,1.08737783373141,0.3710618436406068,0.7395786503538324,1.0,7/30,19.31%,AGO2;ZC3H7B;ZNF346;DDX21;HNRNPA2B1;PUM1;AGO3
prerank,histone demethylase activity (GO:0032452),0.42444447423202,1.0850512609648826,0.36406067677946324,0.743866549997009,1.0,8/27,16.27%,JMJD1C;HR;KDM3A;RIOX1;KDM3B;RIOX2;FBXL19;KDM4D
prerank,chloride channel regulator activity (GO:0017081),0.4736571836056338,1.0844063694056219,0.384418901660281,0.743147144676594,1.0,2/14,2.36%,SGK1;SGK3
prerank,filamin binding (GO:0031005),0.5036412537744459,1.0829489367847636,0.3821138211382114,0.7447041535606842,1.0,1/11,0.29%,FBLIM1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5112852293060781,1.0794779440447637,0.39745403111739747,0.7528674118159955,1.0,5/10,21.48%,CACNA1A;CACNA1D;CACNB3;CACNB1;CACNB4
prerank,G protein-coupled receptor binding (GO:0001664),0.3563141236351894,1.079251310354693,0.3282520325203252,0.7508500978432906,1.0,23/132,15.85%,SDCBP;FLNA;CCDC88C;GNA13;GNAQ;NPPA;POMC;NPB;SAG;PDCD6IP;ZNRF3;WNT6;BAMBI;MYOC;CCL5;FZD1;HSPA8;GPRC5B;HOMER2;GNA11;LRP6;ARHGEF11;C1QBP
prerank,transcription coregulator binding (GO:0001221),0.38647063712080165,1.0786790418323364,0.3929747530186608,0.7499458278857046,1.0,15/50,23.03%,CTNNB1;RPL23;MTF2;PPARD;THAP7;ZBTB16;PHF1;EED;CHD6;NEK6;CCNT2;FAM89B;EHMT1;TERT;AHR
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.43386837602444295,1.077604157118623,0.4026128266033254,0.7504286404371078,1.0,4/25,5.53%,MICAL2;CYP27B1;MICAL1;POR
prerank,metal ion:proton antiporter activity (GO:0051139),0.4814554122326233,1.075345756404332,0.37417654808959155,0.7546092943261291,1.0,5/13,19.58%,SLC9A1;SLC9A8;SLC9A7;SLC9A6;SLC11A1
prerank,tubulin binding (GO:0015631),0.34284973617231496,1.0752927646693866,0.2822822822822823,0.7520781078896952,1.0,77/295,21.76%,FMN1;FGF13;GAS2L3;S100A8;S100A9;UXT;CCDC88C;MAP10;KIF13B;DAG1;ALDOA;TUBGCP4;FAM110C;TTLL12;CDK5;ARL8B;AGBL5;CLIP2;EML4;HTT;HOOK1;TBCA;HAUS8;CFAP157;BRCA1;RMDN2;ABRAXAS1;FYN;REEP3;DCTN1;ATF5;DNM2;DRG1;NDRG1;KIF1A;MAP1LC3B;PRUNE1;GPAA1;CRIPT;KIF20A;DCX;BIRC5;GIT1;INO80;NUMA1;TPR;VAPB;SMC3;ARL8A;RACGAP1;CHP1;TOGARAM2;POLB;IFT74;CEP44;KIFC1;RAE1;HOOK3;KRIT1;KIF21B;RAB11A;REEP1;GJB6;MDM1;CCSAP;AGTPBP1;FAM83D;ARHGEF2;DST;TERF1;RPS3;CCT5;CEP57L1;ARL4C;MARK4;MAP1LC3A;TAOK1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.48555845067320946,1.0740965943848135,0.4059539918809202,0.752998869365729,1.0,4/13,21.85%,BMP8B;BMP6;BMP5;BMP4
prerank,glycine binding (GO:0016594),-0.40612121126257067,-1.0711599186103706,0.3576923076923077,0.6236889478397598,1.0,6/11,16.91%,GLRA3;GRIN2B;GRIN1;GLRA2;GLRA1;GRIN3A
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.39551052081504917,-1.070969786336034,0.36475409836065575,0.6150699798436247,1.0,3/11,6.83%,CASP2;CASP3;CASP6
prerank,diacylglycerol kinase activity (GO:0004143),0.4975696930629476,1.0707166192668496,0.3779840848806366,0.7606071629352823,1.0,4/11,17.10%,DGKZ;DGKA;DGKH;DGKD
prerank,AMP binding (GO:0016208),0.49597928569099464,1.0696480894058704,0.4049586776859504,0.7612381871716285,1.0,4/11,17.08%,PFKL;PFKP;APRT;PRKAG1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4000033092241503,-1.0686649494832723,0.34782608695652173,0.6109599577043054,1.0,8/12,32.75%,ELOVL4;OPN3;GPR88;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,acylglycerol lipase activity (GO:0047372),0.4930525716668255,1.0685751467668891,0.3816689466484268,0.7616884959914759,1.0,2/11,5.96%,ABHD12;MGLL
prerank,microtubule binding (GO:0008017),0.3427818718052602,1.0683181508792448,0.3276553106212425,0.7597933786317208,1.0,53/222,20.19%,FMN1;FGF13;GAS2L3;S100A8;S100A9;UXT;CCDC88C;MAP10;KIF13B;MACF1;TUBGCP4;CDK5;CLIP2;EML4;HOOK1;HAUS8;CFAP157;RMDN2;ABRAXAS1;REEP3;DCTN1;DNM2;DRG1;NDRG1;KIF1A;MAP1LC3B;CRIPT;KIF20A;DCX;BIRC5;NUMA1;VAPB;RACGAP1;CHP1;TOGARAM2;POLB;CEP44;KIFC1;RAE1;HOOK3;KRIT1;KIF21B;RAB11A;REEP1;GJB6;MDM1;CCSAP;FAM83D;ARHGEF2;DST;TERF1;RPS3;FBXW11
prerank,pentosyltransferase activity (GO:0016763),0.40275367268689655,1.0681182938249763,0.3857634902411022,0.757684921119308,1.0,15/36,26.13%,UMPS;LARGE1;PARP4;TNKS2;SIRT5;ART4;TIPARP;QTRT1;ZC3HAV1;SIRT4;PARP3;PPAT;PARP2;SIRT3;PARP16
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.49458143494532897,1.0677325076896618,0.4002659574468085,0.7561589260915332,1.0,1/11,0.25%,TRPC4
prerank,DNA binding (GO:0003677),0.335256046451084,1.0655619321487169,0.222,0.7601350183259573,1.0,187/694,25.87%,BCL2;HIF1A;IKZF3;ERCC6;DNMT3A;CSRNP1;C1D;MMP12;NFYA;NFE2L2;ARID5B;LEF1;DEDD2;TBX21;PARP4;RAD51B;MAFF;EOMES;SOX3;IRF6;NR4A3;SPHK1;VDR;POU3F1;MCM7;MCM2;HDAC4;ERCC1;PPARG;IGHMBP2;SNAPC1;FOXJ1;KLF12;BCL6;GATA3;CUX1;APLP2;TAF4B;RFX5;TRIM28;SOX9;FUBP1;MSL3;SATB1;EGR2;DNMT1;SDE2;BPTF;HES7;TFPT;POLR2H;ZNF395;MTF2;TRIM16;POLE;CHD3;HMGN1;PPARD;E2F3;DDB2;HOXA7;LRRFIP1;BRCA1;NKX2-1;OTP;DDB1;POGK;SMARCB1;ATF5;JUN;RAD50;FOSB;ZNF148;LONP1;CEBPA;HUWE1;XPA;HP1BP3;IRF5;DMC1;ZKSCAN3;PRDM9;TFAP4;SAFB2;BLM;ZBTB16;ELK4;CHCHD2;ZDHHC1;PHF1;FOXJ3;ILF3;MBD4;H1-0;MAFK;YY1;EHF;JRK;NFYB;DNASE2;POLR2D;CENPX;DDIT3;INO80;ERCC4;HSPD1;SP7;TWNK;RPS27;WBP11;SPATA24;ING2;PCBP1;CEBPG;FOXO1;MTF1;NR4A2;PMS1;DHX36;POLG2;ZNF638;MYBBP1A;SP1;HNRNPU;CNBP;PURA;RFC1;USF2;KIN;JCHAIN;DHX9;RAD1;ZBTB6;LYAR;TARDBP;AIFM2;TAF6;YAF2;POLG;TOP1;TCF7L1;HMGB1;RAD51AP1;TERF1;RPS3;MCM6;SREBF1;MEIS3;DCLRE1A;CHD2;MCM8;DNASE1L1;PBX1;HSF1;ZMYM4;TEAD1;SETMAR;SNAPC4;GLYR1;TERT;CALR;RLF;WDR48;AHR;EGR1;CREBZF;KMT2D;XRN1;LHX4;RXRA;XPC;ZBTB4;SOX10;SIRT3;ATF4;HDAC2;ZGPAT;SMC6;SMARCA4;POU2F1;PALB2;GRHL1;CSRNP3;TFCP2;AIM2;MYRF;HIC2
prerank,DNA polymerase binding (GO:0070182),0.451001362118735,1.065440608140417,0.385297845373891,0.7578875346911108,1.0,9/18,26.29%,LONP1;POLG2;RTEL1;PTGES3;HMGB1;HSP90AB1;ACD;SMARCA4;NAT10
prerank,BMP receptor binding (GO:0070700),0.48557216501459183,1.064257531750253,0.4159891598915989,0.7589325077312126,1.0,4/12,21.85%,BMP8B;BMP6;BMP5;BMP4
prerank,calcium ion binding (GO:0005509),0.3386988921639648,1.0641236139342054,0.282,0.7567686372061194,1.0,46/323,11.96%,IQGAP1;LCP1;LPL;S100A8;S100A9;LRP1;ASPH;MMP12;MAN1C1;ANXA5;ANXA1;SLC25A24;PLSCR2;ESYT1;ANXA11;ADAM8;GJB2;MCTP1;ANXA4;SCIN;S100A7A;FER1L5;ADAMTS13;PON1;DHH;S100A6;S100A11;CRACR2A;DSG3;TPT1;SELL;TPD52;ANXA6;CAPN1;RASGRP1;RASGRP3;PRF1;CDH1;TPM4;SRI;ARSA;MASP1;S100A16;EFHD2;FBLN1;GSN
prerank,sequence-specific DNA binding (GO:0043565),0.33375173840104677,1.063750508463971,0.232,0.7553592283516446,1.0,142/590,26.08%,BCL2;CXXC1;HIF1A;IKZF3;CSRNP1;TCF7;MMP12;ATF3;ELF4;KMT2A;NFIC;NFE2L2;LEF1;TBX21;MYBL2;BCL11B;MAFF;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;TBX18;MEF2D;POU3F1;NCL;TGIF1;TFEB;HDAC4;PPARG;SHOX2;SNAPC1;KLF12;KLF6;BCL6;GATA3;CUX1;RFX5;ZBTB7B;SOX9;SATB1;EGR2;BPTF;HES7;ZBTB2;BHLHE40;BHLHE41;PPARD;E2F3;IRF8;HOXA7;TET3;SOX7;KLF13;IRX5;PRMT5;MEF2B;ATF5;JUN;FOSB;ZNF148;ELF2;LONP1;XPA;IRF5;ZFP41;ZKSCAN3;PRDM9;MAFG;TFAP4;SAFB2;ELK4;CHCHD2;FOXJ3;MAFK;YY1;MBNL2;FBXL19;NHLH2;SRF;CEBPG;FOXO1;MTF1;NR4A2;ELK3;ZNF296;GMEB2;CHTOP;GMEB1;MYBBP1A;DMRTA2;TCF12;SP1;HNRNPU;USF2;ZNF177;UPF3A;HOXB4;NR3C1;SP9;TCF7L1;JDP2;NFATC3;TERF1;SPIB;SREBF1;MEIS3;HOXC9;PBX1;RXRB;HSF1;RUNX3;ETV4;ACD;TEAD1;TERT;FOXR2;ZBTB43;KLF11;ARNT2;PRRX2;AHR;EGR1;LHX4;RXRA;ZBTB4;SOX10;GLIS2;SIRT3;ATF4;HDAC2;ZGPAT;POU2F1;GRHL1;CREB5;CSRNP3;TFCP2;MYRF;TLR9;ZBTB12;NR6A1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.43323146393665074,1.06252065547712,0.40572792362768495,0.7563652793196276,1.0,4/24,6.49%,AK8;ITPKB;AK4;AK3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.32584453503752514,-1.0620859750400726,0.3564356435643564,0.6180921557474922,1.0,4/21,5.14%,PDE3B;PDE10A;PDE1A;PDE8B
prerank,cytokine receptor binding (GO:0005126),0.36207330124574033,1.0607280596024948,0.37643378519290926,0.7589106694130692,1.0,23/83,24.48%,CSF1;SDCBP;CD300LF;OSMR;IL27;IL12RB1;VEGFA;IL27RA;KITLG;ADAM17;JAK1;CCL5;TGFBRAP1;SYK;TNFSF9;IL6;IL2;SPRED2;EPO;IL34;MIF;SOCS2;JAK2
prerank,DNA-binding transcription factor binding (GO:0140297),0.3435930264739868,1.0575033954170916,0.34734734734734735,0.7655657745499026,1.0,63/189,29.61%,BCL2;CTNNB1;NFE2L2;HDAC9;HDAC7;ID2;EOMES;MEF2D;BBS10;HDAC4;HSPB1;PPARG;NOC2L;SIK1;EGR2;HDAC1;BHLHE40;BHLHE41;PPARD;CRTC1;JUN;TLE5;CHCHD2;NFYB;DDIT3;PRRX1;NHLH2;SRF;TCF12;TBP;MKKS;SP1;NEK6;PURA;DAPK3;USF2;DHX9;LYAR;MIER2;PIAS1;HMGB1;MTDH;GSK3B;NPM1;MTA3;ATF4;HDAC2;ATN1;YWHAZ;PIAS4;HCFC1;BBS7;KDM1A;EIF4E;HES1;DACT1;ZBTB17;CRTC3;CRTC2;WWP2;TLE1;SIRT1;PURB
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4805466426221031,1.0560170554803565,0.41952506596306066,0.7672503930629982,1.0,5/12,16.27%,JMJD1C;HR;KDM3A;KDM3B;KDM4D
prerank,endopeptidase activator activity (GO:0061133),-0.4102022232191426,-1.055235509864116,0.3559322033898305,0.6251604045677497,1.0,3/10,10.02%,VSIR;APH1B;ADRM1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4065125388494701,1.0546859661212733,0.41133896260554886,0.7686063467366171,1.0,10/29,20.64%,GAA;GALC;GLA;GUSB;NEU1;ADPRS;MGAM;IDUA;GBA2;ABHD10
prerank,methylation-dependent protein binding (GO:0140034),0.36724848653821324,1.0542546029697388,0.40563991323210413,0.7672745879408089,1.0,17/57,22.05%,CXXC1;NCAPG2;MSL3;ING4;BPTF;MTF2;THAP7;RBBP5;WDR5;PHF1;ING3;ING2;ING5;ATRX;CBX2;TRIM24;GLYR1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.33308528433092277,1.0532580709799007,0.278,0.7675706114388123,1.0,137/597,23.49%,TCF7;ATF3;ELF4;FOXN1;NFYA;NFIC;NFE2L2;ARID5B;ORC3;LEF1;TBX21;MYBL2;BCL11B;MAFF;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;TBX18;MEF2D;POU3F1;MCM7;MCM2;TGIF1;GRWD1;TFEB;HDAC4;PPARG;SHOX2;FOXJ1;KLF12;KLF6;RUNX1;BCL6;GATA3;CUX1;RFX5;ZBTB7B;SOX9;EGR2;HES7;ZBTB2;BHLHE40;CHD3;BHLHE41;PPARD;BASP1;E2F3;IRF8;HOXA7;BRCA1;NKX2-1;SOX7;KLF13;IRX5;CREB3L2;MEF2B;ATF5;JUN;FOSB;ELF2;RBBP5;CEBPA;XPA;IRF5;ARID4B;ZFP41;PRDM9;CARM1;MAFG;TFAP4;ELK4;FOXJ3;MBD4;MAFK;YY1;NFYB;MBNL2;DDIT3;NFKB1;HSPD1;NHLH2;SRF;CEBPG;MTF1;NR4A2;ELK3;ZNF296;DHX36;GMEB2;GMEB1;PSPC1;DMRTA2;TCF12;TBP;SP1;HNRNPU;DHX33;GABPB1;GABPB2;KAT7;USF2;DHX9;ZNF177;TAF7;HOXB4;NR3C1;SP9;TCF7L1;HMGB1;JDP2;NFATC3;SPIB;MCM6;SREBF1;MEIS3;MCM8;HOXC9;PBX1;RXRB;HSF1;RUNX3;ETV4;TEAD1;FOXR2;ZBTB43;KLF11;ARNT2;PRRX2;AHR;EGR1;ZNF568;CREBZF;KMT2D;LHX4
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.4010884206748485,-1.0525798782926212,0.3769230769230769,0.6225219834554039,1.0,3/10,6.83%,CASP2;CASP3;CASP6
prerank,leucine zipper domain binding (GO:0043522),0.5017017809493273,1.051998990832227,0.41365461847389556,0.7688170735118262,1.0,5/10,28.94%,MRTFA;DDIT3;DAPK3;ATF4;PAWR
prerank,pyridoxal phosphate binding (GO:0030170),0.4341301957907433,1.0506192654421307,0.41504854368932037,0.7701792381551085,1.0,12/20,36.65%,PDXK;SHMT1;OAT;PSAT1;PYGM;SRR;PLPBP;SHMT2;CBS;PNPO;CTH;PYGB
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.33867512533980554,1.0504684536585478,0.3383383383383383,0.7680503035274139,1.0,83/269,26.20%,BCL2;HIF1A;PSMD1;UBA52;TANK;TRAF2;RPS27A;CCT2;PRDX6;SQSTM1;FBXW7;MFHAS1;TRAF3;DAXX;PTPN22;RPL23;TRIM28;IKBKE;EGR2;ATXN3;ACTG1;UBE2L3;RPL11;BRCA1;VCP;CCNB1;TRAF1;JUN;JAK1;TNFRSF1B;SHPRH;MAP1LC3B;HSPA8;SMAD7;FZD4;SUMO2;UBE2L6;CLU;HSPD1;DERL1;HSPA9;FOXO1;EIF4E2;WFS1;TUBB;RALB;ELOB;NLK;GPI;NEK6;ATP6V0C;CUL3;FBXO7;UBC;RNF20;LAPTM4B;SPART;LAPTM5;CUL1;HSP90AB1;GSK3B;PRKAR1A;MAP1LC3A;TRIOBP;TRIB2;GABARAP;CUL2;CALR;DNAJA1;PSMA3;SCAMP3;MDM2;USP2;SUMO1;PRR5L;HSPA5;SMC6;YWHAZ;CUL4A;ABI2;PIAS4;UBE2C;HM13
prerank,nuclear receptor coactivator activity (GO:0030374),0.3713594809730519,1.045687576437674,0.41471571906354515,0.7794615271375896,1.0,23/52,30.17%,ZMIZ1;FGF2;ZMIZ2;ACTN1;PRKCB;MED17;SLC30A9;CARM1;PPARGC1B;HELZ2;MED13;CCAR2;CCAR1;TMF1;CNOT6;ACTN4;PPRC1;DCAF6;KDM1A;BRD8;MED1;CNOT9;MED30
prerank,GDP binding (GO:0019003),0.36646259828680344,1.0436396332719498,0.4128342245989305,0.7829006995491568,1.0,15/63,17.60%,RRAGD;RAP2A;ARL8B;RAB5C;RASL12;GEM;RAB8A;RAB8B;NRAS;KRAS;RAB7A;RAB5A;RAB22A;RIT1;RALB
prerank,transferrin receptor binding (GO:1990459),-0.4085144731021834,-1.0406987186811845,0.39361702127659576,0.6417697633060979,1.0,2/10,6.06%,SNX2;CD81
prerank,amino acid binding (GO:0016597),-0.29256093430013796,-1.0406728611874607,0.390625,0.6332987002578876,1.0,11/31,16.91%,GRM7;GLRA3;GRIN2B;AGXT;NOS1;GRIN1;GLRA2;CASTOR1;GLRA1;DDAH2;GRIN3A
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4676597018439383,1.0365548749783413,0.44903225806451613,0.8006436920097616,1.0,7/12,35.94%,TENT5C;PAPOLA;MTPAP;PAPOLG;TENT4B;TUT1;TENT4A
prerank,endoribonuclease activity (GO:0004521),0.3898960342655209,1.034935350893504,0.44221698113207547,0.8025602899200313,1.0,9/32,21.81%,AGO2;ERN2;PIWIL2;ERN1;RNASEL;ZC3H12B;AGO3;ZC3H12D;SND1
prerank,transcription corepressor binding (GO:0001222),0.41041702702102567,1.0344162973141173,0.43779904306220097,0.8014994442655828,1.0,12/27,32.34%,MTF2;THAP7;ZBTB16;PHF1;EED;NEK6;FAM89B;EHMT1;HDAC3;PER3;HDGF;USP11
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3715219045596063,-1.03387166732225,0.3948497854077253,0.6405716084404677,1.0,2/13,4.38%,SREBF2;IDI1
prerank,platelet-derived growth factor binding (GO:0048407),0.48149265731552926,1.0335175486701758,0.4445927903871829,0.8016888382136637,1.0,2/11,6.77%,PDGFA;COL4A1
prerank,calcium:sodium antiporter activity (GO:0005432),0.49173557691130976,1.0318583064282616,0.45188284518828453,0.8039203693091107,1.0,2/10,1.52%,SLC3A2;SLC24A4
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.3834399800115553,-1.0315282337923852,0.3661417322834646,0.6371591897399264,1.0,7/12,35.33%,BMPR1B;ENG;LTBP1;BMPR2;TGFBR1;LTBP4;BMPR1A
prerank,ion gated channel activity (GO:0022839),0.4087551135006502,1.0307071984525082,0.45607701564380265,0.8047659641359678,1.0,3/24,5.38%,TTYH2;ANO9;ANO8
prerank,monocarboxylic acid binding (GO:0033293),0.4343166651959582,1.0299825134738738,0.45478036175710596,0.8042421064859846,1.0,2/18,7.21%,PSAP;NAPEPLD
prerank,clathrin adaptor activity (GO:0035615),0.45551370062317637,1.025165106255365,0.45186136071887034,0.8156565129837524,1.0,8/15,33.33%,DAB2;HIP1;AP1G1;HIP1R;AP1M1;STON1;LDLRAP1;AP2B1
prerank,chemokine binding (GO:0019956),0.39170976868221935,1.0241705301113104,0.4652777777777778,0.8160174208074845,1.0,5/30,5.01%,CXCR2;PDPN;PLP2;FGF2;ITGA4
prerank,CoA hydrolase activity (GO:0016289),0.4445280910134244,1.0237633215045614,0.4630606860158311,0.8145934133259668,1.0,6/16,27.29%,ACSBG2;ACOT9;ACOT6;ACOT1;ACAA2;ACOT8
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.30566839562502546,-1.0235233232090448,0.37244897959183676,0.647085878798327,1.0,4/23,5.14%,PDE3B;PDE10A;PDE1A;PDE8B
prerank,nuclear localization sequence binding (GO:0008139),0.43258904655272074,1.0219488489818829,0.4551122194513716,0.8171844232112286,1.0,4/18,10.70%,BRAP;IPO5;KPNA4;KPNA6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4645072915509376,1.0209061809531044,0.465954606141522,0.8176769411491868,1.0,4/13,22.29%,SLC7A1;SLC7A6;SLC38A7;SLC7A2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.43341253357232584,1.0205432442074616,0.46475195822454307,0.8162456595513231,1.0,9/17,35.96%,ACSBG2;ACOT9;ACOT6;ACOT1;ACAA2;ACOT8;ACOT13;ACOT4;PLA2G6
prerank,thyroid hormone receptor binding (GO:0046966),0.40167271364585405,1.0205101833112338,0.4632438739789965,0.8137918943598969,1.0,13/28,30.17%,JMJD1C;TRIP12;MED17;MED13;PRMT2;GTF2H1;TAF7;NSD1;BRD8;OASL;MED1;TRIP6;MED30
prerank,hyaluronic acid binding (GO:0005540),0.47635814262456405,1.0203342013105317,0.4567901234567901,0.8118214039555053,1.0,3/10,15.85%,CD44;CHODL;C1QBP
prerank,transforming growth factor beta receptor binding (GO:0005160),0.43630853664601027,1.0201810924839452,0.46923076923076923,0.8097189499139177,1.0,10/18,38.22%,BAMBI;TGFBRAP1;SMAD7;FERMT2;TGFBR2;FKBP1A;USP15;TGFB1;TGFB2;SMAD6
prerank,endonuclease activity (GO:0004519),0.36330621550668046,1.0193688085601982,0.4760845383759733,0.809456030150387,1.0,14/49,21.92%,AGO2;ERN2;PIWIL2;ERN1;RNASEL;ZRANB3;MBD4;ERCC4;ZC3H12B;AGO3;RPS3;ZC3H12D;SND1;SETMAR
prerank,ubiquitin binding (GO:0043130),0.3517616997601982,1.0179487354641603,0.4533898305084746,0.810930160575132,1.0,35/73,33.94%,SQSTM1;FBXW7;HSPB1;USPL1;PLAA;USP5;SHARPIN;DDI2;ILRUN;UBAP1;UBE2L6;MVB12A;RNFT1;RAE1;FBXO7;MARK4;CKS2;USP33;WDR48;MDM2;BIRC2;VPS28;ASCC2;CXCR4;TNFAIP3;FAF1;UBAP1L;USP13;RNF19B;MVB12B;SIRT2;NEDD4;FAF2;NUP62;RBCK1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4100000531512766,1.0165036474376954,0.4861612515042118,0.8122735699206889,1.0,14/25,31.23%,PARP4;TNKS2;SIRT5;ART4;TIPARP;ZC3HAV1;SIRT4;PARP3;PARP2;SIRT3;PARP16;SIRT1;PARP9;SIRT2
prerank,ribosomal large subunit binding (GO:0043023),0.4700867781156004,1.0160620916779528,0.45382585751978893,0.810998864243872,1.0,5/11,24.75%,EIF6;CPEB2;DHX33;NPM1;MALSU1
prerank,carbohydrate kinase activity (GO:0019200),0.4711654052349029,1.01108653517575,0.46185286103542234,0.8220068721061656,1.0,4/11,17.49%,HK1;GALK2;NAGK;HK3
prerank,sulfotransferase activity (GO:0008146),0.37744636927917213,1.009855584656314,0.45977011494252873,0.8229666668577512,1.0,9/33,27.93%,CHST11;SULT6B1;TPST1;CHST12;HS6ST1;SULT2B1;CHST2;CHST3;HS3ST2
prerank,U6 snRNA binding (GO:0017070),0.44572185589600516,1.007776914180391,0.47003994673768307,0.8261401646557224,1.0,10/14,34.31%,PRPF4;DDX39B;EIF5A;PRPF8;LSM4;RBM22;LSM3;TUT1;SART3;LSM8
prerank,cysteine-type endopeptidase activity (GO:0004197),0.34016144097492335,1.00640793279991,0.503125,0.8272911646150901,1.0,33/78,30.08%,CTSB;CTSZ;CAPN15;MALT1;CTSW;USP12;CAPN1;USP9X;USP5;GPAA1;USP40;CASP7;USP47;CASP4;CAPNS1;USP18;USP46;CASP9;USP28;USP33;USP36;USP14;USP2;USP8;SFRP1;USP1;ESPL1;USP34;USP42;USP30;CTSL;USP13;USP48
prerank,exonuclease activity (GO:0004527),0.3587089601797112,1.005246407558402,0.4824175824175824,0.8278829166027816,1.0,14/46,20.91%,EXOSC4;XRN2;AEN;RAD50;EXOSC9;DXO;EXOSC10;ISG20L2;ISG20;REXO5;RAD1;EXOSC5;POLG;CNOT6
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.44994947218872255,1.0041276352814574,0.4792746113989637,0.8284056158508372,1.0,8/13,35.46%,METTL1;TRMT10C;TARBP1;THUMPD2;TRMT5;WDR4;TRMT10A;TRMT1L
prerank,chloride channel activity (GO:0005254),0.3494559102716035,1.0014483399971634,0.49461206896551724,0.8331149540157808,1.0,6/59,6.00%,PACC1;TTYH2;CLCN7;GABRP;ANO9;CLIC4
prerank,growth factor receptor binding (GO:0070851),0.33564111940810654,1.0009169703028593,0.48290155440414506,0.8320834127347501,1.0,15/95,11.67%,SDCBP;CD300LF;ITGA5;PDGFA;FGF2;IL12RB1;ERN1;GRB2;VEGFA;IL27RA;ADAM17;FGF7;HIP1;FYN;FGF20
prerank,protein kinase inhibitor activity (GO:0004860),0.3656490720769489,1.0008293895196387,0.49776286353467564,0.8298546508570909,1.0,12/42,23.67%,SMCR8;TAOK3;NCK1;RACK1;PARVA;SPRY4;GSKIP;YWHAB;SPRED2;ITPRIP;NPM1;INKA2
prerank,calcium-activated potassium channel activity (GO:0015269),0.4672834567606061,1.0007545035718597,0.4719562243502052,0.8276068473296802,1.0,3/11,11.99%,KCNN4;KCNMA1;KCNMB4
prerank,G protein-coupled receptor activity (GO:0004930),-0.1808299752098427,-1.0,1.0,0.6960264496844165,1.0,29/239,9.23%,P2RY12;CX3CR1;GPR34;ADGRL3;ADGRB3;GPR37;CALCRL;GRM1;CYSLTR1;ADGRG6;P2RY13;GRM5;PAX8;GRM3;GABBR1;GPR22;C5AR2;ADRB1;ADGRG1;LGR5;ELOVL4;GPR173;ADGRE1;TAPT1;RXFP1;ADGRV1;NTSR2;PDGFRL;P2RY6
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3439176642701181,-0.9995399773428464,0.46558704453441296,0.688104289921775,1.0,7/16,17.53%,MACROD2;MACROD1;TDG;NEIL1;NEIL3;BST1;NTHL1
prerank,carboxy-lyase activity (GO:0016831),0.39690487370435223,0.9983873884421524,0.4809069212410501,0.8313829151071402,1.0,5/23,17.29%,UMPS;AZIN1;PCK2;ACOD1;ODC1
prerank,retinoic acid binding (GO:0001972),-0.37911607644027406,-0.9982550726993837,0.43190661478599224,0.6826039238733834,1.0,8/12,37.50%,CYP26C1;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;CYP26B1;NR2F2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.427056336539295,0.998029253797424,0.49047013977128334,0.8298308797831376,1.0,7/15,26.88%,PIK3CB;PI4K2A;ATM;PIKFYVE;PI4KA;PIK3C2A;PI4K2B
prerank,GTP binding (GO:0005525),0.32281523069842766,0.9973404602553716,0.5030181086519114,0.8292615039271534,1.0,43/172,19.35%,TSR1;RRAGD;RAP2A;ARF3;REM1;THG1L;GIMAP7;GTPBP4;MFHAS1;ARL8B;EEF1A1;ARL1;RASL12;ANXA6;RHOD;RHOQ;GEM;BMS1;ARL11;RAB32;RAB8A;NRAS;KRAS;DNM2;RHOG;RAB7A;DRG1;RHOA;RHOU;RAB5A;CDC42;ARL8A;GBP2;RAB22A;RIT1;TUBB;RALB;EIF2B2;DRG2;GNL3;ADSS1;RRAD;RHOT2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4188646697200365,0.9963345752941654,0.5,0.8296631854370511,1.0,7/18,28.45%,PRDX5;SERPINB9;GAS6;BIRC5;BIRC2;NOL3;PRDX3
prerank,chemorepellent activity (GO:0045499),-0.3003908265059681,-0.9948330427481741,0.4430379746835443,0.6824342451514916,1.0,5/25,13.39%,SEMA6D;NRG3;SEMA6A;SEMA6C;SEMA4B
prerank,tRNA methyltransferase activity (GO:0008175),0.43091484400324587,0.9914441132794538,0.5133418043202033,0.8402412585719321,1.0,9/16,31.08%,METTL2B;METTL2A;TRMT13;TARBP1;THUMPD2;TRMT5;ALKBH8;TRMT12;LCMT2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.31199219084744434,0.989890616841709,0.555,0.8419459724169667,1.0,168/731,24.30%,LITAF;MITF;HIF1A;IKZF3;DNMT3A;TCF7;ATF3;ELF4;NFYA;NFIC;NFE2L2;LEF1;ZNF697;TBX21;MYBL2;BCL11B;MAFF;MUC1;STAT4;EOMES;SOX3;IRF6;TCF15;OVOL1;HOXA4;SOX30;NR4A3;TBX18;VDR;MEF2D;SIX5;POU3F1;TGIF1;NFIL3;MNT;CC2D1A;TFEB;HDAC4;PPARG;FOXJ1;ZFHX2;KLF12;KLF6;RUNX1;BCL6;ZKSCAN4;GATA3;ZBTB42;RFX5;ZBTB7B;SOX9;SATB1;EGR2;HDAC1;BPTF;HES7;ZBTB2;BHLHE40;ZNF395;ZNF160;PRDM15;BHLHE41;PPARD;E2F3;IRF8;HOXA7;LRRFIP1;NKX2-1;SOX7;KLF13;IRX5;PRMT5;FOXP4;CREB3L2;MEF2B;JUN;NFE2L1;NRF1;FOSB;ZNF148;CEBPA;IRF5;DACH2;ZKSCAN3;ZNF83;ZBTB34;ZNF569;ZSCAN12;MAFG;TFAP4;ZBTB16;ELK4;FOXJ3;SMAD1;MAFK;YY1;EHF;NFYB;MGA;DDIT3;PRRX1;NFKB1;SP7;NHLH2;SRF;ZBTB40;CEBPG;FOXO1;MYT1;MTF1;NR4A2;ELK3;ZNF296;DHX36;GMEB2;HOXC5;NPAS4;SARS1;GMEB1;DMRTA2;ZBTB25;TCF12;SP1;HNRNPU;WBP2;USF2;DHX9;ZBTB6;CCAR1;HOXB4;NR3C1;ZBTB39;SP9;TOP1;TCF7L1;DACH1;JDP2;NFATC3;SPIB;SREBF1;MEIS3;CHD2;TRIM24;NLRC5;HOXC9;ZNF18;PBX1;RXRB;HSF1;RUNX3;ETV4;TEAD1;KLF11;ARNT2;PRRX2;AHR;EGR1;ZNF568;STAT5B;PBX2;REL;RXRA;ZSCAN22;E2F6;ZBTB4;SOX10;ZSCAN20;GLIS2
prerank,cysteine-type peptidase activity (GO:0008234),0.33773139910175004,0.988607285092703,0.5166666666666667,0.8428226525011153,1.0,35/73,30.08%,CTSB;CTSZ;MALT1;CTSW;ATG4D;OTULIN;USP12;USP9X;USP5;USP40;BLMH;CASP7;ATG4A;USP47;CASP4;GGH;USP18;USP46;CASP9;USP28;USP33;USP36;USP14;USP50;USP2;USP8;SFRP1;USP1;ESPL1;USP34;USP42;USP30;CTSL;USP13;USP48
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3437818104441426,-0.9882031638507759,0.45228215767634855,0.689251825219631,1.0,1/13,0.08%,LPCAT2
prerank,pre-mRNA binding (GO:0036002),-0.3031207339025378,-0.9881080139344478,0.4375,0.6813020032801242,1.0,7/28,10.74%,CELF2;RNPC3;RBM7;RBM41;CELF4;CELF5;RBM4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.40243330940526995,0.9865884600522915,0.5041916167664671,0.8456759776341274,1.0,11/22,31.40%,OPTN;SQSTM1;IKBKE;ZRANB3;UIMC1;PRPF8;TNFAIP3;RNF169;TAB2;MINDY2;ZBTB1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3383280823317205,0.9861375029005514,0.5315126050420168,0.8443917597639014,1.0,12/69,15.66%,PLAAT3;SPHK1;ZDHHC15;ZDHHC18;SOAT1;CERS6;NAA16;LPGAT1;SOAT2;LPCAT3;ZDHHC1;GLYAT
prerank,metalloaminopeptidase activity (GO:0070006),-0.32107343911550523,-0.9837909090200985,0.45454545454545453,0.683931684112005,1.0,3/16,3.86%,RNPEP;TRHDE;MMP16
prerank,ubiquitin-specific protease binding (GO:1990381),0.40686300780785367,0.9827364789470537,0.5128834355828221,0.8510074822424726,1.0,11/19,39.20%,DERL3;VCP;DERL1;SUMO1;PTEN;SYVN1;SART3;LCOR;CHMP3;RAD23A;RHBDD2
prerank,retinoic acid receptor binding (GO:0042974),0.4131118871814876,0.9807638951697837,0.5139593908629442,0.8537070652619376,1.0,10/17,31.94%,VDR;PPARG;ASXL1;PRMT2;NR4A2;ACTN4;SNW1;NSD1;MED1;RARG
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3082403172043237,0.9804284565317457,0.596,0.8522007195349078,1.0,188/831,24.30%,LITAF;MITF;HIF1A;IKZF3;DNMT3A;TCF7;ATF3;ELF4;NFYA;NFIC;NFE2L2;LEF1;ZNF697;TBX21;MYBL2;DEAF1;BCL11B;MAFF;MUC1;STAT4;EOMES;SOX3;IRF6;TCF15;OVOL1;HOXA4;SOX30;NR4A3;TBX18;VDR;MEF2D;SIX5;POU3F1;TGIF1;NFIL3;MNT;CC2D1A;CIC;TFEB;HDAC4;PPARG;FOXJ1;ZFHX2;KLF12;KLF6;RUNX1;BCL6;ZKSCAN4;GATA3;CUX1;ZBTB42;RFX5;ZBTB7B;SOX9;SATB1;EGR2;HDAC1;BPTF;NFX1;HES7;ZBTB2;BHLHE40;ZNF395;ZNF160;PRDM15;BHLHE41;PPARD;E2F3;IRF8;HOXA7;LRRFIP1;NKX2-1;OTP;AEBP1;SOX7;KLF13;IRX5;FOXP4;MEF2B;ATF5;JUN;NFE2L1;NRF1;TBPL1;FOSB;ZNF148;ENO1;CEBPA;IRF5;ZFP41;DACH2;GBX1;ZKSCAN3;ASCL4;ZNF83;ZBTB34;ZNF569;ZSCAN12;MAFG;TFAP4;ZBTB16;ELK4;FOXJ3;SMAD1;MAFK;YY1;EHF;NFYB;MGA;STOX1;ETV6;DDIT3;PRRX1;NFKB1;SP7;NHLH2;SRF;ZBTB40;CEBPG;FOXO1;MYT1;MTF1;NR4A2;ELK3;ZNF296;DHX36;GMEB2;HOXC5;NPAS4;SARS1;GMEB1;DMRTA2;ZBTB25;TCF12;TBP;SP1;HNRNPU;PURA;WBP2;USF2;DHX9;ZNF177;ZBTB6;CCAR1;HOXB4;NR3C1;ZBTB39;SP9;TOP1;TCF7L1;DACH1;JDP2;NFATC3;RPS3;SPIB;SREBF1;MEIS3;CHD2;ZFP57;RFXANK;TCF24;NLRC5;HOXC9;ZNF18;PBX1;RXRB;HSF1;RUNX3;ETV4;TEAD1;ZBTB43;ACTN4;KLF11;ARNT2;PRRX2;EGR1;ZNF568;STAT5B;PBX2;REL;LHX4;RXRA;ZSCAN22;E2F6;ZBTB4;SOX10;ZSCAN20;GLIS2
prerank,telomeric DNA binding (GO:0042162),0.37284092921155465,0.9789824823360032,0.5281030444964872,0.8535565231912162,1.0,14/32,31.47%,NCL;RAD50;BLM;HNRNPA2B1;PURA;UPF3A;TERF1;ACD;TERT;TERF2IP;KDM1A;SMG1;XRCC5;TERF2
prerank,GTPase activator activity (GO:0005096),0.312889874103674,0.9782360312858757,0.58,0.8529879207076421,1.0,98/313,25.17%,RGS1;IQGAP1;MYO9B;ABR;ARHGAP25;ARHGAP10;TBC1D10C;ARHGAP24;CCDC88C;CYTH1;SMCR8;DOCK2;TBC1D22A;RGS3;ASAP1;RGPD1;RGP1;THG1L;RALGAPA2;AKAP13;ALS2;GNAQ;PCP2;SIPA1L2;DENND2D;NRP1;TBC1D2;FGD6;RAPGEF6;DENND4C;DLC1;RASGRP1;RASGRP3;RIC1;RANGRF;RIN2;SERGEF;RASGEF1B;EEF1D;RCC1L;DNMBP;MON1A;ARFGEF2;ARHGAP19;JUN;NPRL2;ARHGEF18;HPS1;RANBP1;IQGAP2;ELMOD3;DOCK5;LLGL2;RANBP2;RCC1;ARHGEF11;RASGRP2;RACGAP1;NF1;KALRN;RASA1;TBC1D22B;TBC1D12;ARHGAP30;ARHGAP9;EIF2B2;RAB3GAP2;TBC1D20;ARFGEF1;RIC8A;ARHGAP17;ELMOD2;BNIP2;ARHGEF2;NPRL3;GMIP;FGD5;ARFGAP3;ARFGAP1;DENND4B;ARHGEF5;HTR2B;LLGL1;TBC1D10A;LARS1;VAV3;ASAP2;EIF2B4;SMAP1;SIPA1L3;CCDC88A;SGSM1;DOCK11;SIPA1;TBC1D16;RAB3GAP1;VAV1;NCKAP1L
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3081327030297248,0.9780122677976796,0.604,0.8511306342180728,1.0,166/732,24.30%,LITAF;MITF;HIF1A;IKZF3;DNMT3A;TCF7;ATF3;ELF4;NFYA;NFIC;NFE2L2;LEF1;ZNF697;TBX21;MYBL2;BCL11B;MAFF;MUC1;STAT4;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;NR4A3;TBX18;VDR;MEF2D;SIX5;POU3F1;TGIF1;NFIL3;MNT;CC2D1A;TFEB;HDAC4;PPARG;FOXJ1;ZFHX2;KLF12;KLF6;RUNX1;BCL6;ZKSCAN4;GATA3;ZBTB42;RFX5;ZBTB7B;SOX9;SATB1;EGR2;HDAC1;BPTF;HES7;ZBTB2;BHLHE40;ZNF395;ZNF160;PRDM15;BHLHE41;PPARD;E2F3;IRF8;HOXA7;FOXN3;LRRFIP1;NKX2-1;SOX7;KLF13;IRX5;FOXP4;MEF2B;JUN;NFE2L1;NRF1;FOSB;ZNF148;CEBPA;IRF5;DACH2;ZKSCAN3;ZNF83;ZBTB34;ZNF569;ZSCAN12;MAFG;TFAP4;ZBTB16;ELK4;TIPARP;FOXJ3;SMAD1;MAFK;YY1;EHF;NFYB;MGA;DDIT3;PRRX1;NFKB1;SP7;NHLH2;SRF;ZBTB40;CEBPG;FOXO1;MYT1;MTF1;NR4A2;ELK3;ZNF296;DHX36;GMEB2;HOXC5;NPAS4;SARS1;GMEB1;DMRTA2;ZBTB25;TCF12;SP1;HNRNPU;WBP2;USF2;DHX9;ZBTB6;CCAR1;HOXB4;NR3C1;ZBTB39;SP9;TOP1;TCF7L1;DACH1;JDP2;NFATC3;SPIB;SREBF1;MEIS3;CHD2;NLRC5;HOXC9;ZNF18;PBX1;RXRB;HSF1;RUNX3;ETV4;TEAD1;KLF11;ARNT2;PRRX2;AHR;EGR1;ZNF568;STAT5B;PBX2;REL;RXRA;ZSCAN22;E2F6;ZBTB4;SOX10;ZSCAN20;GLIS2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.37026978412541556,0.9771005857483525,0.5382830626450116,0.8510324736320792,1.0,8/33,20.37%,RNF125;RNF14;SIAH2;RNF180;DCUN1D2;RPS3;DCUN1D4;RNF19A
prerank,metalloexopeptidase activity (GO:0008235),0.34603888932732324,0.976123651952144,0.5403050108932462,0.8511699596246869,1.0,8/51,9.78%,ANPEP;CPA4;CPA3;AGBL5;CPXM2;AGBL2;CPA6;AEBP1
prerank,heme binding (GO:0020037),0.3318307883354639,0.9753366831575908,0.5360934182590233,0.8507122372295188,1.0,25/65,34.86%,CYBB;HRG;SLC48A1;CYP19A1;CYB5R4;CYP2A6;HMOX1;CYP1B1;CAT;FLVCR2;PTGIS;SDHC;STEAP4;JAK2;FLVCR1;TBXAS1;NOX4;CYCS;HCCS;CYB561D1;CBS;HEBP1;PXDNL;CYB5A;CYP2R1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3811130823250268,0.975285022895048,0.5128805620608899,0.8484287585126783,1.0,7/27,20.37%,RNF125;RNF14;SIAH2;RNF180;DCUN1D2;DCUN1D4;RNF19A
prerank,guanyl ribonucleotide binding (GO:0032561),0.31467068241254187,0.9748426339311,0.5667001003009027,0.8471571538147132,1.0,47/196,19.35%,TSR1;RRAGD;RAP2A;ARF3;REM1;THG1L;GIMAP7;GTPBP4;MFHAS1;ARL8B;EEF1A1;ARL1;RAB5C;RASL12;ANXA6;RHOD;RHOQ;GEM;BMS1;ARL11;RAB32;RAB8A;RAB8B;NRAS;KRAS;DNM2;RHOG;RAB7A;DRG1;RHOA;RHOU;RAB5A;CDC42;CNGB1;ARL8A;GBP2;RAB22A;RIT1;TUBB;RALB;EIF2B2;DRG2;SLC19A1;GNL3;ADSS1;RRAD;RHOT2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.27088009265179047,-0.974458175234863,0.49673202614379086,0.6972086393514676,1.0,10/28,18.50%,MAPK14;RPS6KA1;LRRK2;PRKCG;MAP2K6;PAK3;AURKB;TTK;AURKA;MAP2K4
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.31579805788118487,0.9729699676815924,0.5732931726907631,0.8494679553579741,1.0,61/181,31.01%,MDFIC;CTNNB1;HIF1A;NFE2L2;ANXA4;ID2;EOMES;NCOR2;BBS10;HDAC4;HSPB1;PPARG;TAF4B;EGR2;HDAC1;BHLHE40;BHLHE41;PPARD;JUP;SMARCB1;JUN;ACTB;PRRX1;NHLH2;PSMA6;TACC2;TBP;MKKS;SP1;DHX9;MIER2;TAF6;PIAS1;MTDH;GSK3B;NPM1;ACTN4;ARNT2;RXRA;DNAJA1;MTA3;ATF4;HDAC2;ATN1;SMARCA4;HDAC3;PIAS4;BBS7;SNW1;KDM1A;HES1;DACT1;WWP2;FAF1;MED1;SIRT1;TRIP4;DMAP1;BEX1;EP300;PARP9
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.43194672686540714,0.9727247680573364,0.5124183006535947,0.8477148951692467,1.0,3/14,14.10%,SDHB;NFU1;RSAD2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.44058606199087735,0.9708142578157033,0.5231958762886598,0.8500470023002767,1.0,2/12,3.91%,B4GAT1;B3GNT3
prerank,tau protein binding (GO:0048156),0.35394551295060234,0.9668937409207141,0.5307692307692308,0.857511316808987,1.0,14/40,21.76%,APOE;CDK5;FYN;DCTN1;ROCK1;ACTB;CLU;S100B;PIN1;MARK2;HSP90AB1;GSK3B;MARK4;TAOK1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.35043791356113063,-0.9650097771807467,0.4749034749034749,0.7112783908065716,1.0,5/13,16.29%,PLPPR4;PLPP1;LPIN2;PLPP4;PLPP2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.36111261292752334,0.96494867768483,0.5369515011547344,0.8599838634473239,1.0,11/34,21.14%,IQGAP1;MYO10;ARAP2;IQGAP2;OGT;RACGAP1;ARHGAP9;HIP1R;FERMT2;GAB2;MYO1G
prerank,N-acyltransferase activity (GO:0016410),0.36101216617570786,0.963270631891677,0.5270425776754891,0.8618287084435042,1.0,5/32,10.36%,SAT1;PLAAT3;GNPNAT1;CERS6;NAT8
prerank,Wnt-activated receptor activity (GO:0042813),-0.32649084412597434,-0.963150917087014,0.47257383966244726,0.7075256293865418,1.0,2/15,4.53%,LRP5;TSPAN12
prerank,chemokine receptor binding (GO:0042379),0.3659455606499592,0.9630330955642431,0.5615034168564921,0.8600140101268059,1.0,7/35,13.99%,CCL4;CCL13;CCL7;CCL5;CCL28;CCL14;CXCL16
prerank,Hsp70 protein binding (GO:0030544),0.3696601117205451,0.9610124113454278,0.5452436194895591,0.8627279009925963,1.0,12/31,28.98%,SPN;DNAJB14;ERN1;DNAJC8;DNAJB1;RPS3;DNAJC10;DNAJA1;PACRG;DNAJB12;DNAJC2;IQCG
prerank,double-stranded DNA binding (GO:0003690),0.30137658531744665,0.9566498561911391,0.672,0.8710372738823275,1.0,112/531,23.03%,TCF7;ATF3;ELF4;NFIC;LEF1;TBX21;MYBL2;RAD51B;BCL11B;MAFF;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;TBX18;MEF2D;POU3F1;TGIF1;TFEB;PPARG;SHOX2;KLF12;KLF6;BCL6;GATA3;CUX1;RFX5;ZBTB7B;SOX9;SATB1;EGR2;HES7;ZBTB2;BHLHE40;BHLHE41;PPARD;E2F3;IRF8;HOXA7;SOX7;KLF13;IRX5;MEF2B;JUN;RAD50;FOSB;ELF2;XPA;IRF5;ZFP41;DMC1;MAFG;TFAP4;ELK4;FOXJ3;H1-0;YY1;MBNL2;CENPX;NHLH2;SRF;CEBPG;MTF1;NR4A2;ELK3;ZNF296;GMEB2;GMEB1;POLG2;ZNF638;DMRTA2;TCF12;SP1;HNRNPU;PURA;USF2;KIN;DHX9;ZNF177;TARDBP;HOXB4;NR3C1;SP9;TOP1;TCF7L1;HMGB1;RAD51AP1;JDP2;NFATC3;TERF1;RPS3;SPIB;SREBF1;MEIS3;HOXC9;PBX1;RXRB;HSF1;RUNX3;ETV4;TEAD1;SETMAR;FOXR2;ZBTB43;KLF11;ARNT2;PRRX2;WDR48;AHR;EGR1
prerank,sodium channel activity (GO:0005272),-0.2600420395543286,-0.9561095520552916,0.5565217391304348,0.7155795100190055,1.0,6/37,8.45%,GRIK2;GRIK3;GRIK4;SCN2A;HCN1;KCNK1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3167015741943887,-0.9560376854676672,0.48258706467661694,0.7078313684071933,1.0,3/17,5.41%,PECR;DPYD;DHCR7
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4048908311805537,0.955797286961351,0.5413070283600493,0.8707129047599712,1.0,8/18,33.26%,WDR91;PIK3R5;SOCS5;PIK3R2;SOCS2;SOCS4;SOCS7;SOCS6
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.416706921158834,0.9545806801877701,0.5670103092783505,0.8712300946948357,1.0,6/16,20.53%,SLC1A5;SLC25A14;SLC38A7;SLC13A3;SLC25A18;SLC13A5
prerank,CXCR chemokine receptor binding (GO:0045236),-0.361072403946277,-0.9530058933489586,0.49572649572649574,0.7068704743422884,1.0,5/11,34.78%,ITCH;PF4;CXCL12;CXCL9;CXCL1
prerank,histone acetyltransferase binding (GO:0035035),0.3847087119705868,0.9522294256958925,0.5528554070473876,0.8745495486085144,1.0,12/21,33.78%,HIF1A;ECD;TAF7;KANSL1L;EGR1;KANSL1;TRIM68;TRIP4;GLI3;SIRT2;EPAS1;PCNA
prerank,myosin II binding (GO:0045159),0.45553877667034265,0.9521146332580667,0.5365517241379311,0.8724648477427311,1.0,5/10,24.28%,GSN;LLGL2;TRIOBP;LLGL1;MYL4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.33155281878423937,0.948365020359993,0.587527352297593,0.8792416356077036,1.0,18/54,25.77%,HDAC9;HDAC4;HDAC1;SIRT5;SUDS3;UPB1;GLS2;GLS;PIGL;SIRT4;KLK3;ASAH1;MIER2;AGA;AMDHD2;HDAC11;HDAC2;HDAC3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3401210462642777,0.9479607172707459,0.5737885462555066,0.8779063541063121,1.0,19/53,28.08%,MICAL2;CYBB;XDH;MICAL1;POR;GSR;CYB5R1;MTRR;GCDH;AIFM2;CYB5R3;GFER;ACADL;ACOX3;STEAP4;MTHFR;NOX4;KDM1A;ACOXL
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.4114721739494207,0.9471958141800035,0.5548469387755102,0.8774439144345254,1.0,3/15,21.90%,SLC26A1;SLC26A4;SLC26A6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.430052393076934,0.942302845728029,0.5564409030544488,0.8862288630477216,1.0,4/13,24.69%,SLX4;ZGRF1;DNASE1L1;GEN1
prerank,steroid hydroxylase activity (GO:0008395),-0.3174383754832462,-0.9415819021709516,0.45495495495495497,0.7254722412104726,1.0,5/16,16.32%,CYP27A1;CYP2U1;CYP7B1;CYP39A1;CYP46A1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4461235048642653,0.940157915227059,0.5720279720279721,0.8888763065430204,1.0,7/10,31.16%,OTUD4;ATXN3;DESI2;OTUD5;TNFAIP3;STAMBP;STAMBPL1
prerank,protein phosphatase activator activity (GO:0072542),0.42628362819062215,0.9391247765025581,0.5625823451910409,0.8889176886488706,1.0,8/13,37.12%,PTPA;PPP2R5C;PPP1R15A;CALM3;PPP2R5E;CALM1;B3GAT3;PPP2R5D
prerank,cation channel activity (GO:0005261),-0.2140652183137376,-0.9374982416087041,0.6666666666666666,0.7265351680830587,1.0,28/94,21.15%,CACNB2;SLC24A3;TRPM3;UNC80;CALHM2;TMEM63A;PSEN1;HCN1;ABCC9;KCNK1;TRPM4;MCOLN1;TRPM6;TRPV4;GRIN1;KCNK5;KCNK10;CACNA1E;CHRNA7;KCNK4;CALHM5;CUL5;TRPM2;TRPC6;ANO1;PKD1;KCNK7;KCNG1
prerank,motor activity (GO:0003774),0.32954055744612354,0.9370875931020701,0.6111111111111112,0.8912075830967677,1.0,11/60,18.26%,MYO1E;KIF13B;DNAH8;KLC1;KIF1A;DNAH3;KIF20A;SMC3;KIFC1;KIF21B;PIN1
prerank,leak channel activity (GO:0022840),0.39423403073371016,0.9349670199779364,0.5780274656679151,0.8937053804318986,1.0,2/18,4.45%,KCNK13;PANX1
prerank,vitamin D receptor binding (GO:0042809),0.4120653621628083,0.9342053006813761,0.5624195624195624,0.8931718100774131,1.0,7/14,30.17%,MED17;MED13;TAF7;RXRA;SNW1;MED1;MED30
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3827379733537359,0.9314790423826382,0.5902031063321386,0.897061135961406,1.0,9/22,30.05%,DUSP9;DUSP6;DUSP3;CDKN3;DUSP12;DUSP15;DUSP16;DUSP5;DUSP23
prerank,potassium channel regulator activity (GO:0015459),0.3304896532188134,0.9309413532453994,0.5753275109170306,0.8958976953492287,1.0,6/49,6.08%,FLNA;SGK1;SGK3;SGK2;LRRC52;AMIGO1
prerank,NF-kappaB binding (GO:0051059),0.36669777033424467,0.9285073187219367,0.5825242718446602,0.8991034857207296,1.0,11/24,30.91%,ANXA4;TAF4B;HDAC1;PSMA6;MTDH;GSK3B;NPM1;HDAC2;HDAC3;FAF1;EP300
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3134680400050987,-0.9284468925049562,0.5381165919282511,0.7395649057754414,1.0,1/15,0.08%,LPCAT2
prerank,acid-thiol ligase activity (GO:0016878),0.41429542964358396,0.9276906960781298,0.5907894736842105,0.8986751176807253,1.0,3/13,15.13%,SLC27A5;ACSL1;AACS
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.295019748906831,-0.9276089000197861,0.5978260869565217,0.7338250055022751,1.0,6/20,18.77%,LPCAT2;PLA2G15;GPAT3;PNPLA3;AGPAT4;MOGAT3
prerank,tau-protein kinase activity (GO:0050321),0.38441641313619324,0.9275011879917102,0.5916870415647921,0.8967867643874079,1.0,11/20,30.94%,CDK5;FYN;ROCK1;MARK2;GSK3B;MARK4;TAOK1;SIK3;GSK3A;MARK3;TTBK2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3228560066310903,-0.9274877870911534,0.5859030837004405,0.7264605104228383,1.0,7/15,32.06%,PLA2G4C;PLA2G4E;PLA2G3;PLA2G4F;PLA2G2D;PLA2G4B;PLA2G10
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.3487945470215489,-0.9274130300419157,0.5402298850574713,0.719126141734054,1.0,3/11,19.24%,RYR3;MCOLN1;TRPM2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.31385558704506755,-0.9259287113556635,0.5061728395061729,0.7147890884257944,1.0,3/15,5.81%,HS3ST5;HS6ST2;HS3ST4
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3423470255026436,0.9241438011809364,0.6002331002331003,0.9019302469366363,1.0,6/35,8.69%,PLD3;PLCB4;GDPD3;NAPEPLD;PLCB2;SMPD4
prerank,telomerase RNA binding (GO:0070034),0.37053107868543905,0.9234216376587769,0.5940959409594095,0.9010822606654703,1.0,14/22,37.91%,HNRNPC;EXOSC10;GAR1;DHX36;HNRNPU;DKC1;TERT;XRN1;TENT4B;TEP1;DCP2;NAF1;SNRPB;SNRPD3
prerank,adrenergic receptor binding (GO:0031690),-0.3157625687172979,-0.9215941034855069,0.5066079295154186,0.716914636190948,1.0,5/16,13.52%,RAPGEF2;UCHL1;APLP1;ADRB1;PDE4D
prerank,MAP kinase phosphatase activity (GO:0033549),0.41511994611042785,0.9200159436435061,0.5795601552393272,0.9063439528927631,1.0,7/12,36.19%,DUSP9;DUSP6;DUSP3;DUSP16;DUSP5;DUSP10;DUSP2
prerank,phospholipid transfer activity (GO:0120014),0.3765208044857514,0.9173599071857862,0.5997638724911453,0.90976379585838,1.0,8/21,27.39%,GLTP;TRIAP1;PITPNC1;OSBPL2;PRELID2;PRELID1;PRELID3A;PITPNM1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.36935970015471686,0.9121335617607625,0.6075334143377886,0.9185956584770352,1.0,9/22,32.66%,APOE;LRPAP1;CLU;HSPG2;DNAJA1;HSP90B1;SNX17;LDLRAP1;MESD
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.24775745767954108,-0.9114492863951921,0.5954198473282443,0.7307829364840845,1.0,7/32,10.26%,PHYHD1;PHF8;TET1;KDM4A;JMJD4;KDM7A;TYW5
prerank,growth factor activity (GO:0008083),0.3115571885684761,0.9107515941570086,0.6470588235294118,0.9191581564966688,1.0,12/74,19.64%,CSF1;PDGFA;NRG1;FGF2;JAG1;VEGFA;FGF7;FGF20;FGF18;OSGIN2;IL6;IL2
prerank,cAMP response element binding (GO:0035497),0.4284971697157901,0.9106042411994135,0.6160108548168249,0.9170738547170384,1.0,3/10,10.78%,NR4A3;CREB3L2;JUN
prerank,symporter activity (GO:0015293),0.428379790073194,0.9101855671299999,0.6068866571018652,0.9155332245374558,1.0,5/10,34.62%,SLC28A2;SLC46A2;SLC5A6;MFSD2A;SLC4A4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.30177128484748506,0.9097441799859838,0.6463917525773196,0.9140785800898038,1.0,23/91,22.94%,SH3PXD2B;SDCBP;SLC9A1;CAPG;ATP13A2;SCIN;KCNJ2;WDR45;HIP1;GSN;SESTD1;SYTL2;OSBPL2;TIRAP;SVIL;KRIT1;HIP1R;TTPAL;ACTN2;LAPTM4B;MYO1G;PFN1;SDCBP2
prerank,histone deacetylase binding (GO:0042826),0.30665081812739337,0.9085845527602872,0.6597938144329897,0.9141367027002815,1.0,32/88,31.23%,IKZF3;LEF1;HDAC9;NCOR2;MEF2D;HDAC4;HDAC1;GMNN;BHLHE41;THAP7;MEF2B;SUDS3;TFAP4;PKN2;DHX36;SP1;YWHAB;MIER2;HSP90AB1;NIPBL;MTA3;HDAC2;KCTD21;HDAC3;HES1;DACT1;RAD9A;NUDT21;CCND1;SATB2;GLI3;SIRT2
prerank,glutathione transferase activity (GO:0004364),0.36301636129667947,0.9078730954093168,0.6085889570552148,0.9133472639579757,1.0,2/23,3.94%,PTGES;GSTA2
prerank,hexosyltransferase activity (GO:0016758),0.30481862035744295,0.9072154783871658,0.694129763130793,0.9124043110573272,1.0,10/101,5.70%,B4GALT5;LARGE1;B4GALT7;GCNT2;B4GAT1;B3GNT3;HEXA;GYG1;PIGZ;B3GALNT2
prerank,neurexin family protein binding (GO:0042043),0.4339686504751663,0.9071678310262626,0.6022566995768688,0.9102340913238414,1.0,3/10,12.40%,SYTL1;CEL;SYTL2
prerank,voltage-gated ion channel activity (GO:0005244),0.40646882107542015,0.9046889595225048,0.6135770234986945,0.9131373275942594,1.0,5/14,20.52%,VDAC2;KCNA3;ANO6;GPR89A;GPR89B
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4285056459261203,0.9041267174970399,0.5972602739726027,0.911993587591772,1.0,5/10,32.18%,ANKRD13B;ANKRD13A;LAPTM5;DNAJC2;USP15
prerank,calcium channel inhibitor activity (GO:0019855),0.41184922681686764,0.9039587047389482,0.5806010928961749,0.910090754639454,1.0,5/11,31.26%,PHPT1;FKBP1B;ITPR1;FKBP1A;CALM1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3299748376666793,0.903177502427237,0.6458100558659218,0.9094443087725963,1.0,11/42,22.02%,SIRPA;ANXA1;PDLIM1;NPTN;S100A11;EMB;PALLD;DSCAM;BAIAP2;CD47;IGSF9
prerank,acetyltransferase activity (GO:0016407),0.34605163431380015,0.9013352270534108,0.6424384525205158,0.9108920425174182,1.0,6/31,10.85%,SAT1;SPHK1;GNPNAT1;NAA16;NAT8;PAFAH2
prerank,calcium channel activity (GO:0005262),0.3069396849880766,0.8989590709030381,0.6787941787941788,0.9134675481880166,1.0,20/84,25.65%,CACNA1A;TRPC4;P2RX4;SLC24A4;PANX1;ANXA6;TPCN2;CACNA1D;CACNG7;TRPM7;CACNB3;CACNB1;ORAI2;ORAI3;GRIN3B;CACNB4;PKD1L2;ORAI1;CACHD1;TMCO1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.28893699949880863,0.8979966144549574,0.7827827827827828,0.9130405295800867,1.0,66/232,27.69%,MYLIP;RNF125;NSMCE2;TRIM6;TRIM43;RNF14;NEURL2;TRIP12;BRAP;NHLRC1;RNF7;SIAH2;RNF6;UBR4;EGR2;NFX1;RNF128;RNF180;ZNRF3;VPS18;RNF111;NHLRC3;HUWE1;RNF2;SHPRH;UBE3B;CDC42;VPS11;BFAR;DTX2;MKRN2;CBL;DTX4;RNF157;UBE3C;RNF121;CBLB;ASB1;RNFT1;UBR2;RNF167;RNF149;CUL3;HECTD1;DTX3;PIAS1;RNF19A;TRIM24;RNF216;RNF41;ZNRF2;TRIM21;RNF145;NSMCE1;MDM2;TRIM72;BIRC2;TRIM7;PIAS4;PELI1;CBLL1;RNF24;RC3H1;TRIM3;RNF13;UFL1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3345505974881811,0.8956247126157769,0.6245733788395904,0.9156223673692906,1.0,18/33,33.96%,EXOSC4;NOCT;XRN2;EXOSC9;EXOSC10;ISG20;EXOSC5;CNOT6;USB1;PAN2;XRN1;CNOT6L;ERI2;ERI3;DCP2;TOE1;ANGEL2;ERI1
prerank,peptidoglycan binding (GO:0042834),0.42339716840636776,0.8954743430898687,0.6305818673883626,0.9136583432998199,1.0,4/10,18.60%,HK1;RNASE7;PGLYRP2;JCHAIN
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.36434634703287855,0.8931523832406457,0.6417177914110429,0.9161821220636867,1.0,9/20,26.55%,USP9X;COPS2;USP47;SENP5;DESI2;SENP1;USP50;EIF3H;OTUD5
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3247202896980755,0.8900654928116807,0.654945054945055,0.9201226409708095,1.0,13/48,22.42%,CALHM6;ATP6V1B2;ASIC3;PIEZO1;SLC46A1;PIEZO2;SLC12A4;ATP6V1F;TRPM7;TMEM165;SLC12A7;GRIN3B;SLC39A1
prerank,mechanosensitive ion channel activity (GO:0008381),0.40900075388044266,0.888657046195199,0.6219512195121951,0.9205558885042159,1.0,2/12,7.02%,PIEZO1;PIEZO2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.31607255679939433,0.8873561924368314,0.6857772877618522,0.9209749395519171,1.0,14/51,25.62%,ANKH;SLC35D2;SLC16A10;SLCO5A1;SLC25A3;SLC25A14;SLC7A8;SLC28A2;CLCN4;SLC16A2;SLC46A2;SLCO2A1;SLC20A1;SLC35A1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2597672172582614,-0.8870868883055697,0.6776315789473685,0.774260078271714,1.0,8/29,11.57%,RPTOR;PKIG;KAT2B;SPRED1;PRKAR2A;CDKN2C;PRKAR2B;CDKN2D
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.35467693996949723,0.8869056509200983,0.6378896882494005,0.9195999124531294,1.0,9/26,24.23%,SLC27A1;SLC6A6;SLC16A9;SLC16A3;SLC16A2;SLC26A6;SLC16A13;MPC2;SLC16A1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.28962859307242944,0.8856367402612715,0.7532861476238625,0.9199231403426558,1.0,27/147,11.76%,ABR;CCDC88C;CYTH1;SMCR8;DOCK2;RGP1;THG1L;AKAP13;ALS2;PCP2;DENND2D;FGD6;RAPGEF6;DENND4C;RASGRP1;RIC1;RANGRF;RIN2;SERGEF;RASGEF1B;EEF1D;RCC1L;DNMBP;MON1A;ARFGEF2;ARHGEF18;HPS1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.28260346396454983,0.8853426175645052,0.846,0.9183248622318213,1.0,80/346,22.22%,MYLIP;MALT1;RNF125;TRAF2;CNOT4;TRIM6;TRIM43;RNF14;NEURL2;TRIP12;BRAP;TRAF3;NHLRC1;RNF7;SIAH2;TTC3;RNF6;TRIM28;UBR4;TSPAN17;NFX1;RNF128;UBE2H;UBE2L3;RNF180;ZNRF3;VPS18;DDB2;BRCA1;TRAF1;OBI1;RNF111;NHLRC3;KLHL13;HUWE1;RNF2;SHPRH;UBE3B;BIRC6;SHARPIN;UBE2R2;CDC42;VPS11;UBE2Q1;KCTD10;UBE2L6;BFAR;DTX2;MKRN2;CBL;DTX4;RNF157;BARD1;UBE3C;RNF121;CBLB;RMND5B;ASB1;RNFT1;UBR2;FBXL6;RNF167;RNF149;CUL3;HECTD1;DTX3;FBXO7;RNF20;FBXW11;RNF19A;CUL1;TRIM24;RNF216;RNF41;CDC34;ZNRF2;FBXO11;TRIM21;RNF145;CUL2
prerank,ubiquitin protein ligase activity (GO:0061630),0.28487154566197165,0.8849378913758512,0.8058058058058059,0.9168825911061161,1.0,52/228,22.16%,MYLIP;RNF125;TRIM6;TRIM43;RNF14;NEURL2;TRIP12;BRAP;NHLRC1;RNF7;SIAH2;RNF6;UBR4;NFX1;RNF128;RNF180;ZNRF3;VPS18;RNF111;NHLRC3;UBE4A;HUWE1;RNF2;SHPRH;UBE3B;CDC42;VPS11;BFAR;DTX2;MKRN2;CBL;DTX4;RNF157;UBE3C;RNF121;CBLB;ASB1;RNFT1;UBE4B;UBR2;RNF167;RNF149;CUL3;HECTD1;DTX3;RNF19A;TRIM24;RNF216;RNF41;ZNRF2;TRIM21;RNF145
prerank,RNA polymerase binding (GO:0070063),0.36354014639236076,0.8840963506582887,0.650497512437811,0.9163680351165933,1.0,8/18,26.30%,PHRF1;PABPN1;BRCA1;PKN2;DHX9;CCNT2;ANP32B;STOM
prerank,fatty acid synthase activity (GO:0004312),-0.33793611194390494,-0.8835598788863999,0.6127819548872181,0.773572336910962,1.0,2/10,7.68%,ELOVL6;ELOVL4
prerank,nucleotidyltransferase activity (GO:0016779),0.37218648561912043,0.8831717140428185,0.6654275092936803,0.9159511469550569,1.0,8/19,29.19%,THG1L;NUDT5;YRDC;TERT;REV1;MTPAP;MOCS3;TENT4B
prerank,phosphatase activity (GO:0016791),0.30673432911808873,0.8829671055890238,0.7011494252873564,0.9140906130976885,1.0,20/73,24.20%,PLPP6;ACP5;PON1;CILP;ENOPH1;PTPN22;PLPP3;NOCT;PRUNE1;ACP3;ATP1A2;DUSP3;DUSP11;NANP;DUSP12;DUSP15;PHOSPHO2;DUSP16;PTPMT1;LPIN3
prerank,LRR domain binding (GO:0030275),0.3876682114679492,0.8810466804019852,0.6275252525252525,0.915675153329755,1.0,6/14,24.57%,MRTFA;DDIT3;DAPK3;LRRFIP2;ZXDC;ATF4
prerank,syntaxin binding (GO:0019905),0.30249496407792925,0.8791359747713714,0.6948608137044968,0.9170040384692947,1.0,13/61,19.78%,CACNA1A;ABCA1;STX6;NAPA;VPS18;PTPN2;VPS11;CPLX2;DAPK1;SYPL1;VAMP2;RAB11A;SYT8
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.3666768159758277,0.8777538484894787,0.6545226130653267,0.9174027073777529,1.0,3/18,17.07%,DHRS9;HSD17B8;DHRS11
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4106679226237331,0.8762641058832672,0.652542372881356,0.9179899169401924,1.0,5/11,31.47%,RAD50;HNRNPA2B1;TERF1;TERF2IP;TERF2
prerank,neuropeptide hormone activity (GO:0005184),0.3586790107882568,0.8759691050990979,0.6638246041412911,0.916329631579196,1.0,4/22,15.63%,NPPA;CRH;AGRP;VIP
prerank,3'-5' exonuclease activity (GO:0008408),0.313155516846823,0.8728902894387689,0.6846153846153846,0.9199468826423832,1.0,18/45,28.89%,EXOSC4;NOCT;XRN2;RAD50;EXOSC9;EXOSC10;ISG20;RAD1;EXOSC5;POLG;CNOT6;USB1;PAN2;CNOT6L;ERI2;TRIR;RAD9A;ERI3
prerank,nuclear import signal receptor activity (GO:0061608),0.38002023631957327,0.872053942211482,0.6529562982005142,0.9191979262308472,1.0,3/15,10.70%,IPO5;KPNA4;KPNA6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.3866563864903834,0.8715411722438039,0.6624365482233503,0.9179494637230058,1.0,7/14,32.18%,ATXN3;USP9X;DESI2;OTUD5;USP13;MINDY2;USP15
prerank,insulin-like growth factor binding (GO:0005520),0.3760330234933611,0.8712180778710952,0.6583769633507853,0.9164327254770364,1.0,2/15,8.00%,IGF2R;IGF1R
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.39352031843689445,0.8707247462963928,0.6513761467889908,0.9152035983302066,1.0,6/13,29.88%,GDI1;RANBP1;ITGB1BP1;ARHGDIB;CCDC88A;EIF5
prerank,solute:proton symporter activity (GO:0015295),0.37042763120145705,0.8697253734948078,0.6591194968553459,0.9149237505639631,1.0,3/16,12.11%,SLC17A5;SLC36A3;SLC25A3
prerank,mRNA methyltransferase activity (GO:0008174),0.39413034790003537,0.8686360869259685,0.6476323119777159,0.9148320891381588,1.0,6/12,29.64%,TRMT10C;METTL3;NSUN2;RNMT;METTL8;PCIF1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.37548541096590426,0.867138392275268,0.6692111959287532,0.9132997943683344,1.0,2/16,1.52%,PTPRA;PTPRC
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.37548541096590426,0.867138392275268,0.6692111959287532,0.9132997943683344,1.0,2/16,1.52%,PTPRA;PTPRC
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3077202849799566,0.863522019174916,0.7301075268817204,0.9175815047992002,1.0,5/60,4.62%,FLT1;NRP2;IGF2R;AXL;NRP1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2580269818698508,-0.862654363576571,0.7368421052631579,0.8092455889097018,1.0,5/25,9.30%,SNX2;FER;EFEMP1;EGF;HBEGF
prerank,anion channel activity (GO:0005253),0.29834844089030577,0.8626059859632712,0.7038216560509554,0.9169953890076141,1.0,6/61,6.00%,LRRC8C;CLCN7;VDAC2;GABRP;ANO9;CLIC4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3986458189053644,0.8610385937550656,0.6625850340136055,0.9176548065067336,1.0,6/12,27.91%,HDAC1;TBPL1;TBP;POU2F1;H3-3A;RUVBL2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.40735042807244487,0.8599166125591191,0.6487935656836461,0.9153690122197886,1.0,6/10,36.19%,DUSP9;DUSP6;DUSP16;DUSP5;DUSP10;DUSP2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.40735042807244487,0.8599166125591191,0.6487935656836461,0.9153690122197886,1.0,6/10,36.19%,DUSP9;DUSP6;DUSP16;DUSP5;DUSP10;DUSP2
prerank,damaged DNA binding (GO:0003684),0.3113822805415185,0.8583090659834274,0.7131868131868132,0.9160706496602274,1.0,18/44,32.07%,ERCC1;SDE2;DDB2;DDB1;XPA;ERCC4;RAD1;HMGB1;RPS3;DCLRE1A;XPC;SMC6;APTX;HMGB2;PNKP;EP300;ERCC2;CREBBP
prerank,cytochrome-c oxidase activity (GO:0004129),0.3789647672281515,0.8575827280250694,0.6875,0.9152348801961082,1.0,5/15,22.06%,COX7A1;COX6A2;COX5B;COX10;COX7A2L
prerank,bHLH transcription factor binding (GO:0043425),0.3531574659607196,0.8574105693355817,0.66625,0.9134110386085253,1.0,10/19,34.73%,BHLHE40;BHLHE41;TCF12;SP1;USF2;KDM1A;SIRT1;CREBBP;LMO2;SCX
prerank,phosphatase activator activity (GO:0019211),0.37921823887973266,0.8566526329096542,0.6653944020356234,0.9125604168009313,1.0,8/14,37.12%,PPP2R5C;GTF2F1;PPP1R15A;CALM3;PPP2R5E;CALM1;B3GAT3;PPP2R5D
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3367253696029052,0.856059255911501,0.6711003627569528,0.9114645816566045,1.0,7/27,19.58%,ATP2B1;SLC23A1;MAGT1;CNNM2;TUSC3;TMEM165;SLC11A1
prerank,single-stranded DNA helicase activity (GO:0017116),0.35889742761516996,0.8538317674643474,0.699748743718593,0.9132865903548937,1.0,9/19,33.99%,MCM7;MCM2;DHX9;MCM6;RFC2;RFC4;RFC5;MCM5;RAD51
prerank,four-way junction DNA binding (GO:0000400),0.3681430003225216,0.8511157580977923,0.6871859296482412,0.9158732530731098,1.0,7/17,29.81%,RAD51B;BLM;YY1;HMGB1;GEN1;HMGB3;HMGB2
prerank,adenylate cyclase binding (GO:0008179),-0.33074681986657545,-0.8509616184212012,0.6181818181818182,0.8251810475393454,1.0,4/10,10.39%,ADCY2;ADCY5;AKAP6;AKAP12
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.33002735310424214,-0.8509213830820158,0.6679841897233202,0.8174244031927852,1.0,3/10,9.95%,PHF8;KDM4A;KDM7A
prerank,alpha-tubulin binding (GO:0043014),0.3252811093992455,0.8504333997421327,0.6997690531177829,0.9149779535599541,1.0,10/31,23.65%,FAM110C;ARL8B;EML4;FYN;INO80;ARL8A;RACGAP1;ARL4C;TAOK1;EFHC1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.39779229665030896,0.8499336597602505,0.6796246648793566,0.913766471815014,1.0,5/11,34.51%,UBE4A;UBE4B;UBR5;UBE2K;ANAPC11
prerank,phospholipase A2 activity (GO:0004623),0.33346739821261134,0.8498179297213784,0.6972255729794934,0.9119014722774942,1.0,2/26,3.24%,PLAAT3;PRDX6
prerank,WW domain binding (GO:0050699),0.3224359614583586,0.847860094346816,0.6970059880239521,0.9132659115926618,1.0,1/26,0.23%,LITAF
prerank,fibroblast growth factor binding (GO:0017134),0.34254618867943004,0.8439226419512453,0.6939024390243902,0.9177408789483057,1.0,10/21,34.42%,GLG1;RPS2;RPS19;FGFRL1;FGFR3;FGFR2;FGFBP3;CEP57;ITGAV;FIBP
prerank,hexosaminidase activity (GO:0015929),0.37738658460239227,0.842564741151089,0.6754617414248021,0.917940132402628,1.0,2/12,9.12%,HEXA;OGA
prerank,nucleotide diphosphatase activity (GO:0004551),0.3760112248287475,0.8398854157890072,0.6943734015345269,0.9203858337724002,1.0,2/14,6.83%,CILP;NUDT6
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3625449090786701,0.8375429007143075,0.663563829787234,0.9222063035510997,1.0,2/14,7.68%,CAPN15;CAPN1
prerank,ephrin receptor binding (GO:0046875),0.3450111695843169,0.8366223503785881,0.7110036275695284,0.9215799278612551,1.0,5/21,16.08%,GRB2;FYN;EFNA1;CBL;EFNB2
prerank,exopeptidase activity (GO:0008238),0.2975014213111205,0.834487298592655,0.742671009771987,0.92296373199343,1.0,9/50,17.50%,ANPEP;CTSZ;CTSA;DPP7;CNDP2;BLMH;GGH;XPNPEP1;DPEP2
prerank,cell adhesion mediator activity (GO:0098631),0.33181633987183634,0.8338506365525472,0.7266187050359713,0.9220420400845412,1.0,8/24,22.02%,SIRPA;NPTN;EMB;PALLD;NINJ1;DSCAM;CD47;IGSF9
prerank,phosphatidic acid binding (GO:0070300),0.34756624444844453,0.8336113560229297,0.7123287671232876,0.9204002459427513,1.0,5/19,15.06%,ATP13A2;RAPGEF6;PITPNC1;SESTD1;GRAMD1B
prerank,hydro-lyase activity (GO:0016836),0.30091241422706466,0.8329672604686368,0.740782122905028,0.9194860908965238,1.0,15/41,32.32%,HACD2;ECHDC3;APIP;PCBD2;ENO1;HACD1;ENO2;TGDS;EHHADH;HADHA;TBXAS1;CDYL;ENO4;CBS;NAXD
prerank,lipid phosphatase activity (GO:0042577),0.3700276319702585,0.8284333188069967,0.7065073041168659,0.9247465750538637,1.0,3/14,14.18%,PLPP6;PLPP3;PLPP7
prerank,microtubule plus-end binding (GO:0051010),0.3422257591637243,0.8276944086240048,0.7158808933002482,0.9239089925544532,1.0,8/20,30.94%,CLIP2;DCTN1;NUMA1;DST;FBXW11;MAPRE1;STIM1;TTBK2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.318440112637952,0.8271005756101999,0.7142857142857143,0.9227625056853966,1.0,6/29,15.18%,TNIP1;DUSP9;MAPKAPK3;MAPKAPK2;DUSP6;TPR
prerank,gamma-tubulin binding (GO:0043015),0.34384981559143224,0.8264413637058957,0.7169117647058824,0.9217801954670647,1.0,5/21,21.48%,TUBGCP4;NDRG1;GIT1;RACGAP1;MARK4
prerank,antiporter activity (GO:0015297),0.3382822731632783,0.8250350830615865,0.707673568818514,0.921950415593474,1.0,4/20,18.39%,SLC35D2;ATP1A3;SLC25A14;CLCN4
prerank,general transcription initiation factor binding (GO:0140296),0.3226899204970371,0.8236367076464911,0.7297619047619047,0.9220663557291064,1.0,6/25,23.03%,GTF2A2;THAP7;TBP;DR1;YEATS2;AHR
prerank,MAP kinase kinase activity (GO:0004708),-0.27619733397060625,-0.8213749370472802,0.7219730941704036,0.8645139021312384,1.0,4/15,12.73%,MAPK14;LRRK2;MAP2K6;PAK3
prerank,RNA methyltransferase activity (GO:0008173),0.34149646197674144,0.8212136497809842,0.7274969173859432,0.9237609993537763,1.0,8/19,31.08%,MRM2;METTL3;FTSJ3;TRMT13;METTL8;TRMT5;TRMT12;LCMT2
prerank,FAD binding (GO:0071949),0.3260650783110155,0.8200460461321958,0.71875,0.9234481858663596,1.0,7/24,24.36%,MICAL2;MICAL1;CYB5R1;MTRR;CYB5R3;STEAP4;MTHFR
prerank,active ion transmembrane transporter activity (GO:0022853),-0.22591100702517902,-0.8194839024049995,0.8148148148148148,0.8595239446107262,1.0,4/37,3.76%,SLCO2B1;SLC16A7;COX6A1;SLCO1B1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3872727341820448,0.8194513128892253,0.703551912568306,0.9224026603292899,1.0,5/10,29.07%,RENBP;FUOM;GFUS;DSEL;DSE
prerank,peptidase activator activity (GO:0016504),0.33017396392662884,0.816907875020564,0.7386503067484662,0.9242830738828458,1.0,4/22,13.66%,TANK;CAV1;VCP;PSMD14
prerank,DNA polymerase activity (GO:0034061),0.33199643693382214,0.8167169819067999,0.7213930348258707,0.9225813750567002,1.0,11/22,35.94%,POLE;POLB;POLG;TERT;POLE4;REV1;POLD4;POLA1;POLM;REV3L;POLK
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.30377376941032214,0.8149237000168708,0.76,0.9232039476961692,1.0,7/34,14.46%,UBE2H;UBE2L3;BIRC6;UBE2R2;UBE2Q1;UBE2F;UBE2L6
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3579543967284122,0.8136933972022138,0.7233766233766233,0.9230475598681702,1.0,7/15,33.26%,PIK3R5;SOCS5;PIK3R2;SOCS2;SOCS4;SOCS7;SOCS6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.36221018808747457,0.812942569751089,0.7206851119894598,0.9221698296002828,1.0,5/14,25.25%,PYCR3;MTHFD1;ALDH1L2;MTHFR;PYCR2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.2809998941533282,0.8114525345849807,0.798728813559322,0.9224910264791367,1.0,28/71,32.25%,PTPRA;PTPRC;EYA4;HACD2;PTPN23;PTPN22;PTPN2;PTPN12;PTPN13;DUSP3;DUSP11;CDKN3;PTP4A2;PTPN21;DUSP15;PTPN9;PTPN18;CDC25B;PTPN6;PTPRM;MTMR6;CDC25A;DUSP23;PTEN;PTPN1;PTPRZ1;PTPRN2;PALD1
prerank,kinase activity (GO:0016301),0.27233130260827476,0.8112170761589703,0.8229273285568065,0.9208615484249463,1.0,28/109,25.34%,DGKZ;CERK;ITPKB;GK;SPHK2;PIK3CB;SPHK1;CDK5;CHKB;PDXK;PGK1;PKN2;CDC7;DGKA;DGKH;DGKD;PI4KA;GSK3B;TAOK1;CERKL;COASY;PMVK;PRKD3;PIK3C2A;COQ8B;MAPK15;ADPGK;NADK
prerank,protein phosphatase 1 binding (GO:0008157),0.33553540429754947,0.8106176324533432,0.7475845410628019,0.9198058078012841,1.0,6/21,28.65%,PPP1R9B;LILRB1;PPP1R3F;PPP1R15A;AKAP11;SHOC2
prerank,NADPH binding (GO:0070402),-0.2886857418201764,-0.8075700772683788,0.7404255319148936,0.8735191498009314,1.0,6/13,20.13%,NDOR1;CRYZ;CBR3;QDPR;HMGCR;GRHPR
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.321206445719086,0.8067100486300092,0.7472527472527473,0.9234506253908978,1.0,4/23,11.65%,PLCB4;EDNRA;PLCB2;CCL5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.27408637300314725,0.8048456281624565,0.8063157894736842,0.9242537584731715,1.0,18/72,22.94%,SDCBP;SLC9A1;CAPG;SCIN;KCNJ2;HIP1;GSN;SESTD1;SYTL2;OSBPL2;TIRAP;SVIL;KRIT1;HIP1R;ACTN2;MYO1G;PFN1;SDCBP2
prerank,ribonuclease P RNA binding (GO:0033204),-0.3117092266724404,-0.8028192749420897,0.6763636363636364,0.8735700267314614,1.0,7/10,38.31%,RPP30;POP4;RPP21;RPP14;RPP25;POP7;RPP40
prerank,estrogen receptor binding (GO:0030331),0.3028493617774307,0.8006929152591987,0.7752293577981652,0.9282499931682762,1.0,2/32,2.01%,CTNNB1;LEF1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.23500419207859222,-0.8006190389128577,0.8125,0.8694437137065015,1.0,9/27,19.71%,POLR3F;POLR3K;PRIM1;POLR2C;POLR2L;POLR2J;POLR2G;POLR1B;MED20
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.31351003841602487,-0.7990364976155591,0.6784452296819788,0.8645601525928508,1.0,3/10,16.96%,DPYSL2;CRMP1;DPYS
prerank,retinoid X receptor binding (GO:0046965),0.3694450988445436,0.7981425602293761,0.7413793103448276,0.9299729257561117,1.0,3/11,16.00%,VDR;PPARG;NR4A2
prerank,cytokine receptor activity (GO:0004896),0.27135357104251095,0.7938874664640068,0.8288659793814434,0.9339382848821125,1.0,14/83,14.25%,IL2RB;IL18R1;CD4;IL18RAP;CSF2RA;CD44;OSMR;IL3RA;IL12RB1;IL27RA;CCR2;GHR;FZD4;IL31RA
prerank,phosphatidylglycerol binding (GO:1901611),-0.2755286974531467,-0.7902096121800313,0.7297297297297297,0.872155114675551,1.0,5/13,21.28%,PLTP;UQCC3;GSDMD;PITPNA;MME
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.304292037926669,0.7901552124270096,0.7747641509433962,0.9373293946208969,1.0,9/28,30.15%,AGO2;RNASEH2A;RNASEH1;PRORP;AGO3;RPP38;EDC3;POP1;DBR1
prerank,PDZ domain binding (GO:0030165),0.2786770109979165,0.7898894167735913,0.8261802575107297,0.9357373645597932,1.0,17/61,24.68%,GNG12;CCDC88C;ATP2B1;CADM1;PLEKHA1;ADAM17;FZD1;CRIPT;FZD4;LLGL2;GNG5;GRIA1;SLC26A6;MAP2K2;TBC1D10A;KIDINS220;SYNJ2
prerank,calcium-release channel activity (GO:0015278),0.33998824200346217,0.7875763172255198,0.7583979328165374,0.9370271752083816,1.0,4/17,19.10%,MCOLN2;TPCN2;MCOLN3;ITPR3
prerank,muscle alpha-actinin binding (GO:0051371),0.3421947772329803,0.7864981805700035,0.7538071065989848,0.936493218064507,1.0,2/15,13.14%,PDLIM1;PALLD
prerank,adenyl nucleotide binding (GO:0030554),0.3684412261031631,0.7860819546428478,0.7638326585695007,0.9331162719746677,1.0,6/11,36.41%,SIL1;PFN1;BAG3;GRPEL2;BAG1;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.3684412261031631,0.7860819546428478,0.7638326585695007,0.9331162719746677,1.0,6/11,36.41%,SIL1;PFN1;BAG3;GRPEL2;BAG1;BAG2
prerank,"DNA binding, bending (GO:0008301)",0.3481070011716403,0.7826763037195025,0.7783572359843546,0.9356776268713457,1.0,5/14,29.81%,LEF1;HMGB1;TERF1;HMGB3;HMGB2
prerank,N-acetyltransferase activity (GO:0008080),0.32511271668716224,0.778846985055589,0.7791718946047679,0.9388736198630769,1.0,3/19,10.36%,SAT1;GNPNAT1;NAT8
prerank,ion channel inhibitor activity (GO:0008200),-0.20865106590010182,-0.7761571426027501,0.9191176470588235,0.8863596417805742,1.0,6/35,10.44%,WNK1;COMMD1;SLC30A1;WNK3;KCNMB2;STX1A
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.36348725810183413,0.7749853491297343,0.7662162162162162,0.9420198718198661,1.0,3/10,24.58%,PIK3CB;ATM;PIK3C2A
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.28798426511721364,0.7739269088411769,0.8257403189066059,0.9415470985058224,1.0,13/34,28.89%,EXOSC4;NOCT;XRN2;EXOSC9;EXOSC10;ISG20;EXOSC5;CNOT6;USB1;PAN2;CNOT6L;ERI2;ERI3
prerank,solute:sodium symporter activity (GO:0015370),0.30264495250089724,0.7738193361667811,0.7890995260663507,0.9397654516228823,1.0,7/27,28.60%,SLC5A1;SLC4A9;SLC5A3;SLC28A2;SLC13A5;SLC20A1;SLC5A6
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.349244703848559,0.7694971463068039,0.7782204515272244,0.9435001870773478,1.0,3/12,24.58%,PIK3CB;ATM;PIK3C2A
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2909396454165561,0.7661676890466129,0.8116279069767441,0.9458195079020828,1.0,6/31,14.46%,UBE2H;UBE2L3;BIRC6;UBE2R2;UBE2Q1;UBE2L6
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.2593629330092587,-0.7644302528644069,0.7896995708154506,0.8962475763249561,1.0,2/15,4.22%,SLC1A3;SLC25A12
prerank,calcium activated cation channel activity (GO:0005227),0.3247857378306368,0.76282819547991,0.7940414507772021,0.9479986810411818,1.0,4/17,18.37%,KCNN4;KCNMA1;KCNMB4;ANO6
prerank,RNA stem-loop binding (GO:0035613),0.3433687944562918,0.7560779060953691,0.7887139107611548,0.9544465869932315,1.0,8/12,37.67%,EPRS1;CPEB3;DHX9;RC3H1;CSDE1;ZC3H12A;DDX3X;FMR1
prerank,cardiolipin binding (GO:1901612),-0.2873761505828214,-0.755107865333939,0.8043478260869565,0.9016608569464827,1.0,3/10,21.28%,UQCC3;GSDMD;MME
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3090489548417302,0.753427845822086,0.7989949748743719,0.9560227030575683,1.0,10/21,35.94%,POLE;POLB;POLG;POLE4;REV1;POLD4;POLA1;POLM;REV3L;POLK
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.34455168646486034,0.7530016920828482,0.796423658872077,0.954573078678031,1.0,2/12,3.91%,PDE1B;PDE4C
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.34397932163125766,0.7517397257865381,0.7926330150068213,0.9542201499810865,1.0,3/12,19.36%,NDUFS7;CBR1;AIFM2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3500594482478079,0.7485035234924892,0.7938420348058902,0.9562369497274056,1.0,3/10,25.18%,ECHDC3;EHHADH;HADHA
prerank,neuropeptide receptor binding (GO:0071855),0.32921184291296396,0.7481862391115661,0.8125802310654685,0.9547321042418658,1.0,2/14,13.24%,NPPA;AGRP
prerank,signal sequence binding (GO:0005048),0.2820529887027995,0.746395115683605,0.8308227114716107,0.9551262786179937,1.0,18/35,38.06%,BRAP;IPO5;KPNA4;KPNA6;CAT;TNPO2;TNPO1;NUP214;KDELR2;AP2B1;BABAM2;SEC61A1;NFKBIA;NUP153;IPO4;CEMIP;KDELR1;TIMM22
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.21822177670140017,-0.7455529153078663,0.8848484848484849,0.9071010931477734,1.0,9/27,19.71%,POLR3F;TENT2;POLR3K;POLR2C;POLR2L;POLR2J;POLR2G;POLR1B;MED20
prerank,MAP kinase activity (GO:0004707),0.33902329205316734,0.7441835674795103,0.7989487516425755,0.9557562517043027,1.0,9/14,32.12%,MAPK13;MAPK9;NLK;MAPK7;MAPK15;MAPK12;MAPK3;MAPK1;MAPK6
prerank,phosphate ion binding (GO:0042301),-0.29328722221606096,-0.7439095588230877,0.7711267605633803,0.9013571630028923,1.0,2/10,4.86%,PNP;RELA
prerank,myosin binding (GO:0017022),0.26312987127821785,0.7433369651393487,0.866235167206041,0.9548043263490853,1.0,18/55,26.67%,TRAK1;RAB8A;MYOC;GSN;RHOA;LLGL2;SPATA6;RAB11A;ARFGEF1;LMTK2;TRIOBP;RAB3D;LLGL1;GIPC1;KIRREL1;NCKIPSD;NPHS1;CXCR4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.29357687127313814,0.7411560124491107,0.8329297820823245,0.9554127207631832,1.0,5/24,17.31%,PTK2B;MAPKAPK3;MAPKAPK2;DAPK1;CAMK4
prerank,CARD domain binding (GO:0050700),0.3307304966047262,0.7406529693297524,0.8120104438642297,0.9541093744255265,1.0,7/14,37.40%,CARD10;CASP4;CARD19;MAVS;NOD1;IRGM;CASP1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.3269255395062755,0.7394125445856382,0.8148148148148148,0.9536158123965384,1.0,4/13,24.58%,PIK3CB;PIKFYVE;PIP5K1B;PIK3C2A
prerank,O-methyltransferase activity (GO:0008171),0.34915070898768863,0.7390294397879302,0.7991746905089409,0.9521175349299404,1.0,2/10,16.88%,FTSJ3;COQ3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2538082256332155,0.7366777035471883,0.8921775898520085,0.9529355773109484,1.0,7/73,9.32%,FPR2;EDNRA;BDKRB1;HCRTR1;SCTR;KISS1R;LTB4R
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2605421357690516,0.7348017561506401,0.8768736616702355,0.9531397917797179,1.0,6/60,8.17%,LCK;PPP4C;PPM1J;PPM1H;CTDNEP1;TAB1
prerank,BMP binding (GO:0036122),-0.27889021404808234,-0.7337179695921184,0.8,0.9063530178148096,1.0,11/11,72.14%,ENG;BMPR2;NBL1;HJV;SOSTDC1;TCAP;GDF5;SOST;UCMA;GREM1;GREM2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2527853897986459,0.7335837173539518,0.8934599156118144,0.9525449677915431,1.0,9/70,14.06%,LARGE1;GCNT2;B4GAT1;B3GNT3;HEXA;B3GALNT2;B3GALT6;OGT;B4GALNT1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.31993715303615244,0.7290634755053088,0.8137755102040817,0.9556618023325828,1.0,5/13,29.25%,SOX9;GSK3B;PRKAR1A;GSK3A;PRKAR1B
prerank,DNA secondary structure binding (GO:0000217),0.27797663689374497,0.7267851837881645,0.839390386869871,0.9562880163962997,1.0,9/31,26.41%,KMT2A;RAD51B;BLM;YY1;HMGB1;RAD51AP1;XPC;GEN1;HMGB3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2559819119164658,0.7225004838673528,0.8770226537216829,0.9590736459724343,1.0,13/57,24.68%,NDUFS7;COX7A1;NDUFA1;CYBRD1;COX6A2;COX5B;NDUFA9;COX10;UQCRH;NDUFA2;COX7A2L;UQCR10;UQCR11
prerank,transaminase activity (GO:0008483),0.3365343442161987,0.7204606274779953,0.8255659121171771,0.9594338068536962,1.0,2/11,19.31%,OAT;PSAT1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.25059965316684935,-0.7200248243716536,0.8679245283018868,0.9146112012154745,1.0,1/14,0.33%,SPOCK3
prerank,death receptor binding (GO:0005123),0.3101536120405254,0.7192914294639859,0.8227040816326531,0.9587071753910688,1.0,4/15,28.03%,BID;TMBIM1;CASP8AP2;RIPK1
prerank,GABA receptor binding (GO:0050811),0.3345381884566109,0.7179764099914254,0.8250336473755047,0.9582739199639365,1.0,2/11,10.33%,TRAK1;ARFGEF2
prerank,voltage-gated calcium channel activity (GO:0005245),0.26500555910135704,0.7175768547117948,0.8752808988764045,0.9567996092332819,1.0,7/37,21.48%,CACNA1A;TPCN2;CACNA1D;CACNG7;CACNB3;CACNB1;CACNB4
prerank,TBP-class protein binding (GO:0017025),0.2882635122197488,0.7134782156117815,0.851985559566787,0.9592332399301768,1.0,5/21,27.91%,GTF2A2;DR1;YEATS2;AHR;RUVBL2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.27306869539948186,-0.7111545770003249,0.8396946564885496,0.9167389381670803,1.0,3/11,17.46%,MAP3K7;EGFR;MAP3K5
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.2386995300385738,-0.7111301399792184,0.8737864077669902,0.9091891950197917,1.0,2/16,5.13%,SLC25A17;SLC22A5
prerank,nuclear export signal receptor activity (GO:0005049),0.3290551454041235,0.7065478637576866,0.8508064516129032,0.9646013450027471,1.0,5/11,29.50%,XPO1;EIF4ENIF1;XPO6;NUP42;NUP214
prerank,anion transmembrane transporter activity (GO:0008509),0.31701474590337836,0.7013651653505483,0.8378016085790885,0.9679096447317048,1.0,4/12,18.10%,SLC22A3;SLC26A11;SLC4A2;SLC19A1
prerank,peptide hormone receptor binding (GO:0051428),0.3322941005016769,0.7009495049711489,0.8457300275482094,0.9664643070539292,1.0,2/11,20.40%,VIP;GNRH1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.282797637966372,0.6977072884652046,0.8703703703703703,0.9677650486939989,1.0,5/21,21.18%,AKAP1;ARFGEF2;GSKIP;ARFGEF1;PRRC1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2686444415145096,0.6949720349656675,0.8810623556581986,0.9685103174879528,1.0,8/30,24.65%,ATP7A;SLC39A6;SLC39A7;TMEM165;SLC11A1;SLC39A11;SLC39A1;SLC11A2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.32027509255969244,0.6923277678706726,0.8527027027027027,0.96912768359706,1.0,4/12,21.01%,NUDT5;ENTPD5;ENTPD6;NUDT15
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3101886017903254,0.6911245124955291,0.8751560549313359,0.968352903095697,1.0,7/14,31.88%,MTMR14;MTMR12;MTMR10;MTMR6;MTMR1;PTEN;SYNJ1
prerank,amino acid:sodium symporter activity (GO:0005283),0.3232903483414706,0.6903033915046358,0.8525730180806675,0.9672432768770721,1.0,1/11,1.46%,SLC38A1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.25047863983677043,0.6889706019982182,0.8938547486033519,0.9666483554884812,1.0,5/42,10.73%,CCNY;CCNL1;CCNC;CCNB1;CCNL2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.27973409086106144,0.6872627696367567,0.9008567931456548,0.9663903496227343,1.0,1/21,2.26%,CHRNB2
prerank,SUMO binding (GO:0032183),0.3082418520082051,0.6855902088519831,0.8608923884514436,0.9660507630065939,1.0,2/13,10.00%,USPL1;RNF111
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.27359858533736975,0.6839256470751673,0.8871548619447779,0.9657274506242818,1.0,3/24,13.22%,ZDHHC15;ZDHHC18;ZDHHC1
prerank,histone acetyltransferase activity (GO:0004402),-0.19331052832072393,-0.6765826679121089,0.9565217391304348,0.9356437831705776,1.0,13/30,30.03%,NAA60;KAT2B;KAT5;BRCA2;KAT6B;TADA2A;ARRB1;KAT14;TAF1;CLOCK;KAT6A;KAT2A;NCOA3
prerank,transcription coactivator binding (GO:0001223),0.28008524977145627,0.6744161169652889,0.8953341740226987,0.9723218673490923,1.0,5/20,23.03%,RPL23;PPARD;CCNT2;TERT;AHR
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3199845582858532,0.671637737070758,0.8846675712347354,0.9727752636056831,1.0,4/10,30.39%,EHMT1;SETDB1;ASH1L;SUV39H2
prerank,glutamate receptor binding (GO:0035254),0.2841615699402805,0.6645800980777032,0.897908979089791,0.9770054661765359,1.0,3/17,13.93%,SQSTM1;HIP1;HOMER2
prerank,5'-3' exonuclease activity (GO:0008409),0.2900657071429023,0.6612718543853455,0.8970013037809648,0.9777085386585709,1.0,6/14,32.21%,XRN2;DXO;DCLRE1A;XRN1;TRIR;DCP2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.2607028430373774,-0.6578191754207051,0.9125874125874126,0.9434738084661778,1.0,3/10,11.54%,PKIG;PRKAR2A;PRKAR2B
prerank,NAD binding (GO:0051287),0.2593391018160374,0.6569129584245545,0.9167643610785463,0.9794924251511984,1.0,11/26,31.23%,SORD;NUDT6;SIRT5;HSD17B8;ZC3HAV1;SIRT3;HADH;ME1;SIRT1;PARP9;SIRT2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3059901601663851,0.6482599599522103,0.8789173789173789,0.9844231458618559,1.0,7/10,38.54%,MSL3;HAT1;EP300;NAA50;USP22;KAT8;NAA40
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2532738456138148,0.6463171817429858,0.9221698113207547,0.9839476232455638,1.0,4/26,14.06%,B3GNT3;B3GALNT2;EXTL2;B4GALNT1
prerank,aminopeptidase activity (GO:0004177),0.2530822589657292,0.6434420024189944,0.9135071090047393,0.984200740943852,1.0,7/26,27.02%,ANPEP;BLMH;XPNPEP1;MMP17;METAP1D;LAP3;RNPEPL1
prerank,N-methyltransferase activity (GO:0008170),0.2632691008978825,0.6433174572575023,0.9156327543424317,0.9824384510304015,1.0,6/20,27.24%,PEMT;GNMT;METTL15;RNMT;DIMT1;FDXACB1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2395617017728986,0.6372904036901335,0.9252548131370328,0.9851470857450466,1.0,11/35,32.95%,AARS1;ALKBH1;QTRT1;TRMT13;GATB;TARS2;TRMT5;NT5C3A;TRMT12;LCMT2;DUS4L
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.2752901348187805,0.6299213804422946,0.9075520833333334,0.9885482514408871,1.0,3/15,19.45%,ALDH3A2;ALDH3B1;ALDH1L2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.27867571739310437,0.6281471643337608,0.9178807947019868,0.987948627800376,1.0,6/14,32.91%,SLC7A11;SLC38A7;SLC25A18;SLC17A8;SLC25A22;SLC25A13
prerank,ionotropic glutamate receptor binding (GO:0035255),0.29487127265982305,0.6217494104403373,0.9195250659630607,0.9902993209399044,1.0,1/10,4.39%,SQSTM1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2986911014057896,0.621023953381124,0.9220246238030095,0.9889269869339177,1.0,2/10,9.75%,NAA16;NAA20
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.21970423964610356,0.6179409806887661,0.9657387580299786,0.9890383380569572,1.0,14/55,28.74%,SLC24A4;ATP2B1;PANX1;ANXA6;CACNA1D;TRPM7;TMEM165;GRIN3B;ATP2A2;PKD1L2;ORAI1;TMCO1;ITPR1;PKD2L1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.26127777302766536,0.6170893545933543,0.9351620947630923,0.9877097463670197,1.0,4/18,24.90%,AKR1B10;ALDH3A2;ALDH3B1;HSD17B12
prerank,methyl-CpG binding (GO:0008327),0.2473929609244243,0.6164595801021393,0.9367888748419722,0.9862445372078471,1.0,10/22,37.79%,TET3;PRMT5;CHTOP;LHX4;ZBTB4;UHRF1;PRMT1;ZBTB33;MECP2;MBD1
prerank,O-acyltransferase activity (GO:0008374),0.23246611176167573,0.6152031200029082,0.9590643274853801,0.9852193328853713,1.0,4/30,12.95%,PRDX6;SOAT1;SOAT2;LPCAT3
prerank,palmitoyltransferase activity (GO:0016409),0.24008544632867357,0.6139677046861052,0.9584323040380047,0.9841273949373133,1.0,12/28,38.38%,ZDHHC15;ZDHHC18;ZDHHC1;YKT6;ZDHHC21;ZDHHC6;GOLGA7;HHAT;GOLGA7B;ZDHHC2;ZDHHC8;ZDHHC17
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.281412515868603,0.6135521536895885,0.9233817701453104,0.9825685409534082,1.0,6/12,37.40%,RACK1;APAF1;CASP8AP2;NOD1;ATP2A3;CASP1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2868836818719059,0.607868004153812,0.9299867899603699,0.9840914547136455,1.0,2/11,9.75%,NAA16;NAA20
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.28271009932846314,0.6058679997687236,0.9469387755102041,0.9835091082609301,1.0,3/11,20.16%,ALKBH1;NEIL2;RPS3
prerank,FMN binding (GO:0010181),0.28300577166424545,0.6031424532698869,0.9155313351498637,0.9832303451267881,1.0,2/11,16.98%,POR;MTRR
prerank,phosphoric ester hydrolase activity (GO:0042578),0.21842093602375245,0.6020049985527952,0.9726477024070022,0.9820426898879437,1.0,13/49,22.89%,GDPD3;PTPN22;PRUNE1;ACP3;ATP1A2;DUSP3;SMPD1;DUSP11;DUSP12;DUSP15;PLCXD2;PHOSPHO2;DUSP16
prerank,dynactin binding (GO:0034452),0.27441224512395085,0.6019206521661167,0.9412532637075718,0.9803086716194448,1.0,5/12,32.49%,HTT;HOOK3;GSK3B;BICDL1;SNX5
prerank,adenylyltransferase activity (GO:0070566),0.24705498480455276,0.6011321378950863,0.9513381995133819,0.9789146680895542,1.0,10/21,33.66%,FLAD1;PAPOLA;COASY;NMNAT3;MTPAP;PAPOLG;OASL;TENT4B;TUT1;GPHN
prerank,retinoid binding (GO:0005501),0.24301760351242194,0.5955475793891418,0.9606879606879607,0.9800891928596778,1.0,4/22,28.84%,ABCA4;RBP4;RXRA;RBP1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2684718757438601,0.5874123835540055,0.9342105263157895,0.9823281880572228,1.0,4/12,26.22%,NOCT;CNOT6;PAN2;CNOT6L
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.2582062040709768,0.5857020929850355,0.9536082474226805,0.9814208854319134,1.0,7/14,37.40%,RACK1;APAF1;CASP8AP2;NOD1;ATP2A3;EBAG9;CASP1
prerank,transforming growth factor beta binding (GO:0050431),0.23141164580501375,0.5785617148848954,0.9647630619684082,0.9829885411562629,1.0,4/23,23.00%,WFIKKN1;NRROS;LTBP3;TGFBR2
prerank,death receptor activity (GO:0005035),0.26536314216940404,0.5717643817055171,0.9549668874172186,0.9840624224529282,1.0,1/11,11.70%,TNFRSF1B
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.21546772621130247,0.5651451852292272,0.9769850402761795,0.9831903864744559,1.0,2/34,6.74%,NDUFS7;NDUFA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.21546772621130247,0.5651451852292272,0.9769850402761795,0.9831903864744559,1.0,2/34,6.74%,NDUFS7;NDUFA1
prerank,voltage-gated sodium channel activity (GO:0005248),0.22561115680384797,0.5541683291532576,0.9710843373493976,0.9857253007183125,1.0,3/22,16.28%,SCN4A;SCN1B;SCN3B
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.19167439606100956,-0.551610047766554,0.9673469387755103,0.9921808284183635,1.0,5/14,23.59%,RPP30;ELAC2;POP4;RPP21;RPP14
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2344734751960069,0.5423095028182837,0.9689826302729528,0.9879526523134715,1.0,7/16,31.88%,MTMR14;MTMR12;MTMR10;MTMR6;MTMR1;PTEN;SYNJ1
prerank,microtubule motor activity (GO:0003777),0.19128141724775827,0.5322911309668807,0.9967284623773174,0.9891010506849222,1.0,8/51,17.91%,KIF13B;DNAH8;KIF1A;DNAH3;KIF20A;SMC3;KIFC1;KIF21B
prerank,ribonuclease P activity (GO:0004526),-0.18484146859637512,-0.4756865878814293,0.996031746031746,0.9972522518654634,1.0,4/11,23.59%,RPP30;POP4;RPP21;RPP14
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.20983103822157956,0.46940834958652455,0.996078431372549,0.9996575133079512,1.0,3/13,24.08%,ALDH3A2;ALDH1L2;ADH5
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.18934437353008166,0.45146716828609135,0.9963054187192119,0.999755777911695,1.0,4/20,22.42%,SLC39A6;SLC39A7;SLC39A11;SLC39A1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.20557246965163853,0.43112888153373585,0.9933244325767691,0.9994788205923457,1.0,1/11,12.94%,CNGB1
prerank,R-SMAD binding (GO:0070412),0.1820407115449681,0.4283467843887762,0.9961928934010152,0.9978591606169098,1.0,3/18,26.89%,JUN;PMEPA1;PPM1A
